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Daniel Blanco Melo, Ph.D. 
The Rockefeller University 2016 
About 8 and 10 percent of the human and mouse genomes, respectively, are 
comprised of sequences of retroviral origin. Occasional infection of germ line 
cells can lead to integrated retroviral genomes being vertically inherited as host 
alleles. During thousands to millions of years, some of these sequences acquired 
inactivating mutations and were fixed in ancestral populations by genetic drift, 
while others became fixed by providing an evolutionary advantage to the host. 
Those inherited proviruses are termed endogenous retroviruses (ERVs) and 
have been identified in a variety of animal species representing an extensive viral 
“fossil” record of past retroviral infections. With the advent of whole genome 
sequencing projects and high throughput sequencing platforms, it became 
evident the wide diversity and the important role that these sequences have had 
in the evolution of their hosts. In the present study we developed a computational 
framework to identify ERVs in primate and murine genomes. The results of these 
genome screenings were used to identify suitable candidate sequences in which 
to perform paleovirological analyses that lead to the successful reconstruction of 
two ancient retroviruses. 
MuERV-L is an env-deficient highly abundant mouse specific ERV that has 
undergone two amplification bursts, being the more recent and prolific ~2 million 
years ago (MYA), probably through entirely intracellular mechanisms. MuERV-L 
is transcriptionally active at the two-cell stage of the mouse embryo and recent 
studies have implicated the co-option of its LTR as a promoter for totipotency 
genes. In the present work, we describe the analysis and reconstruction of an 
infectious ancestral MuERV-L (ancML) sequence through paleovirological 
analyses of MuERV-L elements in the mouse genome. The resulting ancML 
sequence was infectious in CHO cells and its replication was dependent on 
reverse transcription. We found that IFN-α could reduce ancML replication by 
~20 fold. Additionally, we found that the expression of mouse APOBEC3 was 
able to restrict the replication of ancML. However, inspection of endogenous 
MuERV-L sequences suggested that the impact of APOBEC3 mediated 
hypermutation on MuERV-L evolution was limited. We discussed the possibility 
that type I IFN responses (maybe through restriction factors) might inhibit 
MuERV-L replication at the two-cell stage of the mouse embryo and have kept 
MuERV-L copy numbers under control. 
Although no extant human gammaretroviruses have been identified, HERV-T is a 
low copy primate ERV lineage that is closely related to the gammaretrovirus 
genus. Through phylogenetic and genomic analysis of HERV-T insertions we 
defined three distinct lineages. Two lineages (HERV-T1 and HERV-T2) entered 
the primate germline after the Old World monkey-ape split about ~32-30 MYA, 
whereas the other (HERV-T3) entered before this divergence ~40 MYA. 
Phylogenetic analysis of complete (LTR-gag-pol-env-LTR) proviral sequences 
showed that HERV-T2 was subjected to APOBEC3 mediated hypermutation, and 
subsequently expanded in apes, most likely through retrotransposon-like 
mechanisms. Phylogenetic and statistical analysis of HERV-T3 proviruses 
allowed us to estimate the sequence of their ~32 MY old ancestor, revealing that 
its unusually long leader sequence encoded a 855-nucleotide ORF separated 
from gag by 36 nucleotides. This pre-gag ORF of unknown function putatively 
codes for a protein that includes a transmembrane domain. Additional analysis of 
the HERV-T3 ancestral sequence allowed us to reconstruct the corresponding 
env sequence (ancHTenv). We found that a modern gammaretrovirus (MLV) 
could be pseudotyped with ancHTenv enabling it to infect a wide variety of 
primate cell lines with titers that are similar to MLV particles carrying the 
amphotropic MLV envelope. A single HERV-T proviral insertion in the genome of 
all great apes contains an env gene with full coding potential. Proteins encoded 
by the extant human HERV-T envelope gene (HsaHTenv) and one estimated to 
be encoded by the hominid ancestor were not able to generate infectious MLV 
pseudotyped particles, probably because HsaHTenv is not correctly processed 
into its mature and functional form. Statistical and phylogenetic analyses indicate 
that the env gene in this locus is evolving slower than the rest of the proviral 
sequences, and that selective pressures have acted on this locus to conserve its 
envelope sequence. Remarkably, we found that expression of the HsaHTenv 
was able to specifically block infection by MLV particles pseudotyped with the 
ancHTenv, but not particles pseudotyped with the amphotropic MLV 
envelope. Additionally, we identified MOT1 as the receptor used by ancHTenv. 
Further experiments are needed in order to test the hypothesis that HsaHTenv 
served as a restriction factor through interference with the receptor once used by 
HERV-T. 
As paleovirology also studies the evolution of the host defense mechanisms that 
have been shaped by past retroviral infections, we investigated the origins and 
evolution of tetherin, an orphan antiviral protein with no known homologs. We 
found that tetherin function is encoded by genes that exhibit no sequence 
homology and share only a common architecture and location in modern jawed 
vertebrate genomes, indicating an origin of ~450 MYA. Moreover, tetherin is part 
of a cluster of three potential sister genes that includes pv1 and a putative gene 
of unknown function, here referred as tm-cc(at), which encode proteins of similar 
architecture. Some variants of these proteins exhibit antiviral activity while others 
can be endowed with antiviral activity following a simple modification. Only in a 
slowly evolving species (coelacanths) does Tetherin exhibit homology to TM-
CC(aT). We suggest that neofunctionalization, drift and positive selection drove a 
near complete loss of sequence similarity among modern tetherin genes, and 
between tetherin and its sister genes. Scenarios by which this orphan gene may 
have arisen and evolved exemplify how protein modularity, evolvability and 
robustness can create new functions and preserve them, despite sequence 
divergence due to genetic conflict with past and present viruses. 
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Chapter I. Introduction 
Viruses are the most abundant biological entities on the planet (Edwards and 
Rohwer, 2005) accounting for approximately 94% of all nucleic-acid containing 
particles present in the oceans (Suttle, 2007). It is estimated that there are in total 
1031 viruses on Earth (Breitbart and Rohwer, 2005), and have been found 
infecting organisms from each of the three domains of life (Koonin et al., 2006). 
Although there is still a debate as to whether viruses originated before or after the 
last universal cellular ancestor (Forterre, 2006; Holmes, 2011; Koonin et al., 
2015), the fact is that viruses have existed for many millions of years. Unlike 
other organisms, viruses have not left a physical fossil record by which 
researchers can document the existence of an extinct lineage or follow their 
evolutionary path from an ancient specie into a modern one throughout millions 
of years (MY).  This fact was generally accepted until integrated retroviral 
sequences were found in normal chicken and mouse embryos in the late 1960s 
(Aaronson et al., 1969; Weiss, 1967; Weiss, 2006). Since then, and with the 
advent of whole genome projects and high throughput sequencing platforms, the 
wide diversity of viral sequences present in animal genomes and the important 
role that these sequences have had in the evolution of their hosts became 
evident. Currently, integrated sequences (known as endogenized viral 
sequences) for almost all classes of viruses have been found in different 
eukaryotic genomes (Aiewsakun and Katzourakis, 2015). However, there is one 
group of viruses that outnumber all the rest, the retroviruses. 
	   2 
Retroviruses: structure, classification and replication. 
The Retroviridae family is composed of positive-sense RNA enveloped viruses 
with two obligate and defining features: (i) the synthesis of a DNA intermediate 
from an RNA genome (a process termed reverse transcription), and (ii) the 
integration of their genetic information into the host genome (resulting in a 
structure termed provirus) (Coffin et al., 1997). This mandatory integration step 
creates a unique and intimate relationship between the virus and the host that 
has shaped the evolution of both entities, and it is the reason why the vast 
majority of endogenous viral elements (EVEs) in animal genomes are from 
retroviral origin. 
Retroviruses can be classified into simple or complex depending on the gene set 
they encode. The minimal structure of the provirus of a simple retrovirus is 
depicted in (Figure 1.1A): 
Long Terminal Repeats (LTR): Direct repeats found flanking the internal 
sequence of a provirus and it is subdivided into three regions. U3 is a sequence 
unique to the 3’ end of the viral genome that promotes the transcription of the 
provirus by containing a RNA polymerase II (RNAP II) promoter and several 
binding sites for transcription factors. The R region is a short sequence repeated 
in both 5’ and 3’ ends of the viral genome. It is involved in strand transfer during 
reverse transcription (see below) and contains signals involved in the 
genomic/mRNA 3’ end cleavage and polyadenylation. U5 is a sequence unique 
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to the 5’ end of the viral genome and contains signals that promote transcriptional 
termination and polyadenylation (Bohnlein et al., 1989; Fields et al., 2001).  
gag (stands for group-specific antigen): Encodes a polyprotein that is cleaved to 
produce the internal structural proteins of the virus (Figure 1.1A and C). The Gag 
polyprotein contains at least three proteins: matrix (MA), which is N-terminally 
myristoylated and targets particle assembly to the plasma membrane (possibly 
through interaction with host tRNAs) (Bieniasz, 2009; Kutluay et al., 2014); 
capsid (CA), which forms the internal virion core; and nucleocapsid (NC), which 
binds to viral genomic RNA and drives genome packaging into virions (Kutluay et 
al., 2014; Pedersen et al., 2011).   
pol: Encodes non-structural proteins required for viral replication (Figure 1.1A 
and C). The Pol polyprotein is incorporated into viral particles joined to Gag and it 
contains: the reverse transcriptase (RT), involved in viral replication and shows 
RNA- and DNA-dependent DNA polymerase and RNase H activities (Champoux 
and Schultz, 2009); and integrase (IN), which mediates the integration of the viral 
DNA into the host genome (Fields et al., 2001; Pedersen et al., 2011). In some 
retroviruses pol also encodes for a third protein, the protease (PR), which drives 
the processing of the Gag and Gag-Pol polyproteins into their functional units 
during particle maturation (Sundquist and Krausslich, 2012). PR can also be 
fused to the 3’ end of the gag gene or encoded by a separate ORF between gag 
and pol (Coffin et al., 1997) (Figure 1.1D).  
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env: Encodes the viral envelope, which interacts with cellular receptors leading to 
the fusion of the viral and cell membranes resulting in virus entry.  The env gene 
is expressed from a different subgenomic mRNA that is joined to a 5’ leader 
sequence by splicing, removing the gag and pol genes (Fields et al., 2001) 
(Figure 1.1A). An N-terminal short hydrophobic signal peptide leads the 
translocation of the Env precursor into the lumen of the endoplasmic reticulum 
(ER) (stopping at its transmembrane domain), where it is glycosylated, folded 
and oligomerized (Figure 1.1B). In order to drive membrane fusion, the 
oligomerized Env precursor needs further proteolytic processing into surface 
(SU) and transmembrane (TM) proteins (Figure 1.1A, B and C) (Coffin et al., 
1997), mediated by the host protease furin in the Golgi apparatus (Hallenberger 
et al., 1992; Stein and Engleman, 1990). This cleavage allows the hydrophobic 
fusion peptide (located in the N-terminus of the TM protein) to mediate fusion of 
the cellular and viral membranes after the specific SU-receptor interaction 
(Pedersen et al., 2011) (Figure 1.1B). 
Some retroviruses also include another gene encoding for a dUTPase in distinct 
locations. The product of this gene reduces the incorporation of dUTP into viral 
DNA, which could induce mutations during viral replication (Lerner et al., 1995). 
Moreover, all retroviruses contain additional signals that are necessary for 
reverse transcription, such as the primer binding site (PBS) and the polypurine 
tract (PPT) (see below), genome packaging such as the packaging signal (psi or 
Ψ) recognized by NC, and other regulatory elements (Figure 1,1A).  
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In addition to all these major components, complex retroviruses also encode for 
“accessory” genes (Figure 1.1D), which in general encode proteins that regulate 
and coordinate viral gene expression, RNA processing, inhibit host defenses and 
other secondary roles. Accessory genes can be located in different regions of the 
viral genome between distinct retroviruses and they are all expressed from 
spliced RNAs (Figure 1.1D).  
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Figure 1.1: Retroviral genome and particle structure.  
(A) Structure of a simple provirus, viral genomic RNA/mRNA, spliced mRNA and 
main protein products. Refer to main text for gene and protein symbols. PBS: 
primer binding site (orange box). PPT: polypurine tract (clear blue box). Ψ: 
packaging signal. SD: splice donor site. SA: splice acceptor site. AAAn: 3’ poly(A) 
tail. 5’ cap is shown as a dark blue half circle. Grey, cyan and purple boxes 
indicate U3, R and U5 regions of the LTR, respectively. (B) Organization and 
processing of the MLV Env glycoprotein. Amino acid positions of each processed 
segment is shown below the black line. Red and orange boxes indicate signal 
and fusion peptides, respectively. Host and viral protease cleavage events are 
shown as blue and white thunderbolts, respectively. (C) Structure of a retroviral 
particle indicating viral proteins described in (A). (D) Genome structures of simple 
and complex retroviruses. ORFs in the same frame are shown in the same line. 
Dashed lines indicate spliced introns. (A and C) adapted from Pedersen et al., 
2006. (B and D) adapted from Coffin et al., 1997. 
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Figure 1.1: Retroviral genome and particle structure. 
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Phylogenetic relationships, based on RT, reveal that the retroviral diversity 
cluster into three distinct clades, also termed classes (although this term does not 
refer to a taxonomic designation) encompassing seven genera (Fields et al., 
2001; International Committee on Taxonomy of Viruses. et al., 2012; Llorens et 
al., 2008) (Figure 1.2): (i) Epsilonretriviruses (class I, prototype: Walleye Dermal 
Sarcoma Virus (WSDV)) are complex retroviruses characterized by a C-type 
morphology (symmetrical spherical inner core) that infect fish and reptile species. 
(ii) Gammaretroviruses (class I, prototype: Murine Leukemia Virus (MLV)) 
constitutes the largest genus known, with members being simple retroviruses that 
infect mammals, birds and reptiles, and show a C-type morphology. (iii) 
Lentiviruses (class II, prototype: Human Immunodeficiency Virus (HIV)) are 
complex retroviruses characterized by having cylindrical or conical cores that 
infect mammalian species. (iv) Deltaretroviruses (class II, prototype: Human T-
cell Lymphotropic Virus (HTLV) comprise a few complex retroviruses with a C-
type morphology that infect some mammalian species. (v) Alpharetroviruses 
(class II, prototype: Avian Leukemia Virus (ALV)) are simple retroviruses with a 
C-type morphology that infect a wide range of avian species. (vi) Betaretroviruses 
(class II, prototype: Mouse Mammary Tumor Virus (MMTV)) are simple 
retroviruses characterized by a B-type (round eccentric core) or D-type 
(cylindrical core) morphology that assembles in the cytoplasm and have 
members infecting rodents, primates and sheep. (vii) Spuma- and spuma-like 
retroviruses (class III, prototype: Simian Foamy Virus (SFV) and Human 
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Endogenous Retrovirus-L (HERV-L) respectively) comprise a broad genus that 
contains the spumaviruses, which are complex retroviruses with a central but 
uncondensed core and, in contrast with the rest of the retroviruses, are able to 
undergo reverse transcription prior to infection (therefore having double stranded 
DNA (dsDNA) in the viral particle). Spuma-like retroviruses are simple 
endogenous retroviruses (ERVs) that are distantly related to spumaretrovirus and 
in some cases lack the env gene resulting in an entirely intracellular replication 
(ERV-L lineage) (Benit et al., 1999). 
In order to enter a cell, all retroviruses require an interaction between the Env 
(SU) protein and a host cell surface molecule, the receptor (Figure 1.3A). This 
interaction is highly specific as minor changes in the receptor binding site can 
completely block viral infection (Albritton et al., 1993). The conservation, 
expression and distribution of suitable surface receptors determine the tissue and 
species tropism of the virus, as well as its pathogenesis. Retroviral receptors 
vary in their nature, structure and cellular function depending on the virus group. 
There are single-pass or multiple-pass transmembrane receptors (Albritton et al., 
1989; Dalgleish et al., 1984), as well as secreted (Anderson et al., 2000) and 
glycosylphosphatidylinositol (GPI) anchored receptors (Rai et al., 2001) (Figure 
1.4). Additionally, some retroviruses require more than one molecule (co-
receptors) for entry (Overbaugh et al., 2001). Once it is correctly folded, 
glycosylated and oligomerized (in the ER), the single-pass transmembrane Env 
precursor is capable to interact with its receptor if encountered along the 
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secretory pathway. This interaction prevents the transport and expression of the 
receptor at the cell surface (Delwart and Panganiban, 1989; Matano et al., 1993; 
Nethe et al., 2005), and might lead to its degradation (Coffin et al., 1997). This 
phenomenon is known as receptor interference (or blockage) and plays a key 
role in superinfection resistance, where the production of an Env protein from an 
initial viral infection interact with its receptor (within the secretory pathway or at 
the cell surface) and prevents superinfection by a second virus that uses the 
same receptor (Coffin et al., 1997; Nethe et al., 2005). This property allowed 
virologists to assigned viruses to specific subgroups depending on their receptor 
usage (Sommerfelt and Weiss, 1990). For MLV the determinants for the receptor 
usage lie largely in two variable regions in its SU protein (Battini et al., 1998; 
Battini et al., 1992), which results in four groups depending on its receptor: 
ecotropic (MLV-E, infecting mouse and rat cells), amphotropic (MLV-A, infecting 
mouse, human and other cells), xenotropic (MLV-X, infecting non-murine cells) 
and dualtropic or polytropic (MLV-P, infecting murine and mink cells) (Weiss and 
Tailor, 1995). Similarly HIV is classified into X4 tropic, R5 tropic or dual tropic 
depending on its co-receptor usage (Berger et al., 1999). The determinants for 
different co-receptors are largely found in the V3 loop of the SU protein (Hwang 
et al., 1991; Shioda et al., 1991). 
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Figure 1.2: Retroviral diversity and classification. 
Unrooted Pol neighbor joining (NJ) dendrogram of the seven retroviral genera 
and major classes (including endogenous and exogenous retroviruses). 
Phylogenetic location of the Gypsy transposon from the metaviridae family of 
retroviruses (errantiviruses) is also shown. Host species are indicated by 
symbols. Adapted from Jern et al., 2005 to include the classes described in 
Llorens et al., 2008.   
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Figure 1.3: Steps in the retroviral life cycle. 
Main steps in the retroviral life cycle from entry to viral production and maturation. 
(A) Receptor interaction, (B) membrane fusion and entry, (C) uncoating, (D) 
reverse transcription, (E) nuclear import, (F) integration, (G) mRNA/gRNA 
expression and export, (H) protein synthesis, (I) virion assembly, (J) budding and 
(K) maturation. Different steps are described in the main text. Gag and PR: gray 
forms. Pol: IN (red stars), RT (orange circles). Env: SU (Pink ellipse), TM (gray 
stem). A hypothetical multi-pass receptor is colored in blue. Viral RNA and DNA 
are colored in black and dark blue respectively. Adapted from an original figure 
kindly provided by Dr. Theodora Hatziioannou.  
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In contrast to other retroviral genera, all gammaretroviruses receptors have been 
identified to be multi-transmembrane solute transporters (Tailor et al., 2003) 
(Figure 1.4). This is the case of CAT-1 (cationic aminoacid transporter 
1)(Albritton et al., 1989), a 14 transmembrane glycoprotein that mediates the 
transport of basic amino acids through the cell membrane and was identified as 
the MLV-E receptor (Figure 1.4A). Functional (amino acid transporters) CAT-1 
orthologs are expressed at the cell surface of diverse animal species but specific 
residues at the third extracellular loop (envelope binding site) and particular 
glycosylation sites are responsible for the species tropism (Albritton et al., 1993; 
Wang et al., 1996). XPR1, an 8 transmembrane glycoprotein that mediates 
phosphate export from the cell (Legati et al., 2015), was found to be the receptor 
for both MLV-X and MLV-P (Battini et al., 1999; Tailor et al., 1999; Yang et al., 
1999) (Figure 1.4A) and, as for CAT-1, a couple extracellular residues mediate 
recognition or resistance to MLV-X and/or MLV-P (Marin et al., 1999). ASCT2 
(also known as SLC1A5 or RDR) is an exceptional 10 transmembrane sodium-
dependent amino acids transporter that has been identified as the receptor for 
highly divergent gammaretroviruses (including some ERVs) and some 
betaretroviruses (Blond et al., 2000; Overbaugh et al., 2001; Sommerfelt and 
Weiss, 1990) (Figure 1.4A). Similarly, the Pit1 (a 12 transmembrane phosphate 
transporter) receptor is shared between GaLV (gibbon ape leukemia virus), 
WMSV (woolly monkey sarcoma virus) and some subtypes of FeLV (feline 
leukemia virus) (Overbaugh et al., 2001), whereas the related Pit2 glycoprotein 
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was determined as the receptor for MLV-A (Miller et al., 1994; van Zeijl et al., 
1994) (Figure 1.4A). Other transporter multi-transmembrane gammaretrovirus 
receptors have been identified including for some ERVs (Soll et al., 2010; Tailor 
et al., 2003) (Figure 1.4A).  
 
Figure 1.4: Retroviral Receptors 
(A) Gammaretrovirus receptors. (B) Other retrovirus receptors. In all cases the 
protein name and the virus name are indicated below and above of each receptor 
diagram. For HIV both the receptor (CD4) and co-receptor (CCR5/CXCR4) are 
shown. Image adapted from Tailor et al., 2003. 
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HIV and other related lentiviruses typically require two receptor molecules for 
viral entry: the single transmembrane receptor CD4, that mediates binding to the 
SU protein (Dalgleish et al., 1984; Klatzmann et al., 1984; Sattentau et al., 1988), 
and a multi-transmembrane co-receptor CCR5 (R5 tropic) or CXCR4 (X4 tropic) 
(Alkhatib et al., 1996; Feng et al., 1996) (Figure 1.4B). Binding to CD4 leads to a 
conformational change that exposes the binding site to the co-receptor, which 
functions as a fusion receptor (Salzwedel et al., 2000). CCR5 and CXCR4 are 
chemokine receptors, while CD4 plays an essential role in the adaptive immune 
response (DeFranco et al., 2007) and is primarily expressed on helper T-cells, 
macrophages, and dendritic cells (Maddon et al., 1986) therefore explaining the 
limited cell tropism of HIV. Intriguingly and correlated with disease progression, it 
has been documented that HIV can shift its co-receptor usage resulting in 
differential CD4+ T cell depletion in specific cellular compartments (Connor et al., 
1997; Ho et al., 2005).  
Although a pH-dependent endocytic pathway seems to be required for some 
betaretroviruses (Wang et al., 2008), alphaviruses (Padilla-Parra et al., 2014) and 
spumaviruses (Picard-Maureau et al., 2003), membrane fusion for most 
retroviruses occurs at the plasma membrane without the need of an acidic 
environment. They undergo complex conformational changes upon receptor 
binding resulting in the SU–TM complex dissociation that expose the fusion 
peptide, leading to the invasion of the target membrane and membrane fusion 
(Coffin et al., 1997; Pedersen et al., 2011) (Figure 1.3B). The events following 
	   16 
membrane fusion are still not completely clear, however in order to continue with 
infection, the retroviral cores need to disassemble in a process known as 
uncoating (Figure 1.3C). For lentiviruses some studies suggest that the core 
does not disassemble until it docks at the nuclear pore (Arhel et al., 2007), while 
others suggest that the uncoating of retroviral cores occurs along the transport of 
the viral genome to the nucleus and is stimulated by reverse transcription (Hulme 
et al., 2011; McDonald et al., 2002). Furthermore HIV CA (thus some kind of a 
core) seems to play a role in nuclear import and infection in non-dividing cells by 
its interaction with various nuclear transport proteins and the nuclear pore 
(Matreyek and Engelman, 2013). Whichever the model there is not a clear 
distinction between the timing of uncoating, reverse transcription and nuclear 
import (Figures 1.3C, D and E) (Campbell and Hope, 2015). In contrast to 
lentiviruses, gammaretroviruses are cell-cycle dependent and require the 
dissociation of the nuclear membrane during mitosis in order to access the 
nuclear DNA (Roe et al., 1993). 
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Figure 1.5: Retroviral reverse transcription and Integration. 
 (A) Reverse transcription process. Steps for the RT-dependent synthesis of the 
dsDNA provirus from a ssRNA viral genome (vgRNA). Diverse viral genomic 
features are indicated as well as the tRNA primer. Steps (i-vi) are described in 
the main text. RNA: light black line. DNA: thick black line. (B) Integration process. 
IN-mediated cleavage and ligation of dsDNA produced in (A) and host DNA. 
Subsequent repair by host enzymes results in a fully integrated provirus. The 
short direct repeat flanking the provirus is shown by vertical lines (||||). Images 
adapted from Pedersen et al., 2006.  
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As infection proceeds, the viral RNA genome needs to be reverse transcribed 
into dsDNA by the action of the viral RT (Baltimore, 1970; Temin and Mizutani, 
1970)(Figures 1.3D and 1.5A). Briefly: (i) A partially unfolded tRNA (different 
tRNA primers are used by distinct retroviruses (Lund et al., 1993)) anneals to the 
PBS of the viral genomic RNA (vgRNA) and (ii) leads to the synthesis of minus-
strand DNA until the 5’ end of the RNA genome, an intermediate termed minus-
strand strong-stop DNA (-sssDNA). (iii) RNase-H degrades the RNA strand of the 
-sssDNA-vgRNA duplex leading to the first strand transfer, where the -sssDNA 
anneals to the R sequence on the cognate 3’ end of the vgRNA (facilitated by NC 
(Rein, 2010)) and (iv) minus-strand DNA synthesis resumes. (v) RNase-H 
degrades the remaining RNA strand except for the duplex (RNA-DNA) 
corresponding to the PPT, which is resistant to RNase-H. The RNA portion of the 
PPT duplex serves as a primer for the plus-strand DNA synthesis that continues 
until a portion of the tRNA primer is reverse-transcribed, resulting in a DNA 
intermediate termed plus-strand strong-stop DNA (+sssDNA). (vi) RNase-H 
degrades the primer tRNA, leading to the second strand transfer, where the 
+sssDNA anneals to complementary sequences to the PBS at the 3’ end of the 
minus-strand DNA (facilitated by NC). Subsequent plus and minus strand DNA 
synthesis results in a complete provirus structure with two LTRs (Coffin et al., 
1997; Fields et al., 2001; Pedersen et al., 2011). Besides strand transfer to the 
ends of the viral genome, RT also shows frequent template shifting at internal 
positions when two heterologous sequences are packaged in the same viral 
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particle (DeStefano et al., 1992; Katz and Skalka, 1990). This internal template 
switching depends on the structure of the donor and acceptor templates and its 
favored by the stalling of the RT (Buiser et al., 1993; Duch et al., 2004).  Co-
infection by two or more viruses (or expression of ERVs) might lead to 
recombination through this internal template switching. In fact it has been 
observed that in multiple occasions, a gammaretroviral env gene recombined 
with other class I retroviruses, which might have facilitated cross-species 
transmissions (even among different vertebrate classes) by the change in their 
tropism (Henzy and Johnson, 2013). This ability to form “mosaic” species 
together with the RT error rate (for HIV-1 is 2 × 10−5 substitutions per site per 
replication cycle and it is similar for other retroviruses (Hu and Hughes, 2012)) 
have resulted in the high diversity observed for retroviruses. 
After reverse transcription the newly synthesized viral dsDNA forms a complex 
with various viral and host proteins named the pre-integration complex (PIC) 
(Craigie and Bushman, 2014). Once inside the cell nucleus (discussed above), 
the PIC will guide the viral dsDNA to its integration into the host genome as an 
essential step in the viral life cycle (Figure 1.3F). The integration site preference 
seems to vary between retroviruses. Whereas lentiviruses preferred to integrate 
into active transcription units (Schroder et al., 2002), gammaretroviruses favor 
integration close to transcription start sites (Wu et al., 2003), while for other 
viruses such as alpharetroviruses integration seems to be almost random (Barr 
et al., 2005). The principal viral protein in the PIC is IN, which in addition to 
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mediating the enzymatic process of DNA integration, seems to be also a major 
determinant for integration site preference (Lewinski et al., 2006). Additional 
cellular co-factors, specifically LEDGF/p75 and BET proteins, have been 
implicated in the integration site preference by interacting with HIV and MLV IN, 
respectively, and tethering the viral intasome (IN in complex with viral dsDNA) to 
particular chromatin regions (Debyser et al., 2015). Once the intasome is docked 
to the targeted chromatin, IN catalyze the initial steps in the integration reaction 
(Figure 1.5B). Briefly, the dsDNA is first cleaved at the 3’ end of each strand to 
form a two-nucleotide 5’ overhang. Mediated by IN, the exposed 3’ hydroxyl 
groups on the viral DNA promote a nucleophilic attack on phosphodiester bonds 
located in both strands of the target DNA and staggered by 4-6 bp (strand 
transfer reaction), resulting in the cleavage of host DNA and the joining of viral 
DNA 3’ ends to the host genome (Kvaratskhelia et al., 2014). This reaction 
leaves DNA gaps at each host-proviral DNA junction that are repaired by cellular 
enzymes resulting in a 4-6 bp duplication of host DNA (Craigie and Bushman, 
2014). Once integrated, the proviral DNA is then replicated together with cellular 
DNA during cell division and now evolves at the host substitution rate (assuming 
no selective pressures) (Feschotte and Gilbert, 2012). The inherent mutagenic 
potential of retroviral integration might result in the truncation or inactivation of 
host genes, as well as in the expression of tightly regulated genes, partially 
explaining the oncogenic capability of some retroviruses.  
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From its location in the host genome, the provirus is expressed and transcribed 
as a cellular gene. As described previously promoter and enhancer elements 
present in the U3 region of the 5’ LTR initiate transcription of the vgRNA/mRNAs 
by the host RNAP II (Figure 1.3G). The RNAs are 5’ capped (7-methyl-
guanosine) and a poly(A) tail is added after particular sequences in the 3’ LTR 
determining the end of the R region. In addition, complex retrovirus might encode 
transcriptional transactivators, such as HIV Tat, that bind to RNA structures in the 
5’ end of the RNA and stimulate RNAP II processivity, resulting in increased 
elongation of the transcripts towards the end of the provirus (Sodroski et al., 
1985a; Sodroski et al., 1985b). Retroviral RNAs also contain splice donor and 
acceptor sites that are recognized by the cellular splicing machinery to produce 
the env and other accessory genes mRNAs. These spliced, partially spliced and 
complete mRNAs/vgRNAs need to be exported outside the nucleolus to start 
protein synthesis (Figure 1.3G). The cellular nuclear export pathway is highly 
selective letting only fully spliced mRNAs to reach the cytoplasm (Legrain and 
Rosbash, 1989). This phenomenon affects complex retroviruses that, in 
comparison to simple retroviruses, produce a range of unspliced, incompletely 
spliced and multiply spliced mRNAs (Figure 1.1D). For this reason some 
accessory genes of complex retroviruses also encode for proteins (such as HIV-1 
Rev, HTLV-1 Rex, MMTV Rem and HERV-K Rec) that facilitate the nuclear 
export of unspliced or partially spliced viral RNAs and regulate their temporal 
expression (Mertz et al., 2009).   
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Whereas Env will be expressed, glycosylated, folded, oligomerized and 
processed as previously described, Gag and Gag-Pol polyproteins (as well as 
other accessory proteins) are translated in the cytoplasm by free ribosomes 
(Figure 1.3H).  Expression of the Gag-Pol polyprotein requires the translational 
suppression of the Gag stop codon.  Depending on the reading frame where Pol 
is encoded (Figure 1.1D), different retroviruses resolve this issue by read-through 
suppression (where a specific aminoacyl-tRNA is placed at the stop codon in the 
ribosome instead of the release factor, allowing for translation to resume) or 
frameshift suppression (where the ribosome undergoes a frame shift at a 
slippage region upstream of the stop codon, allowing for translation to resume in 
the alternative frame), mediated by specific RNA elements around the Gag stop 
codon (Pedersen et al., 2011).  
The majority of retroviruses undergo particle assembly directly at the cell 
membrane (except for retroviruses with a B- and D- type morphology) (Fields et 
al., 2001) (Figure 1.3I). The Gag polyprotein pays the major role in assembly and 
is able to form particles even in the absence of pol or env (Campbell and Vogt, 
1997; Delchambre et al., 1989). Additionally, Gag mediates the packaging of 
most of the particle components, including Pol (in the form of Gag-Pol 
polyprotein), vgRNA and other RNAs (Coffin et al., 1997; Kutluay et al., 2014). 
MA targets particle assembly to the plasma membrane through its N-terminal 
myristate group and a basic amino acid motif, which mediate a direct interaction 
with the plasma membrane and the binding to specific phospholipids (Saad et al., 
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2006). Further Gag multimerization and possible relocation into lipid rafts and 
other membrane microdomains results in particle formation (Ono, 2010). As for 
the Env protein, which reached the plasma membrane though the secretory 
pathway, it is not completely clear how they get incorporated into the nascent 
particles. HIV-1 MA seems to interact and recruit Env proteins through its 
cytoplasmic tail, however this interaction is not essential for Env incorporation 
(Sundquist and Krausslich, 2012). Moreover, the process of Env incorporation is 
promiscuous and retroviruses can form (pseudotyped) viral particles carrying Env 
proteins from distantly related retrovirus or even from other viral families, arguing 
against specific determinants for Env incorporation.  Another possibility that has 
been proposed is that both Gag and Env proteins are directed to the same 
microdomains in the plasma membrane (Briggs et al., 2003), however there is 
not a clear understanding of this process. 
At this point the nascent viral particles need to detach from the cell membrane 
(Figure 1.3J). The budding process requires the recruitment of the host ESCRT 
machinery that stop Gag multimerization and catalyzes the excision of the cell 
and viral membranes (Sundquist and Krausslich, 2012). This recruitment is 
dependent on “late” domains encoded by retroviral proteins (and proteins form 
other viruses) that bind directly or indirectly to members of the ESCRT pathway 
(Bieniasz, 2006), leading to particle release. The remaining step in the retroviral 
life cycle is the maturation of the virions (Figure 1.3K), where the viral PR is 
liberated by autoproteolysis at a late stage of the viral assembly and mediates 
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the cleavage of the Gag and Gag-Pol precursors into their individual proteins 
(Pettit et al., 1998). This process leads to the assembly of CA to form the core 
structures (Ganser-Pornillos et al., 2008). In gammaretrovirus, PR also catalyzes 
the cleavage of the R-peptide at the Env C-terminal tail (Figure 1.1B), which 
activates the fusogenic potential of the TM protein (Rein et al., 1994). This 
maturation step perhaps represents a regulatory process by which retroviruses 
prevent reinfection of the producer cell (Pedersen et al., 2011). Indeed after this 
process the result is a fully infectious retroviral particle that has the ability to 
interact with its receptor on another cell and restart its life cycle (Figure 1.3). 
This complex, and still not too entirely clear, series of events provide the host 
with several opportunities to counteract the detrimental effects of viral infection. 
In this regard the genetic conflict between viruses and their hosts has lead to the 
evolution of clever and efficient defense mechanisms by which both entities are 
trying to win the battle. 
 
Retroviral Restriction Factors. 
Of all the different antiviral mechanisms shown by the host, the first molecular 
lines of defense against viral infections are the restriction factors, which directly 
inhibit and disrupt essential steps for viral replication. In general, restriction 
factors share some common features (Blanco-Melo et al., 2012; Malim and 
Bieniasz, 2012): (i) They are dominantly and autonomously acting proteins that 
exhibit antiviral activity in simple cell-culture based assays. (ii) They are typically 
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expressed constitutively in some cell types, and/or are further induced by 
interferons (IFNs). (iii) They employ unique and unanticipated mechanisms to 
inhibit specific processes in viral replication. (iv) They have unusually diverse 
amino acid sequences as a consequence of antagonistic co-evolution with 
viruses (signatures of positive selection). (v) They can be antagonized by viral 
proteins or specific mutations.  
The number of proposed restriction factors has exploded since the term was 
established in the early 1970s, when the expression of Fv1 was shown to protect 
against MLV infection (Lilly, 1970), and particularly since the discovery of the first 
restriction factor against HIV (Sheehy et al., 2002). Currently there are more than 
20 proteins that have been proposed to serve as restriction factors against a 
variety of animal viruses (Kluge et al., 2015). For the purposes of this chapter a 
number of restriction factors were selected that have been of interest to 
subsequent studies in this thesis (Table 1.1).  
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Table 1.1: Selected Retroviral Restriction Factors 
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(i) APOBEC3: APOlipoprotein B Editing Catalytic subunit-like 3 (APOBEC3) G 
was first characterized as the restriction factor antagonized by the HIV-1 Vif 
accessory protein (Sheehy et al., 2002). It is incorporated into virions and 
exhibits antiviral activity in target cells by catalyzing the deamination of 2’-
deoxycytidine (dC) to 2’-deoxyuridine (dU) on minus-strand DNA during 
reverse transcription, mediated by its cytidine deaminase domain (Yu et al., 
2004). This change leads to guanine (dG) to adenosine (dA) mutations in the 
proviral DNA (APOBEC3-mediated hypermutation), rendering it replication 
defective.  The human genome encodes for seven APOBEC3 proteins from 
which APOBEC3A, APOBEC3B, APOBEC3D, APOBEC3F, APOCE3G and 
APOBEC3H have been shown to significantly decrease primate lentivirus 
infection (Bishop et al., 2004), through hypermutation and deamination-
independent mechanisms (Gillick et al., 2013; Holmes et al., 2007). HIV-1 Vif 
binds to several APOBEC3 proteins and targets them for ubiquitinylation and 
degradation resulting in the down regulation of its antiviral activity (Goila-Gaur 
and Strebel, 2008). The mouse genome encodes only a single APOBEC3 
protein and in addition to its hypermutation function, there are indications for a 
deamination-independent antiviral function targeting reverse transcription and 
antagonized by MLV glycoGag (Stavrou et al., 2013). 
(ii) TRIM5: TRIM5α is a member of the tripartite motif (TRIM) family of proteins 
characterized by a RING domain (E3 ubiquitin ligase), one or two B-box 
domains (required for higher-order assembly) and a coiled-coil domain (for 
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dimerization) (Blanco-Melo et al., 2012; Zheng et al., 2012). TRIM5α 
recognizes CA in incoming retroviral cores and assembles into a three-
dimensional lattice around them (Ganser-Pornillos et al., 2011). The variable 
C-terminal B30.2/SPRY domain in TRIM5α is the determinant for the 
recognition and binding to particular retroviral CA, and this interaction might 
lead to the premature disassembly of viral cores and the degradation of its 
components before reverse transcription is complete (Stremlau et al., 2004; 
Stremlau et al., 2006). Additionally, TRIM5α has been shown to promote 
innate immune signaling upon interaction with the cores (Pertel et al., 2011). 
Surprisingly, in owl monkey and macaques, independent LINE-mediated 
retrotransposition events led to the replacement of the TRIM5 SPRY domain 
for a cDNA expressing cyclophilin A (CypA) (Nisole et al., 2004; Sayah et al., 
2004; Virgen et al., 2008; Wilson et al., 2008). This TRIMCyp fusion protein 
exploits the conserved interaction of lentiviral CA to CypA (Goldstone et al., 
2010), resulting in a potent lentiviral inhibitor. Several CA mutants have been 
identified that antagonize the effects of TRIM5α and TRIMCyp (Chatterji et al., 
2005; Veillette et al., 2013). 
(iii) SAMHD1: SAM domain and HD domain-containing protein 1 (SAMHD1) 
hydrolyzes deoxynucleoside triphosphates (dNTPs) to deoxynucleosides 
leading to the reduction of the intracellular dNTPs concentrations and the 
inhibition of reverse transcription (Lahouassa et al., 2012). Mutations in 
SAMHD1, as well as other cellular nucleases, were initially associated with 
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Aicardi-Goutières syndrome (AGS), a hereditary autoimmune disease that is 
characterized by aberrant up-regulation of type I IFN responses (Rice et al., 
2009). Recently, SAMHD1 has also been shown to have a nuclease activity 
that degrades different retroviral vgRNAs (Choi et al., 2015; Ryoo et al., 
2014). Thus SAMHD1 might also function to regulate the accumulation of 
intracellular endogenous nucleic acids (perhaps expressed from ERVs and 
retrotransposons), which in AGS has been proposed to trigger a type I IFN 
response (Stetson et al., 2008). Lentiviral Vpx proteins (and some Vpr) have 
the ability to induce degradation of SAMHD1 by a similar mechanism to the 
degradation of APOBEC3G by Vif (Hrecka et al., 2011; Laguette et al., 2011; 
Lim et al., 2012). 
(iv) Tetherin: also known as BST-2, CD317, or HM1.24 is a restriction factor that 
traps nascent virions at the cell surface from a broad spectrum of enveloped 
viruses (Neil et al., 2008; Van Damme et al., 2008). Tetherin is a membrane 
glycoprotein comprised of a short N-terminal cytoplasmic tail, a single pass 
transmembrane helix (TM), a helical coiled-coil ectodomain (CC) that drives 
parallel homodimer formation, and a C-terminal glycosylphosphatidylinositol 
membrane anchor (GPI). This highly unusual architecture, rather than primary 
sequence, is critical for Tetherin function (Perez-Caballero et al., 2009), thus 
Tetherin likely traps virions simply by the partitioning of linked membrane 
anchors between virion and cell membranes, from where they may be 
endocytosed. Interestingly, axially configured Tetherin dimers trap virions 
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primarily through the insertion of their GPI anchors into the lipid envelopes of 
budding virions (Venkatesh and Bieniasz, 2013). Remarkably, three different 
primate lentiviral proteins have acquired the ability to antagonize Tetherin: 
Vpu (HIV-1 and some SIVs), Nef (SIV) and Env (HIV-2) by recognizing 
distinct Tetherin epitopes (Jia et al., 2009; Le Tortorec and Neil, 2009; McNatt 
et al., 2013; Zhang et al., 2009). Interestingly, pathogenic revertants of the 
normally non-pathogenic SIVmac (Δnef) arise in rhesus macaques, in which 
SIVmac Env has also adapted to antagonize Tetherin (Serra-Moreno et al., 
2011). In addition to its minimalistic antiviral mechanism, Tetherin has also 
been implicated to promote innate immune signaling by detecting HIV-1 
particles (Galao et al., 2012).  
(v) Mx2: also known as MxB, has been proposed to prevent the nuclear import 
and integration of proviral DNA, through a mechanism not yet completely 
understood (Goujon et al., 2013; Kane et al., 2013; Liu et al., 2013). Human 
Mx2 primordially inhibits lentiviruses and co-localizes with nuclear pore 
components at the nuclear envelope (Goujon et al., 2013; Kane et al., 2013).  
It appears that as for TRIM5α, CA is the determinant for Mx2 activity and CA 
mutants have been identified that antagonize the effects of Mx2 (Busnadiego 
et al., 2014).  
(vi)  SERINC5 & 3: Although the antiviral mechanism is still elusive, SERINC5 
and SERINC3 are incorporated into virions and block the complete delivery of 
their viral cores into the cytoplasm during viral entry (Rosa et al., 2015; Usami 
	   31 
et al., 2015). Nef (SIV and HIV) and MLV glycoGag antagonize the effects of 
SERINC5 and SERINC3 by preventing their incorporation into virions (Rosa et 
al., 2015; Usami et al., 2015).  
(vii)MOV10: MOV10 activity has been contradictory and a clear mechanism of 
action is still pending. MOV10 has been implicated in maintaining genome 
integrity of germ line cells by silencing ERVs and transposon transcripts 
(Frost et al., 2010). As such, MOV10 was found to be the mammalian 
ortholog of plant and insect RNA silencing effector proteins (Zheng et al., 
2012). In somatic cells, MOV10 is also able to restrict retrotransposition of 
endogenous retroelements, but has no effect on exogenous retroviruses 
(Arjan-Odedra et al., 2012). However, and with contradictory results, other 
studies have shown that MOV10 is also packaged into virions (through 
interaction with Gag and RNA) where it has been proposed to interfere with 
viral reverse transcription in target cells (Abudu et al., 2012; Burdick et al., 
2010). Additionally, MOV10 also localizes to mRNA processing bodies 
(involved in the storage and decay of some RNA species) suggesting a role in 
mRNA decay (Gallois-Montbrun et al., 2007). 
(viii) Fv1: like TRIM5α, the precise mechanism of Fv1 restriction is unclear but 
this protein also has the ability to recognize the CA protein of incoming 
retroviral cores (particularly MLV) and interfere with viral integration after 
reverse transcription (Hatziioannou et al., 2004; Hilditch et al., 2011; Jolicoeur 
and Rassart, 1980; Yang et al., 1980). Remarkably, Fv1 was the first 
	   32 
documented case that ERV sequences can be co-opted as antiviral genes, in 
this case from an ERV gag gene related to the Murine ERV-L (MuERV-L) 
(Best et al., 1996; Yan et al., 2009). Fv1 can also inhibit HIV-1 infection upon 
fusion to CypA impairing its integration (Schaller et al., 2007).  
(ix) Fv4: similar to Fv1, the Fv4 protein was also co-opted from an ERV, this time 
from an env gene closely related to the ecotropic MLV, which potently blocks 
MLV infection (Inaguma et al., 1991; Odaka et al., 1980). Fv4 contains a 
single aminoacid substitution in its fusion peptide that destroyed its fusogenic 
potential, while still retaining the ability to interact with its receptor (mCAT1) 
(Taylor et al., 2001; Yamaguchi et al., 2003). These results suggest that Fv4 
was co-opted as an antiviral protein by exploiting the receptor interference 
mechanism showed upon superinfection resistance by exogenous infections, 
as discussed above. It is estimated that the co-option of this protein occurred 
~500,000 years ago (Kozak, 2015). 
(x) enJSRVs: as with Fv4, sheep and goats have co-opted recent ERVs derived 
from the betaretrovirus Jaagsiekte sheep retrovirus (JSRV). There are at least 
20 proviral loci closely related to JSRV (endogenous JSRVs or 
enJSRVs)(Arnaud et al., 2007), many of which have retained gag and env 
genes with full coding potential. Therefore, enJSRVs can inhibit exogenous 
JSRV infections by two distinct mechanisms, one by receptor interference, by 
expressing inactive env proteins (Spencer et al., 2003), and by expressing 
Gag proteins that act in a transdominant fashion. This is achieved by forming 
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particles together with exogenous JSRV Gag in the cytoplasm that are 
defective in particle release (Murcia et al., 2007). At least one enJSRV 
provirus expressing a complete env gene is estimated to be ~3 MY old, and is 
fixed in the domestic sheep population (Varela et al., 2009). 
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Figure 1.6: Molecular arms race between virus and host and its effect on 
host restriction factors. 
(A) Molecular arms race between a restriction factor (Tetherin) and lentiviral 
accessory proteins. Nef proteins of SIVs antagonize Tetherin by interacting with 
the Tetherin cytoplasmic tail, the genetic conflict posed by this interaction 
embarks both proteins into a molecular arms race that, in this case, led to the 
evolution of Vpu, as primate lentiviruses were transmitted between species. 
Colored figures indicate Tetherin sequences in the cytoplasmic tail that are 
recognized by Nef and are hence rapidly evolving under positive selection. (B) 
Cumulative frequency distribution of dN/dS ratios for 12,404 Human-Chimpanzee 
orthologous gene pairs. Adapted from previously computed data (Consortium, 
2005). Strict positive selection (dN/dS>1) and purifying selection (dN/dS<1) are 
indicated by purple and orange arrows respectively. The dN/dS value for each 
restriction factor is indicated by the dotted lines. The solid lines indicate the 
percentage of orthologous gene pairs with lower dN/dS ratios. Images adapted 
from Blanco-Melo et al., 2012. 
B A 
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It is clear that restriction factors target key steps of the viral life cycle that are 
essential, and in order for the virus to replicate in a particular host it had to 
acquire specialized countermeasures against these antiviral proteins. It is likely 
that this antagonistic coevolution represents a major driver for evolutionary 
change in both viruses and their hosts. Restriction factors variants that confer an 
advantage are selected by detrimental viral infections and could be rapidly fixed 
in the host population. On the other hand, the reduction in viral fitness in the 
newly adapted host requires the selection of viral variants that have acquired 
mutations or new functions that relieve restriction and restore fitness. Iterative 
cycles of this genetic conflict constitute a molecular “arms race” and can result in 
the rapid evolution of restriction factors and their viral targets or antagonists 
(Blanco-Melo et al., 2012; Daugherty and Malik, 2012) (Figure 1.6A).  
A molecular arms race between protein-coding genes is often identified by an 
observed abundance of mutations that change the amino acid sequence (non-
synonymous mutations) over those that do not (synonymous mutations).  Protein 
sequences that show this imbalance are thought to have evolved under positive 
selection, where the sequence diversification is justified by the fixation of 
beneficial alleles. This type of selection contrasts with purifying selection 
(abundance of synonymous over non-synonymous mutations), where fixation of 
alleles is driven by the need to preserve protein function through the elimination 
of deleterious mutations. A simple numerical way to distinguish between both 
types of selection is by calculating the ratio of non-synonymous mutations over 
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all potential non-synonymous sites (dN) and compare it to the ratio of 
synonymous mutations over all potential synonymous sites (dS).  In alignments 
of genes, portions of genes, or individual codons, a dN/dS > 1 would be indicative 
of positive selection, whereas a dN/dS <1 is indicative of purifying selection. As 
intuitively expected, the majority of human genes have evolved under purifying 
selection (dN/dS <1) with a small subset of genes that have evolved under 
positive selection (Figure 1.6B) (Blanco-Melo et al., 2012; Consortium, 2005; 
Meyerson and Sawyer, 2011). Genes that exhibit signatures of positive selection 
include those involved in sensory perception, likely driven by temporal or 
migration-induced changes in the need to sense the environment, food, or 
location of predators. Predictably, positively selected genes also include those 
involved in immune responses and pathogen defense (Kosiol et al., 2008), 
including restriction factors. The entire coding sequence of APOBEC3G and 
TRIM5α are among the highest dN/dS ratios of all human genes (Sawyer et al., 
2004; Sawyer et al., 2005; Song et al., 2005) (Figure 1.6B). Positive selection 
typically acts on domains or codons that participate in the interaction between 
proteins and their targets. Although the entire coding sequence of Tetherin and 
SAMHD1 show dN/dS < 1 (when comparing it to the orthologous chimpanzee 
sequence, Figure 1.6B), sequences that are targeted by viral antagonists are 
shown to have clear signatures of positive selection (Gupta et al., 2009; Lim et 
al., 2012; McNatt et al., 2009) (Figure 1.6A), and similar results have been 
observed for other restriction factors (Table1.1).  
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Positive selection has caused high protein sequence variability in restriction 
factors from different species. Consequently, viral adaptation to antagonize or 
evade a particular restriction factor variant in one host species can come at the 
cost of susceptibility to variants of the same restriction factor in another potential 
host. Thus, antagonistic co-evolution of virus and a particular host can reduce the 
probability of an individual virus to evade (or antagonize) the defense 
mechanisms that will confront it when the opportunity to colonize a new host 
species appears. It should be straightforward at this point to notice that although 
restriction factors are most frequently studied because of their ability to inhibit 
modern, clinically important retroviruses, their existence (and its current 
sequence) in modern genomes is the result of molecular arms races and 
selective pressures imposed by viruses in the past. 
While the aforementioned restriction factors share some common properties, 
their mechanisms of action and evolutionary origins are quite different from each 
other. How did such a diverse array of antiviral proteins arise? Or equally 
daunting, how do new genes and functions arise in general? In principle, new 
functions could be generated through minor adaptation of cellular genes whose 
products already have an intrinsic capacity to perform such a function. 
Alternatively, they might originate de novo as new genes with trace side activities 
or innovations that ultimately become the selected new function (Bergthorsson et 
al., 2007). Moreover, the fate of any gene depends on its ability to preserve its 
function (robustness) while accumulating mutations to adapt to a changing 
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environment (evolvability). Although initially contradictory, the interplay between 
this two forces (robustness and evolvability) might allow evolving genes to 
sample different variants while resisting potentially deleterious mutations (Masel 
and Trotter, 2010; Wagner, 2011). In either case, gene duplication provides the 
genetic “raw material” that might facilitate genotype sampling (by releasing 
evolutionary constraints in the paralog gene) leading to the acquisition of new 
functions (Ohno, 1970). 
The APOBEC3 family is likely derived from duplicated copies of cytidine 
deaminases (AID and APOBEC1) that have specific roles in editing cellular DNA 
and RNA. Thus, in this case, a normal cellular function was simply redirected to 
hypermutate viral genomes. In a similar manner, Mx2 was most certainly evolved 
from a duplication of the also antiviral mx1 gene. One could imagine that the 
enzymatic regulation of cellular dNTP levels by SAMHD1 might have served 
some important regulatory function that was subsequently exploited by cells to 
inhibit the replication of retroviruses (and perhaps other DNA viruses). TRIM5 
likely represents an intermediate example, whereby genes with some pre-
existing, but mechanistically unrelated, function were mutated to a form with 
antiretroviral activity. Consistent with this idea, most of the dozens of TRIM 
proteins do not possess intrinsic antiretroviral activity. However, there are some 
that can exhibit weak antiretroviral activity when overexpressed (Yap et al., 2004; 
Zhang et al., 2006). Moreover, a variety of TRIM genes, that otherwise lack 
antiretroviral function, can be endowed with anti-HIV-1 activity if their C-terminal 
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SPRY domains are replaced with cyclophilin (Yap et al., 2006; Zhang et al., 
2006). These data suggest that the architecture of TRIM proteins, perhaps a 
propensity to assemble hexameric lattices (Ganser-Pornillos et al., 2011), lends 
itself to the acquisition of antiretroviral activity.  
In the case of Tetherin, it is difficult (albeit not impossible) to imagine a precursor 
gene with a similar function. There are no known cellular proteins that have 
related sequence or function, and so far tetherin appears to be an orphan gene 
present only in mammals and some reptiles (Heusinger et al., 2015). Moreover, 
Tetherin is not expressed in the vast majority of cells unless they are treated with 
interferon, and mice that lack a tetherin gene have no obvious deficiencies 
(Liberatore and Bieniasz, 2011). Every sequenced genome harbors a significant 
fraction of "orphan" genes whose origins are obscure due to the absence of 
sequence or functional similarity to other genes (Khalturin et al., 2009; Palmieri et 
al., 2014; Tautz and Domazet-Loso, 2011), thus addressing the evolutionary 
history of Tetherin certainly will be a challenging task.  
Another recurrent source for genetic innovation is represented by the ERV 
sequences that have provided an evolutionary advantage for the host to keep. In 
the particular case of ERV env genes mediating receptor interference, examples 
of this mechanism have been documented in chickens (Robinson et al., 1981), 
sheep (Spencer et al., 2003), mice (Gardner et al., 1991; Odaka et al., 1980; Wu 
et al., 2005) and cats (Ito et al., 2013), emphasizing its simple but profound 
effect. Co-opted ERV sequences such as Fv1, Fv4, enJSRVs and others have 
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arisen independently at different times and in different species to deal with 
diverse viral infections, highlighting the key role that ERVs have in shaping the 
evolution of their hosts.  
 
Endogenous Retroviruses. 
About 8 and 10 percent of the human and mouse genomes, respectively (Lander 
et al., 2001; Mouse Genome Sequencing et al., 2002), are comprised of 
sequences of retroviral origin. These ERV sequences originated from an initial 
retroviral infection that was able to infect and integrate in the host germ line cells. 
This integrated retroviral genome was then vertically inherited to the offspring as 
a host allele. During thousands to millions of years, some of these sequences 
acquired inactivating mutations and were fixed in ancestral populations by 
genetic drift, while others became fixed by providing an evolutionary advantage 
to the host (Figure 1.7A). Since their discovery, numerous ERVs (mostly simple 
retroviruses) have being identified in a variety of animal species indicating that 
germ line retroviral infection events have occurred multiple times during the 
course of evolution (Hayward et al., 2013). This ERV diversity observed in 
modern animal genomes corresponds to germline retroviral insertions that 
survived natural selection and reached fixation, which is a significantly reduced 
set of all past retroviral infections. Nevertheless, this ERV diversity still 
represents a vast molecular “fossil record” of past retroviral infections. 
	   41 
Once within the germline, the endogenized provirus can proliferate giving rise to 
multi-copy lineages (or families) of related ERV sequences in the host genome 
(Bannert and Kurth, 2006). Such lineages are primordially named by adding one 
or two letters before the abbreviation ERV describing the host species in which 
they were initially identified. Additionally, based on the particular tRNA used to 
prime reverse transcription, a one-letter amino acid symbol for that tRNA is 
added to end of the name. For example, the human HERV-K lineage uses tRNA-
Lys as a primer while the mouse MuERV-L uses tRNA-Leu.  
	    
	   42 
 
 
 
 
 
 
Figure 1.7: Origins of ERVs and their mechanisms of expansion.  
(A) Process of endogenization of a retrovirus. An initial retroviral infection that 
expanded through a population by horizontal transmission is fortuitously able to 
infect the germline cells of the host. From there the virus could be inherited 
vertically from generation to generation. Some of these retroviral sequences will 
be fixed in the population as cellular genes. Image adapted from Dewannieux 
and Heidmann, 2013. (B) Mechanisms used by ERVs to expand in the germline. 
Reinfection: ERVs that have maintained coding potential for all its genes 
(specially env) can make retroviral particles and reinfect germline cells (and also 
other somatic cells). Retrotransposition: ERVs that have lost its env gene can still 
re-integrate into the same cell through entirely intracellular mechanisms. 
Complementation in trans: Partially or completely inactive ERVs may continue its 
expansion by using the replication machinery of other endogenous or exogenous 
retroelements (indicated in red). Image adapted from Bannert and Kurth, 2006.  
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The mechanism behind the expansion of a particular lineage is related to the 
proviral structure itself. If an ERV is still able to encode for all major proteins 
(Gag, Pol and Env), this sequence could expand in copy numbers by producing 
infectious particles that could (re-)infect other germ line cells (and possibly also 
some somatic cells) (Figure 1.7B, Reinfection). This is the case when a provirus 
has been recently acquired or is not yet completely endogenized (fixed in the 
population). Indeed, a recent study observed 36 HERV-K proviruses that are 
polymorphic among different human populations with two of them retaining full 
coding capacity for all of their genes (including the rec accessory gene), 
suggesting that they could still be infectious (Wildschutte et al., 2016). Another 
important example is that of the koala retrovirus (KoRV) that recently entered the 
germline (~100 years ago (Tarlinton et al., 2006)) and is present in variable copy 
numbers in north Australian koalas, but absent in some south Australian ones 
(Simmons et al., 2012). This mode of expansion is especially dependent on a 
functional env gene to secure (re-)entry into cells. It has been observed that 
some lineages with very large copy numbers lost its env gene and expanded by 
reintegrating in the same cell through completely intracellular mechanisms similar 
to retrotransposition (Figure 1.7B, Retrotransposition) (Magiorkinis et al., 2012). 
This amplification mechanism also requires the adaptation of Gag to assemble 
particles in the cytoplasm and not at the plasma membrane, as shown by studies 
that interchanged the mode of replication of related ERVs by swapping the N-
terminal end of Gag between them (Ribet et al., 2008a). The success of this 
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mode of replication can be explained by an increased probability of reintegration 
if the “infectious” elements are present locally at high concentrations or they do 
not have to avoid targeting by the extracellular immune system (Dewannieux and 
Heidmann, 2013). Although there can be some advantages for the host to keep 
proviruses with coding potential (see below), the vast majority of the ERVs in 
animal genomes are filled with inactivating mutations, including deletions and 
insertions. These inactive proviruses can still proliferate by “borrowing” the 
required components from active retroviruses (endogenous or exogenous) or 
other retrotransposons (such as LINE elements), as long as they can still be 
transcribed and regulatory sequences are preserved (PBS, PPT, Ψ, etc.) (Figure 
1.7B, Complementation in trans). This mechanism has also been widely used 
and in fact more than 60% of all HERV-W proviruses have been generated with 
the help of LINE elements (Pavlicek et al., 2002). Ultimately, the single most 
abundant ERV structure in animal genomes is just composed of one LTR 
(soloLTR) that arose by homologous recombination between the paired LTRs of 
complete proviruses (Belshaw et al., 2007) and it is in 10-fold excess compared 
to other ERV structures (Mager and Stoye, 2015). This internal deletion could 
further reduce the burden to the host genome and might have been preferentially 
fixed in the population by genetic drift (Dewannieux and Heidmann, 2013). 
The potential for amplification of ERVs despite inactivation, impose an important 
pressure on the host to regulate their expression and minimize their effects. 
Although the role of ERVs in disease is still debatable, ERV transcription (and in 
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some cases protein expression) is often unregulated in certain cancers, 
autoimmune diseases and even in other retroviral infections (such as HIV) 
(Magiorkinis et al., 2013; van der Kuyl, 2012).  As previously mentioned some 
restriction factors, such as APOBEC3G, SAMHD1, MOV10, Fv1, Fv4 or enJSRV, 
can act against ERVs and inhibit their detrimental effects, although their action 
seems to have been more critical to prevent the initial germline invasion 
(Johnson, 2015). Another way to keep ERVs under control is by tight epigenetic 
regulation of their expression through DNA methylation or histone modifications 
(Leung and Lorincz, 2012; Maksakova et al., 2008). In fact, epigenetic silencing 
is such an important mechanism for the control of distinct ERV lineages and 
retrotransponsons that a particular family of zinc finger proteins (KRAB-ZFB), 
which recruit histone methylation complexes and guide them to distinct ERVs, 
seems to be fast evolving and expanding in mammalian genomes, suggesting its 
involvement in a molecular arms race with past endogenous or exogenous 
retroviruses (Thomas and Schneider, 2011).  
In a few rare occasions the ERV provirus is fixed in the population because it 
provided an advantage for the host. As mentioned previously restriction factors 
such as Fv1, Fv4, enJSRV and others have been co-opted by the host from a 
retroviral germline invasion, in order to combat other endogenous or exogenous 
viral infections. However, there are additional examples of ERV co-option for 
other cellular processes. One of the most striking examples is the recurrent co-
option of the fusogenic potential of env genes to mediate the required cell-cell 
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fusion to form the syncytial trophoblast layer during the development of the 
placenta (Mager and Stoye, 2015). Indeed, different ERV env genes have been 
independently co-opted to perform a similar function in a variety of mammalian 
orders such as apes, rodents, lagomorphs, ruminants and carnivores (Lavialle et 
al., 2013), highlighting the major role that ERV co-option has had on the evolution 
of placentation.  
Surprisingly not only protein coding ERVs have been co-opted, but RNA 
structures and regulatory elements encoded in non-coding regions of the proviral 
DNA might also provide an advantage for the host to keep. Particularly, the 
promoter functions of the retroviral LTRs have been redirected to control the 
expression of specific genes (Diehl et al., 2013; Romanish et al., 2007), but also 
to control entire regulatory networks (Rebollo et al., 2012), including the 
mammalian IFN response (Chuong et al., 2016). One particular example is that 
of MuERV-L, a highly abundant mouse specific endogenous retrovirus that 
continues to be transcriptionally active at an early stage of the mouse embryo 
(Kigami et al., 2003; Ribet et al., 2008b). Recent studies have shown that the 
early embryonic activation of MuERV-L might be in part due to the co-option of its 
LTRs, whose promoter function has been redirected to control the expression of 
genes involved in the zygotic genome activation, particularly at the two-cell stage 
of the mouse embryo (Macfarlan et al., 2011; Macfarlan et al., 2012). Activation 
of MuERV-L LTRs results in the expression of hundreds of genes that contribute 
to maintaining the totipotency of the blastomeres, and it also results in the 
	   48 
expression of the MuERV-L Gag-Pol polyprotein and the formation of intracellular 
viral-like particles (Macfarlan et al., 2011; Macfarlan et al., 2012; Ribet et al., 
2008b). In later stages and as development progresses, MuERV-L LTRs and 
their regulated genes (including MuERV-L) are epigenetically silenced by 
repressive chromatin modifying enzymes coinciding as well with the expression 
of pluripotency genes such as Oct4, Sox2 or Nanog (Guallar et al., 2012; 
Macfarlan et al., 2011; Rowe and Trono, 2011). It is not entirely clear if the 
presence of these MuERV-L transcripts, proteins and particles at the two-cell 
stage have an impact on the mouse development, however it is important to point 
out that the over-expression of MuERV-L during this stage does not correlate 
with an increase in their copy numbers, suggesting that the expressed proviruses 
do not have the potential to re-integrate into the genome (Guallar et al., 2012). 
Additionally, ERVs can also regulate gene expression by the production of long 
non-coding RNAs (lncRNAs), such as in the case of transcripts promoted by the 
HERV-H LTR, which seem to play an important regulatory role in human stem 
cell identity and pluripotency (Fort et al., 2014; Lu et al., 2014). 
 
Paleovirology. 
In addition to the previously mentioned co-option events, the discovery of the 
retroviral “fossil record” also uncovered an exceptional opportunity to expand our 
knowledge on the co-evolution of retroviruses and their hosts. Previous studies 
have been able to reconstruct an infectious version of an ancient human 
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retrovirus by making a consensus sequence of the most recent expansions of 
HERV-K (HML2) in the human genome (Dewannieux et al., 2006; Lee and 
Bieniasz, 2007). Those pioneer studies set the groundwork for the new field of 
paleovirology that is interested in the study of ancient extinct viruses and the 
effects that such agents have had on the evolution of their hosts (Emerman and 
Malik, 2010). The HERV-K reconstruction also established that this ancient 
retrovirus integrates preferentially into transcriptionally active regions, and that 
members of the APOBEC3 family restricted its replication (Lee and Bieniasz, 
2007; Lee et al., 2008). Partial reconstructions of the chimpanzee 
gammaretroviruses CERV-1 and CERV-2 (present in a variety of primates 
including old world monkeys but absent in humans) have similarly identified 
APOBEC3 proteins as strong inhibitors of their replication (Perez-Caballero et al., 
2008), although there is evidence that TRIM5α may affect CERV-1 as well 
(Kaiser et al., 2007). ERV reconstructions have also shed light into the 
mechanisms of tissue tropism and host range with the identification of copper 
transport protein 1 (CTR1) as the receptor used by a reconstructed CERV-2 env 
gene and presumably required by the ancient (and possibly extinct) CERV-2 (Soll 
et al., 2010). Furthermore the same study revealed a set of mutations in CTR1 
that made hamster cells resistant to this virus. In parallel, bioinformatic studies 
identified endogenous lentiviruses in the genomes of leporids (rabbit endogenous 
lentivirus type K (RELIK)) (Katzourakis et al., 2007; Keckesova et al., 2009), 
lemurs (prosimian immunodeficiency virus (pSIV)) (Gifford et al., 2008; Gilbert et 
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al., 2009), ferrets (Cui and Holmes, 2012; Han and Worobey, 2012) and colugos 
(Han and Worobey, 2015; Hron et al., 2014), contrary to the idea that lentiviruses 
were a modern retroviral group. Further analysis of RELIK and pSIV allowed 
reconstruction, expression and crystallization of their Gag proteins, revealing the 
conservation of the CA-CypA interaction, a feature present in modern day 
lentiviruses and essential for HIV-1 infectivity (Goldstone et al., 2010). More 
recently a study followed the evolutionary history of a particular ERV (ERV-Fc) 
along the entire mammalian class and discovered how exogenous ancestors of 
this ERV lineage were remarkably able to spread between distant species, 
highlighting the power of recombination in order to achieve its wide distribution 
(Diehl et al., 2016). 
As previously noted, the existence and sequence of retroviral restriction factors 
have been shaped by past viral infections. In this regard reconstructions of 
ancestral TRIM5α proteins have revealed how different ancestral lentiviral groups 
have shaped lineage-specific variations in modern day TRIM5α proteins 
(Goldschmidt et al., 2008; McCarthy et al., 2015), as well as modern primate 
Tetherins (Figure 1.6A). Along the same lines, it is also possible to speculate that 
ancestral viruses like HERV-K, CERV-1 and CERV-2, might have shaped the 
evolution of APOBEC3 proteins. Although all these examples illustrate how it has 
been possible to infer interactions between hosts and viruses, it has not yet been 
possible to unequivocally demonstrate that specific past retroviral infections were 
responsible for the origin of any particular restriction factor. Nor has it been 
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possible to demonstrate that any particular restriction factor was responsible for 
extinction of any retrovirus (Blanco-Melo et al., 2012). The limited and incomplete 
nature of the retroviral “fossil” record might difficult answering such questions. 
However, additional paleovirological resurrections of extinct ERVs might have the 
potential to discover unidentified restriction factors that were responsible for their 
extinction and might also act on modern exogenous viruses.  
In the following chapters I will describe the paleovirological analysis performed 
during the course of my Ph.D. work, and I will provide additional insights into the 
evolution of antique retroviral lineages and the diverse mechanisms responsible 
for the innovation of host defenses against ancient and modern retroviral 
infections. 
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Chapter II. Materials and Methods 
Database Integrated Genome Screening (DIGS). 
Screening for ERV elements was performed using DIGS (Robert J. Gifford, 
Unpublished). The DIGS framework is composed of Perl scripts that utilize the 
BLAST+ package of programs (Camacho et al., 2009). Briefly, a scheme for a 
simple DIGS screening involves two steps (Figure 2.1):  (i) Coding (translated) 
and non-coding sequences derived from a user defined sequence reference 
library are used as probes for tBLASTn (translated coding sequences) or 
BLASTn (non-coding sequences) searches on target genomic sequences. (ii) 
Significant BLAST hits (e-value < 1E-50) were used as probes for a second 
round of BLASTx (translated coding hits) or BLASTn (non-coding hits) searches 
against the previously defined sequence reference library. Significant hits of the 
first and second round of BLAST searches were added into a relational database 
to facilitate the management of the screening process and further processing of 
the results. 
An initial reference genome library to screen for ERV sequences was composed 
of 119 sequences from previously characterized endogenous and exogenous 
retroviral families. Exogenous retroviral sequences were retrieved from the 
RefSeq database (Pruitt et al., 2014), and ERV sequences were based either on 
consensus sequences of previously published ERV sequence data (Benit et al., 
2001; Sverdlov, 2005; Tristem, 2000; Villesen et al., 2004), lineage specific 
mammalian ERVs previously characterized by Robert J. Gifford (unpublished), or 
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previously inferred consensus sequence analyses (Jern et al., 2005; Lee and 
Bieniasz, 2007). RT sequences of entire reference genome library were used as 
probes for the initial “phylogenetic screening” performed by Robert J. Gifford. The 
probes used for the refinement of the HERV-T and other HERV lineages 
corresponded of inferred consensus sequences of RT containing elements 
flanked by paired repeats (likely corresponding to LTRs) identified in the initial 
“phylogenetic” ERV screen. These sequences were used as well to update the 
reference sequence library.  
A genome target database was built with complete and low coverage primate 
genome sequences that were retrieved from publicly available databases. For 
this particular study we selected six ape genomes corresponding to the catarrhini 
parvorder of higher primates (old world monkeys and apes): human (Homo 
sapiens) (Lander et al., 2001), chimpanzee (Pan troglodytes) (Consortium, 2005), 
bonobo (Pan paniscus) (Prufer et al., 2012), gorilla (Gorilla gorilla) (Scally et al., 
2012), orangutan (Pongo pygmaeus) (Locke et al., 2011), gibbon (Nomascus 
leucogenys) (Carbone et al., 2014), baboon (Papio hamadryas) (Pruitt et al., 
2014),  and rhesus macaque (Macaca mulatta) (Rhesus Macaque Genome et al., 
2007).  
The reference sequence library used to screen for MuERV-L elements in the 
mouse genome contained sequences of endogenous and exogenous Class III 
retroviral sequences (Spumaviruses, HERV-S, and other ERV-L elements 
including HERV-L and MuERV-L) retrieved from the general reference sequence 
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library described above. Amino acid and nucleotide sequences of the MuERV-L 
reference sequence (MuERV-Lref, GenBank: Y12713) (Benit et al., 1997) were 
used as probes. Two mouse genome assemblies were used as target genomes: 
Mm_Celera (NCBI: GCF_000002165.2) (Mural et al., 2002) and GRCm38/mm10 
(UCSC: mm10) (Mouse Genome Sequencing et al., 2002).  
 
Figure 2.1: Schematic representation of a basic DIGS screening process 
implemented for ERV discovery. 
(1) Sequence probes derived from a user-defined set of endogenous and 
exogenous reference retroviral sequences are used to screen target databases. 
(2) The reference sequence library is used to classify, or “genotype”, significant 
sequence hits derived from (1). Results might be used to refine the reference 
library through an iterative process. XRV: exogenous retrovirus. This figure was 
kindly provided by Dr. Robert Gifford. 
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Consolidation of DIGS hits. 
The consolidation process involves the assembly of adjacent or overlapping hits 
from the resulting DIGS screening pipeline into a proviral loci. The consolidation 
process is composed of a series of Perl scripts that retrieve the significant hits (e-
values < 1E-50) from the second BLAST search of DIGS, orders them by 
genome scaffold and orientation and evaluate if two consecutive hits should be 
“consolidated” following simple rules (Figure 2.2). Two consecutive hits are 
referred as “consolidated” when the program merges their corresponding 
coordinates. Briefly, when corresponding to the same genomic feature (same 
coding or non coding region, i.e. LTR, gag, pol, env or leader), the coordinates of 
a pair of consecutive hits in the genome scaffold and in the correspondent 
reference sequence are compared between them and decided to be consolidated 
following rules depicted in Figures 2.2 A–D. Alternatively, when the pair of 
consecutive hits involve two distinct genomic features (as defined above) the 
consolidated process will evaluate their consolidation by keeping the continuous 
and discrete structure of a provirus (LTR-leader-gag-pro-pol-env-LTR) (Figure 
2.2E). The consolidation process allows for insertions no longer than the 
length_threshold parameter (used with the default value of 10,000 nucleotides). 
Once two consecutive hits are consolidated, the program will treat this 
consolidated hit as a single hit and will evaluate further consolidation by 
comparing it to the following one as two consecutive hits (using the process 
described above). If two consecutive hits should not be consolidated, the 5’ most 
	   56 
hit (in the context of its position in the genome scaffold), previously consolidated 
or not, will be stored in a relational database as a provirus and the program will 
continue the consolidation of the 3’ most hit by comparing it to the following one 
as two consecutive hits (using the process described above).  
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Figure 2.2: Rules governing the consolidation of the DIGS results.  
Hits corresponding to the same gene:  (A) two consecutive non-overlapping hits 
will be consolidated only if the distance between them on the scaffold is less than 
the length_threshold. (B) Two consecutive hits with overlapping coordinates on a 
scaffold will be consolidated. (C) Two consecutive hits with overlapping 
coordinates on a reference sequence will be consolidated only if the distance 
between them on the scaffold is less than length_threshold. (D) Two consecutive 
overlapping hits on both scaffold and reference sequence will be consolidated if 
the terminal coordinate on the reference sequence of the first hit is smaller than 
the corresponding coordinate on the second hit. Hits corresponding to different 
genes: (E) consecutive hits will be consolidated into a locus only if the distance 
between them on the scaffold is less than length_threshold, and the assigned 
gene of the 3’ most hit correspond to a succeeding gene on the reference 
genome structure (LTR-leader-gag-pro-pol-env-LTR). All consolidations 
performed for this work used a length_threshold = 10,000nt. 
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Figure 2.2: Rules governing the consolidation of the DIGS results. 
  
|""""|# |"""""..."""""|#
X Y 
Reference 
gene  
Scaffold 
Consolidated 
 hits 
X ≤ length_threshold < Y 
a)#
Reference  
gene 
Scaffold 
Consolidated 
 hits 
b)#
|""""|# |"""""..."""""|#
X Y 
Reference  
gene 
Scaffold 
Consolidated 
 hits 
X ≤ length_threshold < Y 
c)#
Reference  
gene 
Scaffold 
Consolidated 
 hits 
d)#
b 
| 
a 
| 
a < b 
Hits Hits 
Hits Hits 
|""|#
i 
A"B"C%
Reference 
genome    
structure 
Scaffold 
Consolidated 
 loci 
i, i' ≤ length_threshold < j 
e)#
C%!% D%!% !%A% B%
B%D%
Consolidated
hits 
|""""""""""""""""""""""""""""""""""""|#
i' j 
|""""""""""""""""""""""..."""""""""""""""""""""|#
%
Genes 
A B 
C D 
E 
	   59 
The consolidation process was validated using a synthetic sequence data set.  A 
different Perl script was developed to produce 369 synthetic proviral structures 
representing the major categories of ERV loci found in animal genomes (i.e. solo 
LTR, proviruses with paired LTRs, and fragmented loci containing internal 
regions but lacking paired LTRs). The script takes each artificial proviral structure 
and assigns it to one of three artificial ERV lineages and inserts it into a random 
position on one of three artificial scaffolds from each of three artificial organisms 
(369 loci from 3 artificial ERV lineages distributed between 3 artificial organisms, 
each of which has 3 artificial scaffolds).  Each of the artificial proviral structures 
was further subjected to a function that randomly “mutates” the proviral structures 
by introducing insertions or deletions of different lengths. These “mutational” 
processes also produce distinct small local duplications (resulting in overlapping 
coordinates) at both the scaffold position (nucleotides) and/or the position in the 
reference sequence (amino acids). The resulting artificial data set contained 
1,132 artificial hits that were used to populate an artificial DIGS result table that 
was further consolidated into proviral loci by testing different values for the 
length_threshold parameter. The consolidation of synthetic hits into larger loci 
corresponded exactly with the expected outcome (i.e. the consolidation process 
was able to revert the random mutations introduced and the initial 369 synthetic 
proviruses were regenerated). 
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Multiple sequence alignment of ERV sequences. 
Due to the high degree of mutations, especially indels, accurate multiple 
sequence alignments (MSA) of ERV sequences retrieved from genomic data is 
challenging. To overcome this difficulty we aligned each retrieved ERV sequence 
to its corresponding retroviral reference genome sequence individually using 
MUSCLE (Edgar, 2004), followed by the creation of a “gapped” MSA using the 
profile alignment function of MUSCLE. Insertions relative to the retroviral 
reference genome sequence were treated as putative insertions and were 
eliminated from the MSA, but saved in a separate file. A function that retrieves 
consolidated DIGS results and creates the MSA as described was programed in 
Perl. If needed, the same function can reconstruct the “gapped” MSA by taking 
both the final MSA and the saved putative insertions relative to the retroviral 
reference genome. 
 
Phylogenetic tree construction. 
Maximum likelihood (ML) phylogenetic trees were constructed from a nucleotide 
MSA using raxML (Stamatakis, 2006) with the following parameters: rapid 
bootstrap analysis with 10,000 replicates under the GTRCAT model followed by a 
ML search under GTRGAMMA model to evaluate the final tree topology (-m 
GTRCAT -# 10000 -x 13 -k -f a). Quick Neighbor Joining trees were constructed 
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from protein MSA based on distances using PAUP* (set criterion=distance) 
(Swofford, 2002). Phylogenetic trees were then analyzed using FigTree v1.4.2 
(Rambaut, 2008). Thereafter the tree was rooted on the tree midpoint or by an 
outgroup sequence.  
 
Integration dates of ERV data. 
Dates of integration for ERV elements were calculated using PAUP* (Swofford, 
2002) by determining the divergence (K) to: (i) a consensus sequence, for 
soloLTRs; (ii) to its cognate LTR, for proviral loci flanked by paired LTRs; (iii) or 
to the corresponding orthologous sequence, in the case of the complete protein-
coding HERV-T env locus. The resulting K was divided by 2 times the neutral 
substitution rate (r) in order to obtain the estimated integration date (K/2r) 
(Lebedev et al., 2000; Subramanian et al., 2011). Neutral substitution rates used 
for human and mouse were 2.2 x 10-9 and 4.5 x 10-9 substitutions per site per 
year, respectively (Lander et al., 2001; Mouse Genome Sequencing et al., 2002). 
 
Hypermutation analysis. 
Hypermutation analysis and statistics were performed using Hypermut 2.0 (Rose 
and Korber, 2000) on (i) the set of 230 gag-pol containing sequences used to 
reconstruct the ancestral MuERV-L gag, or on (ii) 49 gag-pol-env HERV-T2 
	   62 
containing sequences in catarrhine genomes using default parameters or 
excluding sites with a 5’ C next to the mutated G. 
 
Annotation and Statistics of MuERV-L elements in mouse genomic features. 
MuERV-L loci were annotated into genomic features for GRCm38 (downloaded 
using BioMart from Ensembl (Hubbard et al., 2002)) by comparison of their 
coordinates using in-house Perl scripts. Contingency table and goodness-of-fit 
tests for MuERV-L elements in the mouse genome were performed using the 
Pearson's Chi-squared test for count data (chisq.test), implemented in R. Two 
sets of random coordinates in the mouse genome were computationally 
generated using in-house Perl scripts and the runif function implemented in R. 
For comparisons of soloLTRs distributions 10,000 random mouse sequences of 
500 nucleotides in length were generated. For comparisons of proviral loci 
distributions 5,000 random mouse sequences of 6,500 nucleotides in length were 
generated. The distribution of both random control sets into mouse genomic 
features was determined as previously described for MuERV-L elements. A third 
set of 1,000 EcoRV containing random Chinese Hamster sequences of 1,000 
nucleotides in length was generated using in-house perl scripts. For ancML 
integration comparisons each ancML integration site was matched with three 
random genomic sequences (from the third random control set) that were 
equidistant to the EcoRV site where the adaptor was ligated. Statistical 
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comparisons of integration data were performed as described in (Marshall et al., 
2007). 
 
Ancestral Reconstructions. 
All ML ancestral reconstructions were guided by a MSA together with a 
phylogenetic tree using baseml from the PAML package (Yang, 1997) (model: 
REV, initial values of alpha and kappa were calculated on the MSA by jmodeltest 
(Darriba et al., 2012), branch lengths were used as initial values). A correction for 
the effect of methylation-induced mutations at CpG islands was applied on both 
strands of all ancestral reconstructed sequences as described in (Goldstone et 
al., 2010). 
The ancestral reconstruction of MuERV-L was performed on two distinct 
sequence sets. For the ancestral reconstruction of the pol ORF and the LTRs we 
constructed a MSA and a midpoint rooted ML phylogenetic tree using a set of 95 
complete proviral sequences (LTR-gag-pol-LTR) identified by default BLASTn 
searches on GRCm38 that were highly similar to MuERV-Lref. Insertions relative 
to MuERV-Lref in the MSA were treated as putative insertions and were 
eliminated, except for a 6nt insertion at position 298 and 6249 on both LTRs that 
were shared between 25% of the sequences. For the ancestral reconstruction of 
the gag ORF we constructed a MSA and a midpoint rooted ML phylogenetic tree 
on 230 gag-pol containing sequences (identified by our previous screening of the 
mouse genome). We determined the presence or absence of the 33 and 39nt 
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deletions in the gag ORF relative to MuERV-Lref (that does not show any 
deletion) and identified a monophyletic clade of 40 sequences that showed the 
33nt deletion in gag (irrespective of the status of the 39nt deletion). The resulting 
ancestral gag, pol and LTR sequences were combined together to produce 
ancML. 
For the ancestral reconstruction on HERV-T we first analyzed the 5’ and 3’ 
flanking sequences of 32 HERV-T1 and HERV-T3 proviruses retrieved from 
catarrhine genomes. These analyses resulted in two and fourteen unique HERV-
T1 and HERV-T3 integration events (orthologous groups), respectively. Ancestral 
nodes for each orthologous group were used to construct the corresponding MSA 
and ML phylogenetic tree required for the ancestral reconstruction. The HERV-T3 
pre-gag ORF ancestral sequence was further refined to include the last 43 
codons of the pre-gag ancestral HERV-T1 sequence and the state of particularly 
polymorphic sites was hand curated by a combination of their frequency and the 
phylogenetic relationships between the corresponding sequences. The variation 
present in HERV-T1 sequences was also taken into account to break possible 
ties. Logo plots were constructed to visualize the variation present in HERV-T3 
and HERV-T1 sequences using WebLogo (Crooks et al., 2004). The final revised 
sequence corresponded to HTpG. A similar procedure was performed on the 
initial HERV-T3 ancestral env sequence with the addition that if the CpG 
reversion on a particular position results in the change in chemical nature of the 
amino acid, the residue at this position is reverted back. The final revised 
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sequence corresponded to ancHTenv. The ancestral reconstruction for the most 
recent ancestor of the protein-coding HERV-T3 env locus was performed 
manually by selecting residues based on the phylogenetic relationships of 
human, gorilla and orangutan. Particularly polymorphic sites were resolved by 
comparison to the ancHTenv sequence. The final revised sequence 
corresponded to ancHsaHTenv. 
Ancestral PV1 and TM-CC(aT) sequences were inferred on MSA and ML 
phylogenetic trees constructed from amniote species without any CpG 
reversions. 
 
In virtro simulation of neutral evolution. 
Monte-Carlo simulations of in silico neutral evolution on the ancHsaHTenv were 
performed using seq-gen (Rambaut and Grassly, 1997) under the GTR model 
(10,000 iterations) as performed in (Katzourakis and Gifford, 2010). Expected 
branch lengths were calculated using the neutral substitution for human (defined 
above) for the minimum and maximum estimates of the origin of hominids (13.45 
and 19.68 MY respectively) (Perelman et al., 2011). The simulated 10,000 
human sequences were then evaluated for the presence of a 5’ methionine and 
the number of stop codons.  
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mVISTA plots. 
Analysis of introns and neutrally evolving sequences of divergent pv1 and tm-
cc(at) genes, as well as HERV-T orthologous loci, were carried out using the 
mVISTA visualization tool for glocal sequence alignments (Frazer et al., 2004). 
FASTA and annotated sequence files were uploaded to the mVISTA website 
(http://genome.lbl.gov/vista/mvista/about.shtml) and aligned by the Shuffle-
LAGAN algorithm to detect rearrangements (Brudno et al., 2003). A VISTA-Point 
alignment was generated using a non-overlapping sliding window of 100 bp, and 
a screenshot of all the alignments was captured.  
 
Identification of TM-CC proteins. 
All 105,281 human and 54,447 mouse annotated protein sequences were 
downloaded from Ensembl (Release 71) using BioMart (Flicek et al., 2013). A 
Perl script was written to automate a pipeline to find protein sequences that 
contain one TM domain followed by coiled-coil domains. Protein sequences were 
scanned for TM domains using tmhmm 2.0 (Krogh et al., 2001). Sequences with 
only one TM domain and a probability > 0.5 were selected and scanned for coil-
coiled segments C-terminal to the TM domain using COILS (probability > 0.5) 
(Lupas et al., 1991). A complete list of all human and mouse gene locations was 
retrieved from Ensembl (Release 71) using BioMart. A Perl script was written to 
compare the locations of the resulting TM-CC proteins and the entire gene 
location list to establish the identity of the adjacent genes. Homology between 
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TM-CC proteins that are adjacent to each other was established by BLASTp 
searches. Similar structural analyses were performed on genomic sequence 
spanning GTPBP3 and CILP2 (were a contiguous locus was found), Gnomon 
gene predictions (Souvorov et al., 2010), proteomic and transcriptomic data 
(Benson et al., 2009) from different animal genomes used in this study. GPI 
anchor prediction was performed using Pred-GPI (Pierleoni et al., 2008). Splicing 
variants and expression of a particular TM-CC protein was addressed by 
consulting public RNAseq data when available. 
 
Analysis of TM-CC(aT), PV1, Tetherin and HERV-T env sequences. 
ML analyses on the type of evolution showed by pv1, tetherin and tm-cc(at) 
genes were performed using CODEML from the PAML suite of programs (Yang, 
1997). Due to the high divergence of the N- and C- termini of tetherin sequences 
across mammalian species, the following analyses were performed on a reduced 
sequence alignment that is composed of the transmembrane (TM) and coiled-coil 
domains (codons 22 to 133 of human Tetherin). Likewise the PV1 alignment 
does not include the last two codons (codons 1 to 440 of human PV1). Likelihood 
ratio tests were used to compare paired, nested models of sequence evolution 
that allow, or do not allow, variable selective pressure among sites (NSsites 
models 0 vs. 3), or positive selection (NSsites models 1 vs. 2 and 7 vs 8). The 
F3X4 model of codon frequencies was used for all analyses in CODEML. The 
gene trees used in these analyses were constructed using RaxML as previously 
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described. Model M0 was first used to obtain the branch lengths of the gene 
trees. The branch lengths were then used as initial values when running more 
complex models. The chi-square test was performed using 4 degrees of freedom 
for M0 vs. M3 or 2 degrees of freedom for M1 vs. M2 and M7 vs. M8. For all 
alignments used, sites where only one or two taxa contain data (i.e. the vast 
majority of the sites contain gaps) were removed from the alignment. 
BLASTp sequence similarity searches were performed under default parameters 
using either extant or ancestral PV1, TM-CC(aT) or Tetherin protein sequences 
as queries. The target database contained all Tetherin, PV1 and TM-CC(aT) 
protein sequences utilized/inferred in this study and the protein products from the 
211 human TM-CC genes. A heatmap graph of the e-values associated with the 
BLAST hits was constructed using Heatmap from Los Alamos HIV databases 
(http://www.hiv.lanl.gov). Alignment of Coelacanth PV1 and a TM-CC(aT) HMM 
model was obtained by using the HMMER3 web server 
(http://www.ebi.ac.uk/Tools/hmmer/) (Finn et al., 2011) with an alignment of TM-
CC(aT) protein sequences as query.  
Analysis for the features of HERV-T envelope sequences was performed using 
tmhmm 2.0 (Krogh et al., 2001) for TM and hydrophobic domains, and ProP1.0 
(Duckert et al., 2004) for signal peptide and propeptide cleavage sites.  
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Reconstruction of the tetherin locus. 
Sequences proximal to the tetherin gene from various animal genomes were 
retrieved using the Genome Browser at the University of California at Santa Cruz 
(http://genome.ucsc.edu/index.html) and synteny was assessed using the 
Genomicus Browser (http://www.genomicus.biologie.ens.fr/genomicus-70.01/cgi-
bin/search.pl) and the NCBI Sequence viewer 
(https://www.ncbi.nlm.nih.gov/tools/sviewer/). In the cases where pv1, tetherin or 
tm-cc(at) were not annotated in Ensembl, NCBI or UCSC, those genes were 
identified using orthologous protein queries from closely related species in BLAT 
searches (Kent, 2002). Publicly available RNA-seq data associated with the 
tetherin locus was analyzed using Ensembl and the NCBI Sequence Viewer. 
 
Plasmid construction. 
For the ancML construct we substituted the U3 region of the 5’ LTR with a CMV 
promoter sequence until its TATA box. We also added 12nt containing two MluI 
sites after the pol stop codon to facilitate the cloning of a reporter gene. The 
modified ancML sequence was synthesized and cloned on to pUC57 expression 
vector (Genewiz, NJ). Dr. John V. Moran kindly provided the replication 
dependent L1.3 plasmid (Moran et al., 1999). The replication dependent 
neomycin resistance (neo) cassette (a neo gene controlled by a separate SV40 
promoter and interrupted by an intron) was PCR amplified from L1.3 plasmid and 
cloned into ancML using the MluI (New England Biolabs) restriction sites 
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introduced after the stop codon of pol. A separate pCR3.1 expressing GFP and a 
neo gene (NEO) was utilized as a control.  
The ancML-RTmut construct was created by overlapping PCR to ancML utilizing 
primers that annealed to the RT active site with four nucleotide mismatches, 
resulting in a mutated RT active site (YIDD to AIAA). The PCR reactions were 
further treated with DpnI (New England Biolabs) restriction enzyme for an hour at 
37°C to eliminate plasmid DNA. The complete PCR fragment was cloned back to 
ancML using unique surrounding BstZ17I and NheI (New England Biolabs) 
restriction sites contained in the outmost primers. 
The ancMLΔGAAGT construct was generated using a reverse primer to the 
beginning of the PBS and the end of the U5 region of the 5’LTR and that lacked 
the 5nt linker sequence (GAAGT). The PCR product was DpnI (New England 
Biolabs) treated for an hour at 37°C to eliminate plasmid DNA. The PCR 
fragment was cloned back to ancML using unique AgeI and KpnI (New England 
Biolabs) restriction sites contained in the forward and reverse primers, 
respectively. 
Mouse MOV10 and SAMHD1 (isoform 2) were PCR amplified from total RNA 
extracted from NIH3T3 cells and cloned into pCR-Blunt II-TOPO using the Zero 
Blunt TOPO PCR cloning Kit (Life technologies). A plasmid expressing mouse 
APOBEC3 (C57BL/6J strain) was kindly provided by Dr. Rachel Liberatore 
(unpublished). HA-tags were introduced into the C-termini of SAMHD1 and 
APOBEC3 and into the N-terminus of MOV10 by PCR using primers containing 
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two HA tags and a 15nt linker sequence. All three constructs were introduced into 
the retroviral expression plasmid pLBCX (Clontech) using unique SfiI (New 
England Biolabs) sites.  
The codon-optimized sequences for expression in human of HTpG, ancHTenv, 
HsaHTenv and ancHsaHTenv were synthesized (Genewiz, NJ) and subsequently 
cloned into the pCAGGS expression vector (Niwa et al., 1991) using EcoRI and 
XhoI enzymes. Furin site modified HERV-T envelopes were generated by 
interchanging the active furin cleave site of ancHTenv for the inactive one in 
HsaHTenv, and vice versa. Primers that annealed to the respective furin 
cleavage sites with eigth nucleotide mismatches were used in overlapping PCR 
reactions, resulting in the interchange of the furin cleavage site to create 
ancHTenv-FurinMut (SRFRRAA to PRLHQAV) or HsaHTenv-FurinFix and 
ancHsaHTenv-FurinFix (PRLH(Q|R)AV to SRFRRAA). The PCR reactions were 
further treated with DpnI (New England Biolabs) restriction enzyme for an hour at 
37°C to eliminate plasmid DNA. The complete PCR fragment was cloned back 
into pCAGGS using EcoRI and XhoI (New England Biolabs) restriction sites 
contained in the outmost primers. HA tagged versions were produced by 
introducing two HA tags into the C-termini of all HERV-T envelopes, and into the 
N-terminus of HTpG, by PCR using primers containing two HA tags, a 15nt linker 
sequence and at least 30nt annealing to the corresponding termini. Tagged and 
un-tagged HERV-T envelope constructs were subcloned into pCCIB and 
pCCIGW (Kane et al., in preparation) lentiviral expression plasmids to produce 
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stable cell lines and for transient expression (for FACS experiments), 
respectively. HERV-T envelope sequences and SIV Nef were PCR amplified 
using primers containing SfiI (pCCIB) or SnaBI and BstXI (pCCIGW) for 
subcloning. The sequence of human MOT1 was amplified from the gDNA of DF-1 
cells expressing a 293T cDNA library (described below). The amplified sequence 
was cloned into pCCIB utilizing SfiI sites to make stable DF-1 cell lines 
expressing human MOT1. Human SERINC5 construct was kindly provided by Dr. 
Fengwen Zhang (unpublished). SIV and HIV Nef constructs have been previously 
described (Zhang et al., 2009). The MLV glycoGag construct was kindly provided 
by Dr. David Perez-Caballero (unpublished). The MLV Gag-Pol (MLVgp), MLV-A 
and MLV-E expressing plasmids were kindly provided by Dr. François-Loïc 
Cosset. 
All Tetherin, PV1, TM-CC(aT) or TM-CC proteins were transiently expressed 
using pCR3.1 (Invitrogen) based plasmids. The human PV1, the Tasmanian devil 
Tetherin, human CD72 and mouse CLEC1A expression plasmids were kindly 
provided by Dr. Siddarth Venkatesh (unpublished). All remaining tetherin/tm-cc-
gpi (except human) and tm-cc(at) genes were synthesized with codon-
optimization for human cells (Genewiz, Inc.) and cloned into pCR3.1 using EcoRI 
and NotI restriction sites. 
The sequences used in this study were: (i) Tetherin/TM-CC-GPI proteins: Human 
(NP_004326.1), Opossum (XP_007489270.1), Tasmanian devil 
(XP_012399618.1), Chinese alligator (XP_006017476.1), and Elephant shark 
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(XP_007897024.1). The Falcon Tetherin protein was derived from the incorrect 
gene annotation of the CILP2 gene (XM_005444350.1), which resulted in a 
fusion of CILP2 and Tetherin and was guided by Gnomon prediction 
2189215010.p. The Coelacanth Tetherin protein was derived from a Gnomon 
gene prediction (16424589.p) at the genomic sequence NW_005819727.1 from 
positions 98723 – 108999. The lamprey TM-CC-GPI sequence was derived from 
the TM-CC-GPI analysis (see above) of assembled transciptome data from the 
Lamprey sequencing consortium (Smith et al., 2013) (transcript number 
1626467). (ii) TM-CC(aT) proteins: Mouse (XP_003945491.1), Painted turtle 
(XP_008169839.1). Human TM-CC(aT) was derived from GenBank entry 
XP_011526778.1 excluding the predicted fifth exon so that it has four exons 
similar to the mouse variant. Chinese alligator TM-CC(aT) was derived from a 
Gnomon gene prediction (2147496003.p) and refined using the predicted 
American alligator TM-CC(aT) protein (KQL90195.1). Coelacanth TM-CC(aT)B 
was derived from GenBank entry XP_006001674.1 with the first 12 amino acids 
removed, guided by an alignment of other TM-CC(aT) proteins. (iii) PV1 protein: 
Human (NP_112600.1).  
All GPI anchor additions were generated by using a reverse primer that encoded 
the Tetherin GPI anchor sequence (amino acids 160 to 180) and a NotI site. HA-
tagged versions of all the constructs were generated using a forward primer 
encoding 2 repeats of the HA tag previous to the initiation codon. Alternatively 
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spliced variants of TM-CC(aT) were constructed by PCR using different 3’ 
primers.  
The sequence for all plasmids was verified by Sanger sequencing (Genewiz, 
Macrogen). 
 
Cell culture. 
All cells used in this study (except CHO-K1 and pgsA cells) were maintained in 
Dulbecco’s Modified Eagle Medium (DMEM), Eagle's Minimum Essential Medium 
(EMEM) or Roswell Park Memorial Institute medium (RPMI) supplemented with 
10% FBS and gentamycin (2µg/ml, Gibco) according to ATCC instructions. CHO-
K1 and pgsA cells were maintained in Ham’s F-12 media supplemented with 
10% FBS, 1mM of L-glutamine and 2ug/ml of gentamycin. All cells were 
incubated at 37°C, except DF-1 cells that were incubated at 39°C.  
In order to make stable cell lines, 293T cells were transfected with plasmids 
expressing MLV gag-pol polyprotein (MLVgp), VSV glycoprotein (VSV-g) and 
pLBCX plasmids containing HA tagged or untagged versions of mouse 
APOBEC3, MOV10, SAMHD1 (described above) using polyethylenimine. 
Alternatively, 293T cells were transfected with plasmids expressing HIV-1 gag-
pol polyprotein (pCRV1, (Zennou et al., 2004)), VSV glycoprotein and pCCIB 
plasmids containing human MOT1 or HA tagged/untagged, mutated/non-mutated 
versions of different HERV-T envelopes (described above) using 
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polyethylenimine. In every case viruses were harvested and filtered two days 
after transfection and were used to infect the naïve cells of interest (seeded in 24 
well plates). Infected cells were expanded in 10 cm dishes with media 
supplemented with the corresponding amounts of blasticidin S (Thermo Fisher 
Scientific Inc.) and were monitored from 3 to 10 days before performing 
experiments or isolating single cell clones. 
Single cell clones expressing mouse APOBEC3, MOV10 and SAMHD1, or 
different HA tagged/untagged, mutated/non-mutated versions of HERV-T 
envelopes were further generated by expanding blasticidin resistant cells seeded 
at 0.5 cells per well in a 96 well plate. Single colonies on 96 well plates were 
monitored and sequentially expanded. 
 
MuERV-L replication assays. 
Sixteen cell lines (Table 4.1) were seeded on 12 well plates one day before being 
transfected with 700ng of plasmids expressing L1.3, ancML or a plasmid 
expressing gfp and a neo gene using 4µl of Lipofectamine 2000 (Thermo Fisher 
Scientific Inc.) according to manufacturer instructions. DNA and Lipofectamine 
2000 dilutions were performed using Opti-MEM (Gibco). Cells were expanded 
into 6 well plates under G418 selection media two days after transfection. 
Amounts of G418 were titrated previously for each cell type. Ten days after 
selection cells were fixed with 4% paraformaldehyde (PFA) and colonies were 
stained using 0.3% crystal violet in 20% ethanol for counting.  
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The ancML replication assays on CHO-K1 cells were performed as follows. CHO-
K1 cells were seeded at a concentration of 3 x 105 per well on a 12 well plate. 
One day after, the cells were transfected with 1µg of plasmid DNA using 3µl of 
Transit-CHO supplemented with 0.5µl of CHO-mojo reagent (Mirus) diluted in 
Opti-MEM (Gibco). One day after, the cells were expanded on a 10cm dish with 
media supplemented with or without different concentrations of Zidovudine (AZT) 
or mouse INF-α (Pestka Biomedical Laboratories, Inc.). Two days after, cells 
were expanded on a 15 cm dish or three 96 well plates (for analysis of single cell 
clones) with media supplemented with 1µg/ml of G418. 1/1000 of the cells initially 
transfected with the NEO plasmid were expanded on a 15 cm dish with selection 
media. Cells in 15 cm dishes were cultured under selection for an additional 10 
days before treatment with 4% PFA and colonies were stained with 0.3% crystal 
violet in 20% ethanol for counting. Single colonies on 96 well plates were 
monitored and sequentially expanded until reaching confluency on a 10 cm dish. 
Genomic DNA (gDNA) was extracted of 5 x 106 cells using QIAmp DNA mini kit 
(QIAGEN) for genome walker assays (see below). AZT was obtained from the 
NIH AIDS Reagent Program, Division of AIDS, NIAID, NIH.  
 
Integration sites analyses (Genome Walker). 
Integration sites of ancML were cloned and sequenced using the universal 
genome walker kit (Clontech). Nested PCRs were performed on gDNA of single 
cell clones of CHO cells transfected with a plasmid expressing ancML and 
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previously digested with EcoRV (New England Biolabs) and ligated to adaptors. 
Forward primers to amplify 3’ flanking sequences were designed to anneal to the 
R region of the 3’LTR and the reverse primers to the adaptor sequence. Reverse 
primers to amplify 5’ flanking sequences were designed to anneal to the U3 
region of the 5’LTR and the forward primers to the adaptor sequence. Major 
bands from secondary PCRs were gel purified and cloned into pCR-Blunt II-
TOPO using the Zero Blunt TOPO PCR cloning Kit (Life technologies) for 
sequencing. Resulting CHO gDNA sequences were mapped to the CHO genome 
(criGri1) using BLAT (Kent, 2002) searches on the UCSC genome browser (Kent 
et al., 2002). Similar searches were performed on the matched random 
sequences.  
 
PCR analyses. 
To estimate the fate of the intron interrupting the neo gene, gDNA of CHO cells 
transfected with a plasmid expressing ancML, ancMLΔGAAGT or an empty 
vector, were used as template for PCR analysis. Forward and reverse primers 
were designed to anneal to the extremes of the neo gene. Human MOT1 and the 
non-coding fragment of human atg12 were PCR amplified from gDNA of RFP 
expressing DF-1 cells infected with a 293T cDNA retroviral library (described 
below) and resistant to G418 and Hygromycin. Forward and reverse primers 
were designed to anneal to the extremes of the pCCIB vector in which the cDNA 
library was cloned into (described below). Mouse TM-CC(aT) was PCR amplified, 
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cloned and sequenced from cDNA derived from 7-day mouse embryo total RNA 
(Clontech, Cat. # 636607) using forward primers specific to the first and third 
exon and reverse primers specific to the third exon and to the 3’UTR. For all 
PCRs performed in this study we used Phusion High-Fidelity DNA Polymerase 
(ThermoFisher).   
 
Virion yield assays. 
MLV particles pseudotyped with the amphotropic envelope (MLV-A), the 
ecotropic envelope (MLV-E), VSV-g and different HERV-T envelopes were 
produced in 293T cells by co-transfecting the corresponding envelope plasmids 
with plasmids expressing a MLV gag-pol polyprotein (MLVgp), a neo gene and 
GFP/RFP (pCNCG/pCNCG) (Soneoka et al., 1995) or a hygromycin resistance 
gene (pLHCX, Clontech), using polyethylenimine. Additionally for certain 
experiments, 293T cells were also co-transfected with increasing amounts of 
plasmids expressing HTpG, MLV glycoGag, SIV Nef, HIV Nef (pCAGGS), and for 
some experiments also with 15µg of a plasmid expressing human SERINC5. In 
every case the total amount of DNA was held constant by supplementing the 
transfection with an empty vector (pCAGGS). Viruses were harvested and filtered 
(0.22 µm) two days after transfection and serial dilutions (1/3) were used to infect 
the cells of interest (293T, DF-1, NIH3T3, HT1080, etc). Viral titers were 
calculated by expanding the infected cells in 10 cm dishes with media 
supplemented with the corresponding amounts of antibiotic and monitored for 10 
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days before resistant colonies were counted (for MLV particles expressing neo 
and hygromycin resistance genes). Alternatively, viral titers were calculated by 
determining the percentage of infected cells expressing GFP or RFP 2 days post 
infection using the Guava EasyCyte flow cytometer (Millipore). Where specified, 
viruses were concentrated using the Amicon Ultra-15 filters (10kDa, Millipore). 
HIV-1(WT) and HIV-1(ΔVpu) versions of the HIV-1 molecular clone NL4-3 have 
been previously described (Neil et al., 2006). 293T cells were co-transfected 
using polyethylenimine with 300ng of wild-type (HIV-1(WT)) or Vpu-deficient 
(HIV-1(ΔVpu)) proviral plasmids along with varying amounts of Tetherin, PV1, 
TM-CC(aT) or TM-CC expression plasmids and a plasmid expressing YFP 
(100ng), to monitor transfection efficiency. For experiments with Tetherin 
proteins, 5 to 20 ng of plasmid were used. In all transfection experiments, the 
total amount of DNA was held constant by supplementing the transfection with an 
empty expression vector (pCR3.1). Two days post transfection, the culture 
supernatants were harvested, clarified by centrifugation at 3000 rpm, and filtered 
(0.22 µm). Infectious virus yield was determined by inoculating sub-confluent 
monolayers of HeLa-TZMbl cells (NIH AIDS Reagent Program, Division of AIDS, 
NIAID, NIH) that were seeded in 96 well plates at 10,000 cells/well with 100 µl of 
serially diluted supernatants. At 48 hours post infection, β-galactosidase activity 
was determined using GalactoStar reagent, in accordance with the 
manufacturer’s instructions (Applied Biosystems).  
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For all experiments, physical particle yield was determined by layering 600 µl of 
the virion containing supernatant onto 1 ml of 20% sucrose in PBS followed by 
centrifugation at 20,000xg for 90 minutes at 4°C. Virion pellets were then 
analyzed by Western blotting. 
 
Western blot assays 
Pelleted virions and cell lysates were resuspended in SDS-PAGE loading buffer, 
with the addition of 0.5% β-mercaptoethanol, and resolved on NuPAGE Novex 4-
12% Bis-Tris Mini Gels (Invitrogen) in MOPS running buffer. Proteins were 
blotted onto nitrocellulose membranes (HyBond, GE-Healthcare) in transfer 
buffer (25 mM Tris, 192 mM glycine). The blots were then blocked with Odyssey 
blocking buffer and probed with mouse monoclonal anti-HIV-1 capsid (R183, 
NIH), rat monoclonal anti-MLV capsid (R187, ATCC), mouse monoclonal anti-HA 
(Covance), or mouse monoclonal anti-PV1 (Abcam) primary antibodies. The 
bound primary antibodies were detected using a fluorescently labeled secondary 
antibody (IRDye 800CW Goat Anti-Mouse Secondary Antibody, LI-COR 
Biosciences). Fluorescent signals were detected using a LI-COR Odyssey 
scanner and quantitated with Odyssey software (LI-COR Biosciences). 
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Immunofluorescence assays. 
Transfected, stable cell populations or single cells clones expressing a particular 
HA-tagged HERV-T envelope or HTpG were seeded one day previous to the 
immunofluorescence assay. Cells were fixed with 4% PFA for 30 minutes 
followed by treatment with 10mM glycine (diluted in PBS) for another 30 minutes. 
Cells were permeabilized with a buffer containing 0.1% of Triton X-100 
(ThermoFisher) and 5% goat serum (diluted in PBS) for 15 minutes. Cells were 
then washed 2 times with PBS before being treated with mouse monoclonal anti-
HA (Covance) diluted in a buffer containing 0.1% Tween-20 (ThermoFisher) and 
5% goat serum (diluted in PBS) for 2 hours at room temperature. Cells were 
washed three times with PBS before being treated with goat anti-mouse 
secondary antibody (Alexa Fluor 488 dye, ThermoFisher) diluted in a buffer 
containing 0.1% Tween-20 (ThermoFisher) and 5% goat serum (diluted in PBS) 
for 1 hour at room temperature. DNA was stained with 50µg/ml of 4',6-diamidino-
2-phenylindole (DAPI) (diluted in PBS) (Invitrogen) for 5 seconds. Cells were 
washed three more times with PBS and fluorescent microscopy images were 
analyzed using the DeltaVision software (GE Healthcare) or the EVOS FL Cell 
Imaging System (ThermoFisher).  
 
Fluorescence-Activated Cell Sorting (FACS). 
Viruses were produced in 293T cells transfected with plasmids expressing HIV-1 
gag-pol polyprotein (pCRV1), VSV glycoprotein and pCCIGW plasmids 
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expressing GFP and containing mutated/non-mutated versions of different 
HERV-T envelopes (described above) or an unrelated protein (SIV Nef) using 
polyethylenimine. Viruses were harvested and filtered (0.22 µm) two days after 
transfection and were used to infect 2 x 105 naïve 293T cells seeded in 24 well 
plates. Transduced cells were expanded in 10 cm dishes until reaching 
confluency. Afterwards, serial dilutions of concentrated frozen stocks of MLV 
expressing RFP (pCNCR) pseudotyped with ancHTenv were used to infect 2 x 
105 transduced 293T cells in 24 well plates. Two days post infection the number 
of GFP positive, RFP positive and double positive cells were counted by FACS 
using CyFlow space (Partec). The resulting data was analyzed with the FlowJo 
analysis software. The percentage of RFP and GFP positive cells was calculated 
by gating on the GFP positive population.  
 
293T cDNA library preparation and screening.  
Total RNA was isolated from a confluent 10cm dish of 293T cells using Trizol 
(Invitrogen). mRNA transcripts were enriched using Oligotex polyA+ resin 
(Qiagen). polyA RNA was used to construct a cDNA library using the SMART 
cDNA Library Construction Kit (Clontech). Briefly, cDNA containing SfiI restriction 
sites was synthesized using the SMARTScribe MMLV reverse transcriptase 
(Clontech) with SMART primers. The resulting cDNA was further amplified by 15 
cycles using Phusion High-Fidelity DNA Polymerase (ThermoFisher) using 
SMART primers. PCR products were treated with Proteinase K (Clontech) for 20 
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minutes at 45°C before they were digested by SfiI restriction enzyme (NEB) for 2 
hours at 50°C. Digested products were then size fractionated using CHROMA 
SPIN-400 columns (Clontech). The first cDNA containing fractions (>500bp) were 
selected to ligate into a previously digested pCCIB plasmid with the 
corresponding SfiI sites. Overnight ligation was performed using T4 DNA ligase 
(NEB). The resulting 293T cDNA library had a complexity of 3.5 x 106 colony 
forming units and was expanded by transformation into electrocompetent DH5α 
bacteria cells. Transformed bacteria were cultured on 6lt of SeaPrep soft agarose 
(Lonza) diluted in 2xLB media at 30°C for 2.5 days, followed by DNA preparation.  
Viral stocks carrying the cDNA library were produced by transfecting 6 x 106 293T 
cells with plasmids expressing HIV-1 gag-pol polyprotein (pCRV1), VSV 
glycoprotein and the cDNA library plasmids (pCCIB). Viruses were harvested, 
filtered (0.22 µm), concentrated (Amicon Ultra-15 filters 10kDa, Millipore) and 
frozen two days after transfection. DF-1 cells (or NIH3T3) were infected with the 
library at an MOI of 8. Infected DF-1 cells were challenged with frozen stocks of 
MLV particles pseudotyped with ancHTenv containing a neo resistance gene 
(pCNCG) two days after infection with virus carrying the cDNA library. Infected 
DF-1 cells were placed in G418 selection two days post infection (dpi) with the 
neo containing virus and resistant colonies were collected after 10 days. G418 
resistant DF-1 cells were then challenged with ancHTenv pseudotyped MLV 
particles containing a hygromycin resistance gene (pLHCX). Cells were placed in 
hygromycin selection two dpi and resistant colonies were collected after 10 days. 
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Hygromycin resistant DF-1 cells were infected with ancHTenv pseudotyped MLV 
particles expressing RFP upon infection (pCNCR). gDNA was extracted from the 
RFP positive DF-1 cell population and possible receptor candidates were 
amplified by PCR using primers to the pCCIB vector. 
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Chapter III. Screening for primate and murine ERVs 
Essential for any paleovirological analysis is the initial screening to assess the 
endogenous viral elements (EVEs) diversity present in the genome(s) of interest. 
Comparative investigations based on sequence similarity searches have been 
crucial in the discovery and characterization of EVEs (Katzourakis and Gifford, 
2010; Katzourakis et al., 2007; Tristem, 2000). However given the large volumes 
of sequence data available, an organized similarity-search based approach is 
needed to identify highly mutated EVEs in multiple genomic sequences.  
 
Database Integrated Genome Screening. 
We collaborated with Dr. Robert Gifford at the MRC-University of Glasgow Center 
for Virus Research, to develop DIGS (database-integrated genome screening), a 
computational framework to identify EVEs in a variety of animal genomes by 
implementing systematic BLAST-based in silico screens of molecular sequence 
databases. 
The DIGS framework is composed of Perl scripts that utilize the BLAST+ 
package of programs (Camacho et al., 2009) to identify, extract, and classify 
EVEs present in genomic sequences. It requires a control file that specifies the 
parameters used for the BLAST-based screening, as well as a set of target 
nucleotide sequence databases for screening (i.e. complete genomes or 
scaffolds), and a reference library containing well characterized viral sequences. 
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A basic DIGS screening project is comprised of two steps (Figure 2.1). In the first 
step, query sequences selected from the reference library are used to search the 
target databases. In the second step, significant hits from the first round of 
BLAST are classified, or “genotyped”, by a second BLAST comparison to the 
reference library. The screening progress and their results are captured in a 
relational database enabling both the management of the screening process and 
the interrogation of the data generated, using structured query language (SQL). 
Subsequent analysis of the results might be used to refine the reference library 
allowing the screen to proceed through multiple iterations and reconfigurations.  
Dr. Robert Gifford performed an initial screening in which he used RT amino acid 
sequences of endogenous and exogenous retroviruses as probes to identify ERV 
sequences in catarrhine genomes (old world monkeys and apes). This initial 
“phylogenetic” screening exploited the fact that the retroviral RT is relatively 
resistant to mutation, and can be used for molecular phylogenetic investigations 
across the entire retroviridae family. Therefore, RT sequences recovered by this 
screening were placed into an alignment containing RT sequences of well-
characterized retroviral families, and used to construct a phylogenetic tree. As 
expected, all catarrhine ERV RTs were clustered into monophyletic lineages 
inside three major clades, corresponding to the three major divergences in the 
evolution of retroviral RTs (Llorens et al., 2008; Tristem, 2000), and grouped 
outside the clades defined by exogenous retrovirus genera. Eighteen of these 
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ERV lineages were selected for further investigation, representing four major RT 
clades (Table 3.1). 
We inferred consensus genomes of those 18 ERV lineages by extracting and 
aligning sequences containing a RT flanked by paired repeats (likely to constitute 
LTRs). The major polypeptides and non-coding LTR sequences of those 
consensus genomes were used as probes on a second round of DIGS screening 
in catarrhine genomes. Individual results of this screening were automatically 
assembled into representative proviral loci using a “consolidation” function 
adapted for DIGS. This function orders the DIGS results by genome scaffold and 
orientation; adjacent or overlapping entries are assembled into a proviral locus by 
comparison with a canonical ERV reference genome structure of the form LTR-
gag-pol-env-LTR (see chapter II and Figure 2.2). The consolidation function 
allows not only the defragmentation of individual results into a contiguous proviral 
locus, but also can potentially uncover possible recombination events by 
consolidating ERV sequences that were classified to belong to distinct ERV 
lineages. The results of this second round of DIGS screening and consolidation 
are summarized in Table 3.1.  
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Table 3.1: Analysis of 18 ERV lineages present in catarrhine genomes 
identified by DIGS 
Re
co
m
bi
na
nt
 
Lo
ci
* 
5.
28
%
 
4.
29
%
 
14
.3
4%
 
60
.4
0%
 
37
.6
3%
 
8.
40
%
 
20
.4
7%
 
11
.3
1%
 
12
.0
3%
 
29
.1
1%
 
20
.5
7%
 
45
.3
3%
 
23
.4
3%
 
33
.0
7%
 
13
.0
7%
 
11
.6
0%
 
31
.8
2%
 
16
.0
4%
 
# P
ro
vir
us
es
 c
las
sif
ied
 a
s 
po
l a
re
 th
os
e 
th
at
 o
nly
 c
on
ta
in 
po
l s
eq
ue
nc
es
. *
 R
ec
om
bin
an
t l
oc
i r
ef
er
 to
 th
e 
pe
rc
en
ta
ge
 o
f n
on
-s
olo
LT
R 
loc
i c
om
po
se
d 
of
 h
its
 b
elo
ng
ing
 to
 m
or
e 
th
an
 o
ne
 a
ss
ign
ed
 lin
ea
ge
. 
en
v-
 
72
10
 
28
4 
17
38
 
11
7 
19
83
 
52
13
 
11
8 
18
8 
10
2 
85
6 
16
9 
23
8 
31
9 
31
 
40
9 
15
5 
43
 
95
9 
en
v+
 
11
 
20
6 
13
58
 
32
 
40
9 
49
9 
53
 
95
 
51
 
11
81
 
18
1 
12
6 
38
1 
96
 
29
5 
25
0 
19
9 
57
5 
Pr
ov
iru
s 
11
40
 
9 79
7 
33
 
53
3 
23
39
 
19
 
25
 
23
 
12
7 
12
7 
66
 
16
7 
39
 
25
 
15
 
69
 
70
 
so
lo
LT
R 
17
69
8 
32
 
19
19
7 
26
7 
30
54
 
57
18
 
25
0 
26
4 
23
5 
73
4 
11
66
 
45
0 
11
41
0 
20
62
 
10
5 
99
 
12
93
 
78
8 
po
l# 
20
33
 
19
0 
37
9 3 18
2 
65
1 
57
 
29
 
28
 
96
 
12
 
70
 
55
 
3 21
9 
17
 
18
 
36
9 
To
ta
l 
24
91
9 
52
2 
22
29
3 
41
6 
54
46
 
11
43
0 
42
1 
54
7 
38
8 
27
71
 
15
16
 
81
4 
12
11
0 
21
89
 
80
9 
50
4 
15
35
 
23
22
 
RT
 
Cl
ad
e 
L/
S 
L/
S 
9/
30
/W
 
9/
30
/W
 
9/
30
/W
 
H/
XA
/F
 
H/
XA
/F
 
H/
XA
/F
 
H/
XA
/F
 
E/
T 
E/
T 
HE
RV
-K
 
HE
RV
-K
 
HE
RV
-K
 
HE
RV
-K
 
HE
RV
-K
 
HE
RV
-K
 
HE
RV
-K
 
Li
ne
ag
e 
HE
RV
-L
 
HE
RV
-S
 
ER
V-
9 
HE
RV
-3
0 
HE
RV
-W
 
HE
RV
-H
 
HE
RV
-X
A 
HE
RV
-F
b 
ER
V-
Fc
 
HE
RV
-E
 
HE
RV
-T
 
HE
RV
-K
14
C 
HE
RV
-K
-H
M
L2
 
HE
RV
-K
-H
M
L4
 
HE
RV
-K
-H
M
L5
 
HE
RV
-K
-H
M
L6
 
HE
RV
-K
-H
M
L8
 
HE
RV
-K
-H
M
L9
 
  
	   89 
As expected, soloLTR sequences are in high excess compared to other proviral 
structures for most of the lineages analyzed. The low soloLTR proportion for 
some lineages can be explained by the alternative usage of other related LTR 
sequences. This is the case of HERV-S where the soloLTRs account for only 6% 
of all the loci. According to RepBase (Jurka et al., 2005) HERV-S elements can 
be associated with 3 types of LTR sequences LTR18A, B and C, which share 65 
- 79% nucleotide identity between them, but with a high proportion of indels. It is 
possible that the lack of HERV-S soloLTRs identified in this analysis is due to the 
underrepresentation of other related LTR sequences in the consensus reference 
genome and in the reference library. A similar scenario might be true for lineages 
such as HERV-Fb and HERV-E in which their elements are associated to diverse 
LTR groups. 
All lineages selected contained a percentage of sequences that might have a 
recombinant origin. For HERV-E members, where the percentage of non-
soloLTR recombinant loci is close to 30%, the main contributors are sequences 
assigned to HERV-W, HERV-I, HERV-K-HML2 and ERV-9. The Harlequin 
recombinant element is composed of pieces of HERV-E, HERV-W, HERV-I and 
HERV-P (Jurka et al., 2005), thus it is possible that some of the HERV-E mosaic 
loci identified by DIGS represent Harlequin elements. Similarly other HERV-E 
mosaic loci might account for the low copy DA and Xiao elements composed of 
HERV-E, HERV-K, HERV-T and HERV-H fragments (Ji and Zhao, 2008; Li et al., 
2009). Sequences belonging to the ERV-9/HERV-30/HERV-W RT clade showed 
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a high degree of mosaicism within elements of the same clade, this is particularly 
the case for HERV-30 where 60% of their non-soloLTR loci are of recombinant 
origin and are mainly composed of sequences assigned to ERV-9 (52%) and 
HERV-W (20.81%). This high degree of putative recombination in a RT clade can 
also be an artifact of the “genotypification” step implemented in DIGS, where 
closely related sequences can be incorrectly assigned to a member of the same 
clade. A similar scenario might be true for members of the HERV-K RT clade, 
where the percentage of recombinant non-soloLTR loci ranges from 11% for 
HERV-K-HML6, to 45% for HERV-K14C. Of this putative mosaic species, a high 
proportion contain sequences assigned to other HERV-K members (particularly 
HERV-K-HML2, 9 and 14) and, to a lower extent, sequences assigned to ERV-9 
and HERV-H. The opposite scenario seems to be true for the abundant HERV-H 
lineage where the majority of its loci are composed solely of HERV-H sequences.  
HERV-H possess the most proviruses flanked by two LTRs, 2,339 loci or ~20% 
of all HERV-H loci, including soloLTRs. Larger lineages are abundant in 
sequences that had replicated by complementation in trans or by 
retrotransposon-like replication (Figure 1.7B) (Belshaw et al., 2005). Consistent 
with the inference that they had arisen via these processes, such large lineages 
overwhelmingly lacked complete ORFs (Magiorkinis et al., 2012) or showed 5’ 
truncations and poly-A tails indicative of LINE retrotransposition (Esnault et al., 
2000). In the case of HERV-H there are 10 fold more loci with missing env genes 
than env containing loci, which argues for a retrotransposon-like replication, in 
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agreement with previous observations (Goodchild et al., 1995). A similar scenario 
is true for HERV-L and HERV-W (Belshaw et al., 2005; Magiorkinis et al., 2012). 
HERV-L is distantly related to spumaviruses and prototypical members show a 
complete lack of an env gene. In the current study, DIGS was able to 
characterize 11 proviruses containing an env gene, however a closer look into 
these sequences show mosaic origin with predominantly HERV-L LTRs flanking 
env genes belonging to HERV-E and HERV-I. Overall DIGS successfully 
identified and assembled loci associated with the selected lineages in catarrhine 
genomes with numbers in accordance to previous estimates. 
 
Analysis of a human ERV lineage closely related to gammaretroviruses. 
Although no extant human gammaretroviruses have been identified, HERV-T is 
an ERV lineage that shares significant similarity with members of the 
gammaretrovirus genus (Blusch et al., 1997). Indeed, the initial “phylogenetic” 
screening found HERV-T as the lineage closer to the gammaretroviruses clade. 
Our previous DIGS screening revealed relatively low copy numbers in catarrhine 
genomes with soloLTRs accounting for more than 75% of all elements. HERV-T 
also has a moderate rate of mosaicism (20%) mostly with lineages outside its RT 
clade (mainly HERV-H, HERV-K, ERV-9 and HERV-30). Additionally, and 
consistent with its low copy number, HERV-T has an envelope sequence 
associated with the majority of their non-soloLTRs elements (52%). Previous 
analysis of these envelope sequences has revealed a significantly low dN/dS 
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ratio suggesting past purifying selection and a replication mechanism dependent 
on reinfection (Belshaw et al., 2005).   
In order to further investigate the evolution of this lineage, we downloaded 44 
non-mosaic proviral sequences containing coding fragments (gag, pol and env) 
flanked by paired LTRs and aligned them to the consensus reference HERV-T 
sequence (see chapter II). The resulting alignment was used to guide a 
maximum likelihood phylogenetic tree that was rooted based on an out-group 
sequence, a HERV-T related sequence in the genome of a platyrrhine (new world 
monkey) primate (Saimiri sciureus) (Figure 3.1). The phylogenetic tree clearly 
identifies three distinct monophyletic clades. This topology was corroborated on 
phylogenetic trees obtained using an alignment of the soloLTRs. A closer look 
into the LTRs of HERV-T shows three classes of LTRs, which correspond to the 
paired LTRs of the three monophyletic clades in Figure 3.1. Two were previously 
annotated in RepBase, LTR6A and LTR6B (corresponding to HERV-T3 and 
HERV-T2 in our notation), and a more divergent third one (HERV-T1) that shares 
55% and 63% of identity with the other two, respectively (Table 3.2). On average 
in alignments comparing HERV-T2 or HERV-T3 to HERV-T1 LTRs, 26% of sites 
correspond to gaps, inserted primordially in the first two thirds of the alignment 
(Table 3.2). Each of these LTR classes might account for three independent 
germ line invasion events, or for three expansion periods of a subset of ancestral 
HERV-T elements. In order to obtain more information about the dynamics of 
these lineages, and given that there are relatively low numbers of paired LTR 
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elements (Table 3.1), we extracted each soloLTR identified in catarrhine 
genomes, classified them to belong to one of the three classes of LTRs and 
create a consensus sequence of each class. Each LTR was then compared to 
the corresponding consensus sequence and its divergence was calculated using 
PAUP* (Swofford, 2002) under a GTR model (see chapter II). Integration dates 
for each LTR were subsequently calculated by adjusting the distance to the 
consensus using a human neutral substitution rate of 2.2 x 10-9 substitutions per 
site per year (Lander et al., 2001; Subramanian et al., 2011) (Figure 3.2). The 
cumulative lineage through time plots for each HERV-T class indicates that 
HERV-T3 is the oldest. HERV-T3 started a slow expansion before the old world 
monkeys diverged from the rest of the apes, and might have derived from the 
HERV-T-like elements present in platyrrhini species. HERV-T3 elements then 
started a fast expansion period between ~25 and 15 MYA, probably through 
reinfection mechanisms, as indicated by the integrity of the envelope and further 
analysis described in chapter V. HERV-T1 slowly expanded during ~15 MY and 
showed a boost about 15 MYA. HERV-T2 might have derived from a HERV-T1 
(Figures 3.1 and 3.2) and showed an initial slow expansion with a further boost 
~20 MYA, about the times gibbons diverged from the rest of the hominids. These 
estimated dates of integration were further corroborated with dates calculated 
from paired LTRs containing elements (see Chapter V).  
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Table 3.2: Percentage of identity and gaps inserted in pairwise alignments 
of HERV-T LTR classes. 
LTR 
class 
  
HERV-T1 HERV-T2 HERV-T3 
% 
Identity 
% 
Gaps 
% 
Identity 
% 
Gaps 
% 
Identity 
% 
Gaps 
HERV-T1 100 0      
HERV-T2 63.6 24.2 100 0    
HERV-T3 55.1 28.9 67.7 17.8 100 0 
Alignments generated on consensus LTRs using a Needleman-
Wunsch algorithm. 
 
As observed in the phylogenetic tree of HERV-T proviruses (Figure 3.1), a 
subgroup of HERV-T2 sequences clustered into a tight monophyletic clade of 
closely related sequences, depicted by short branch lengths compared with the 
rest of HERV-T sequences.  A close examination of all non-mosaic HERV-T2 
proviral elements, containing fragments of coding genes (gag-pol-env), revealed 
that 59% of these elements showed significant signatures of APOBEC3-mediated 
hypermutation (Rose and Korber, 2000) (Figure 3.3), and share similar sequence 
deletions compared to a consensus HERV-T sequence, particularly involving gag 
and env genes. These observations suggest that the majority of the copy 
numbers observed for HERV-T2 elements were derived from a reduced set of 
hypermutated and inactivated elements (most likely due to APOBEC3 proteins) 
that were expanded by complementation in trans, probably through 
retrotransposon-like mechanisms. Further paleovirological analyses were 
performed on HERV-T1 and HERV-T3 elements described in chapter V. 
	   95 
 
 
 
Figure 3.1: HERV-T proviruses cluster into three monophyletic clades. 
Maximum Likelihood phylogenetic tree of 44 HERV-T proviral loci with a structure 
of the form LTR-gag-pol-env-LTR. The three distinct monophyletic clades are 
indicated with colors. The phylogenetic tree was rooted based on an out-group 
sequence (SsT_5144). Bootstrap support on internal nodes is indicated by 
asterisks: (*) > 80, (***) > 99. (1000 bootstrap replicates). 
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Figure 3.2: Dynamics of the HERV-T lineage through time. 
Cumulative distribution of soloLTRs by its date of integration. Integration date 
approximated by adjusting the distance to their corresponding consensus 
sequence and a human neutral substitution rate of 2.2 x 10-9 substitutions per site 
per year (Lander et al., 2001) (see chapter II). Speciation dates for distinct 
primate groups or species are indicated by dotted lines. OWM: Old World 
Monkeys. 
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Figure 3.3: Hypermutation analysis of HERV-T1 and HERV-T2 proviral 
sequences. 
Profile of G to A transitions of HERV-T2 and HERV-T1 proviral sequences 
containing fragments of coding genes (gag-pol-env). Proviral sequences were 
aligned to a consensus HERV-T sequence and its APOBEC3 mediated 
hypermutation profile was assessed using Hypermut 2.0 (Rose and Korber, 
2000) with default parameters. Lines in red and cyan represent A3-derived G to A 
transitions (GG to AG and GA to AA respectively), whereas lines in green and 
magenta represent non APOBEC3-derived G to A transitions (GC to AC and GT 
to AT respectively). Lines in yellow indicate gaps compared to the consensus 
sequence. (*) p-value < 0.05, (**) p-value < 0.01, (***) p-value < 0.001 
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Analysis of a murine specific ERV lineage transcriptionally active in the mouse 
embryo. 
As previously described in chapter I, MuERV-L is a highly abundant mouse 
specific endogenous retrovirus that continues to be transcriptionally active at an 
early stage of the mouse embryo (Kigami et al., 2003; Macfarlan et al., 2011; 
Macfarlan et al., 2012; Ribet et al., 2008b). Previous analyses have established 
that MuERV-L underwent two amplification bursts, one after the divergence of the 
Mus and Rattus genera around ~10 million years ago (MYA), and a more recent 
burst about 2 MYA (Costas, 2003). MuERV-L belongs to a large family of ERVs 
that has been active throughout the evolution of mammals (Benit et al., 1999; 
Cordonnier et al., 1995; Lee et al., 2013). RT phylogenetic trees show MuERV-L 
inside class III retrovirus, clustering together with spumaviruses and human ERV-
L (HERV-L) and HERV-S. In contrast to their human counter part, most of 
MuERV-L copies have complete coding potential, encoding open reading frames 
(ORFs) for gag and pol (Benit et al., 1997). As other ERV-L elements, MuERV-L 
is characterized by the complete absence of an env gene that, coupled with its 
early transcription profile, suggest an entirely intracellular expansion through 
retrotransposon-like replication (Magiorkinis et al., 2012). In fact it has been 
shown that MuERV-L transcripts are able to form intracellular viral-like particles 
that accumulate in the ER (Ribet et al., 2008b). 
In order to further investigate the evolution of this ERV lineage, we first aimed to 
describe the diversity of MuERV-L related sequences in the mouse genome 
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using DIGS. Currently there are two available complete genome assemblies: the 
Mouse Genome Reference Consortium build 38 (GRCm38 also known as mm10) 
corresponding to the C57BL/6J strain (Mouse Genome Sequencing et al., 2002), 
and the whole genome shotgun (WGS) assembly from Celera that corresponds 
to a mixture of 5 strains (129X1/SvJ, 129S1/SvImJ, DBA/2J, A/J and C57BL/6J) 
(Mural et al., 2002). We mined both genome assemblies by DIGS using separate 
Gag, Pol and LTR probes from the MuERV-L reference sequence (GenBank: 
Y12713) (Benit et al., 1997), followed by consolidation of the resulting hits. 
 
Table 3.3: MuERV-L sequences identified in different mouse genome 
assemblies 
Assembly Strain Reference Total soloLTRs Provirus Fragments 
GRCm38 C57BL/6J 
Mouse Genome 
Sequencing et 
al., 2002 
2971 1588 719 664 
Mm_Celera Mixture Mural et al., 2002 2768 1775 220 773 
 
 
Overall we found less than 3,000 MuERV-L elements in the mouse genome 
involving three main types of structures (Table 3.3 and Figure 3.4). Proviruses 
flanked by two LTRs show the biggest discrepancy between genome assemblies 
finding 220 proviruses in the Celera assembly and 719 in GRCm38 (Table 3.3). 
This observation might be explained by the different mouse strains and/or 
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assembly methods used for each project. As expected, soloLTRs account for 
more than 50% of the elements present in the mouse genome (Table 3.3). The 
remaining MuERV-L structures, those composed of internal sequences with or 
without an associated LTR, roughly represent ~25% of all elements (Table 3.3). 
Given that GRCm38 is well supported by external and internal annotations we 
utilized this assembly to analyze the distribution of MuERV-L elements in the 
genome (Figures 3.4 and 3.5). We found an even distribution of MuERV-L 
elements in mouse chromosomes with a slightly higher density of soloLTRs in the 
X chromosome (0.77 soloLTRs/Mb) and of provirus in chromosomes 7, 12 and 
13 (~0.35 Proviruses/Mb) (Figure 3.4A). The large heterochromatin region in 
chromosome Y might explain the relative low density of MuERV-L elements in 
this chromosome, possibly by preventing new integrations in this region (Figure 
3.4A). The vast majority of elements were found in intergenic regions while ~7% 
of elements were found inside introns (Figure 3.4B). The remaining elements 
(0.94%) were found in non-coding RNA genes; un-translated regions and only 4 
LTRs were found overlapping coding exons (corresponding to pramel5, 
d5ertd579e, rpia and naalad2 genes) (Figure 3.4B). Such distribution differs 
significantly compared to randomized controls (p-value < 0.001). Similar 
scenarios are showed by soloLTR, proviral and fragment elements separately. 
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Figure 3.4: Distribution of MuERV-L elements in the mouse genome. 
(A) Density of distinct MuERV-L structures in mouse chromosomes. Density 
measured as the number of elements divided by the size of the chromosome. (B) 
Distribution of MuERV-L structures in distinct mouse genomic features. The 
number of elements in each feature as well as the corresponding percentages is 
indicated. Data from a DIGS screen on GRCm38/mm10 (Mouse Genome 
Sequencing et al., 2002). 
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 We noticed that the distribution of soloLTRs integrated in genes or intergenic 
regions also varies significantly from randomized controls (p-value < 0.001) 
(Figure 3.5). By classifying each soloLTR by integration date (see chapter II), we 
observed a negative trend between the age of the integration and its presence in 
genes (Figure 3.5). This difference is statistically significant when comparing 
soloLTRs of 0-2 MY old and those of 6-10 MY old (p-value = 0.01243) (Figure 
3.5). Proviral sequences also show a negative trend in genes between elements 
involved in the first or second expansion (Figure 3.5). Although the distribution of 
these proviral elements is not significantly different, they differ significantly from 
randomized controls (p-values < 0.01) (Figure 3.5). These observations suggest 
a selective pressure against fixation of MuERV-L elements in genic regions. 
Moreover this selective pressure seems to be more relaxed for younger 
integrations. Further paleovirological analyses were performed on MuERV-L and 
are described in the following chapter. 
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Figure 3.5: Distribution of MuERV-L elements in genic or intergenic regions 
in the mouse genome relative to random controls. 
The measured value indicates the percentage of MuERV-L elements in each 
population divided by that of the random controls (10,000 random controls of 
500nt for soloLTRs comparisons and 5,000 random controls of 6,500nt for 
proviral comparisons). The horizontal black line indicates no difference between 
the ratio of MuERV-L elements in each population and that of the controls. (*) p-
value < 0.05. (**) p-value < 0.01. (***) p-value < 0.001. P-values are based on 
chi-squared goodness-of-fit or contingency table tests. 
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Summary  
These analyses showed the capability of DIGS to identify complex proviral 
structures despite the numerous mutational processes by which these sequences 
have evolved. Consolidation of proviral loci also revealed that most ERV lineages 
analyzed have a significant amount of mosaic species. The mosaicism observed 
could account for true recombination events, particularly between closely related 
lineages, but also between distant ones. Overall this screening tool, together with 
previously published programs and functions, are instrumental in guiding us 
through the process of identifying suitable candidate sequences in which to 
perform paleovirological analyses to approximate a possibly infectious ancient 
retroviral sequence. 
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Chapter IV. Ancestral reconstruction of an infectious murine ERV 
Given the characteristics of MuERV-L we decided to construct an infectious 
sequence using the information gained from the screening of MuERV-L related 
sequences in the mouse genome described in the previous chapter.  
	  
Strategy for ancestral reconstruction of MuERV-L 
As mentioned earlier, a previous study (Costas, 2003) had determined that 
MuERV-L elements involved in the most recent and prolific expansion (~2 MYA) 
differentiate from the ones involved in a previous expansion (~10 MYA) by a 33 
nucleotide in-frame deletion in the 5’ half of the gag ORF (Figure 4.1A). In order 
to infer the sequence of the most recent infectious ancestor, while still accounting 
for informative variation, we decided to approximate the putative infectious 
ancestral sequence of MuERV-L by reconstructing the gag sequence separated 
from the rest of the genome (LTR and pol). For the reconstruction of the LTRs 
and the pol ORF we selected 95 complete (LTR-gag-pol-LTR) proviruses closely 
related to the reference MuERV-L sequence (Benit et al., 1997) to guide a 
maximum likelihood (ML) reconstruction of the root node (pol n96) and an 
identical pair of LTRs (Figure 4.1B and 4.1D).  
To select gag sequences only belonging to the most recent expansion we 
downloaded 230 gag-pol containing loci (identified by DIGS) that were present in 
both Celera and GRCm38 assemblies. After aligning those loci to the reference 
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sequence we identified a monophyletic clade of 40 elements that exclusively 
contained a 33-nucleotide in-frame deletion in the 5’ half of their gag ORFs. The 
loci in this clade were selected to guide a maximum likelihood (ML) 
reconstruction of the root node (gag n377) (Figure 4.1C and 4.1D). The 
combined LTR, gag and pol ancestral sequences were corrected for possible 
mutations derived by deamination of methylated CpG dinucleotides to create a 
~2 MY ancestral MuERV-L sequence (ancML) (Figure 4.1D and Figure 4.2) (see 
chapter II).  
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Figure 4.1: Strategy and reconstruction of an ancestral MuERV-L genome. 
(A) Schematic representation of the structure of MuERV-L elements. (B) 
Maximum likelihood phylogenetic tree of 95 LTR-gag-pol-LTR MuERV-L 
elements in the mouse genome. Blue circle denotes the ancestral node 
reconstructed by baseml (pol and LTR, node 96). (C) Maximum likelihood 
phylogenetic tree of 230 gag-pol containing MuERV-L elements in the mouse 
genome. The monophyletic red clade contains only elements with a 33-
nucleotide deletion in gag at position 671 with or without the additional deletion in 
gag at position 1597. Red circle denotes the ancestral node reconstructed by 
baseml (gag, node 377). (D) Organization of the ancML construct. Green arrows 
indicate promoter sequences. OEN: neo gene in reverse orientation from the 
ancML transcription. White boxes represent the 33 and 39 nucleotides deletions 
in gag at positions 671 and 1597, respectively.   
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Figure 4.2: Nucleotide sequence and translation products of ancML.  
LTR sequences are shown in bold italics. Nucleotide and protein sequence of 
gag and pol are indicated in red and blue, respectively (amino acid single letter 
code, (*) represents stop codons). The 33-nucleotide deletion in gag is shown 
with a magenta triangle. The position of the 39-nucleotide deletion in gag is 
highlighted in magenta. The RT active site is highlighted in yellow. The PBS is 
indicated in violet, the polypurine tract in red, the TATA box in green and the 
polyadenylation site in bright blue. Protein positions are indicated in bold, while 
nucleotide positions are not. 
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1" TGTAGTGGCTATTCCTGGTTGTCAACTTGACAATATTTGGAATGAACTACAATCCGGAATTGGAAGGCTCACCAGTGACCCTTATCTGGAGGCTTGGAGATCCTTATCTGGATCTTGGTATGGAGATCT%
130% TGAGCCATAGTGGCTATGGATTCCAGAAGATTGAATCTCCGAGTTTAAGGAACACACCTTTAATCTGGGCTACGCCTTTCATCTGGGATTAAAGGTGTGGTGGAACACACCTTTAATCTGGGCTACACC%
259% TTCTGCTGGAGACAATATAAGGACATTGGAAGAAGGGAGTCTAGCTCTAGCTCTTGCTCTTGCTCCTTCGCCTGCTTGCTGCGTGAGACTGAGTAACTGCTAGATCCTTGGACTTCCATTCACAGCTGC%
388% GACTGAACAATTGTTGGGAATTGGGCTGCCGACTGTAAGTCATCAATAAATTCCTTTACTATCTAGAGACTATCCATAAGTTCTGTGACTCTAGAGAACCCTGACTAATACAGAAGTTGGTACCAGGAG"
517" TGGTTCTAGAGTAACAGAAGTACAAGGATGAATCTTTTAAAATTCTGGAATTGGCTTGTTGATCCACCAGCACTTTCAACTATTGAAACCTCTCCAGATTCTCTCCCTCCTGGGAGCTCAGAGAATTTT%
1% % % %%%%%%M%%N%%L%%L%%K%%F%%W%%N%%W%%L%%V%%D%%P%%P%%A%%L%%S%%T%%I%%E%%T%%S%%P%%D%%S%%L%%P%%P%%G%%S%%S%%E%%N%%F%%
646% GAAGACCCATGGTTGAAACTATATTCCGAACTTAAAGAAGCTAATGCCCTTGATTTTCTTAATGAATTAGGTGATTCAGTGCACAAAGCTTTCTACAAGATGGGGAAAAAATCGAAAAATGATTTTACT%
35% %E%%D%%P%%W%%L%%K%%L%%Y%%S%%E%%L%%K%%E%%A%%N%%A%%L%%D%%F%%L%%N%%E%%L%%G%%D%%S%%V%%H%%K%%A%%F%%Y%%K%%M%%G%%K%%K%%S%%K%%N%%D%%F%%T%%
775% GGCTGGCTGCTCTTAGTATCTGTGGAAAAAATGATGAATGAAAGGAAGGAGTTGTGTGATAAAATCGAAAGGCTCCAGACACAAGTAAACGATCTAAAAGTTGCTAAGTGTGTCCTTGAGGAGAATCTT%
78% %G%%W%%L%%L%%L%%V%%S%%V%%E%%K%%M%%M%%N%%E%%R%%K%%E%%L%%C%%D%%K%%I%%E%%R%%L%%Q%%T%%Q%%V%%N%%D%%L%%K%%V%%A%%K%%C%%V%%L%%E%%E%%N%%L%%
904% CTCTCTTGTAGCAATAGAGCTCAAGTTGCAGAAAATCAAACAGAAACTCTCATTGTAAGGTTGGCTGAACTACAGCGAAAATTCAAGTCTCAGCCTCAGAGTGTGTCGACAGTTAAAGTAAGGGCTCTA%
121% %L%%S%%C%%S%%N%%R%%A%%Q%%V%%A%%E%%N%%Q%%T%%E%%T%%L%%I%%V%%R%%L%%A%%E%%L%%Q%%R%%K%%F%%K%%S%%Q%%P%%Q%%S%%V%%S%%T%%V%%K%%V%%R%%A%%L%%
1033% ATTGGCAAAGAATGGGATCCTACAACATGGGACGGGGATGTGTGGGAAGACCATGTTGAAGCTGAGAATTTTGAATCCTCAGATTCTCAAGGGTTTGCCCCACCTGAGGAAGTAGTACCCTCAGCCCCA%
164% %I%%G%%K%%E%%W%%D%%P%%T%%T%%W%%D%%G%%D%%V%%W%%E%%D%%H%%V%%E%%A%%E%%N%%F%%E%%S%%S%%D%%S%%Q%%G%%F%%A%%P%%P%%E%%E%%V%%V%%P%%S%%A%%P%%
1162% CCTCTTGAAATAATGCCTTCCCCACATGAGGAAATTAATTTTGCAGAGTCTGCTCACGGCCCACCAATAGTTTCTTCTAGACCTGTAACCAGACTCAAAGCAAAACAGGCTCCTAGAGGGGAGGTAGAA%
207% %P%%L%%E%%I%%M%%P%%S%%P%%H%%E%%E%%I%%N%%F%%A%%E%%S%%A%%H%%G%%P%%P%%I%%V%%S%%S%%R%%P%%V%%T%%R%%L%%K%%A%%K%%Q%%A%%P%%R%%G%%E%%V%%E%%
1291% AGTGTAGTCCATGAGGAAATTCGCTACACTACTAAGGAGCTTAATGAGTTTGCTAATTCATTCAAGCAGAAACCTGGTGAATATGTGTGGGAATGGATTTTAAGGGTGTGGGATAAGGGTGGAAGGAAC%
250% %S%%V%%V%%H%%E%%E%%I%%R%%Y%%T%%T%%K%%E%%L%%N%%E%%F%%A%%N%%S%%F%%K%%Q%%K%%P%%G%%E%%Y%%V%%W%%E%%W%%I%%L%%R%%V%%W%%D%%K%%G%%G%%R%%N%%
1420% ATAAAACTAGAGCAGGCTGAGTTTATTGACATGGGTCCTCTGAGTAGAGATTCTAGGTTTAATACGGAAGCTCGCATAGTTAAAAAAGGTGTCAAAAGTTTGTTTGAATGGTTGGCTGAGGTGTTTATC%
293% %I%%K%%L%%E%%Q%%A%%E%%F%%I%%D%%M%%G%%P%%L%%S%%R%%D%%S%%R%%F%%N%%T%%E%%A%%R%%I%%V%%K%%K%%G%%V%%K%%S%%L%%F%%E%%W%%L%%A%%E%%V%%F%%I%%
1549% AAAAGATGGCCTACTGGAAATGACTTGGAGATGCCTGATATTCCGTGGCTTAGTGTTGATGAAGGGATTTTAAGACTTAGGGAAATTGCAATGCTAGAGTGGATATATTGTGTAAAGCATAATTGTCCA%
336% %K%%R%%W%%P%%T%%G%%N%%D%%L%%E%%M%%P%%D%%I%%P%%W%%L%%S%%V%%D%%E%%G%%I%%L%%R%%L%%R%%E%%I%%A%%M%%L%%E%%W%%I%%Y%%C%%V%%K%%H%%N%%C%%P%%
1678% CAATGGGAAGGTCCAGAAGATATGCCTTTCACCAGCTCTATAAGACGCAAATTGGTGAGAGGGGCACCAGCACATTTGAAGGGTTTTGTTCTTTCCCTTTTCCTTGTGCCAGATCTTAGCATTGGAGAT%
379% %Q%%W%%E%%G%%P%%E%%D%%M%%P%%F%%T%%S%%S%%I%%R%%R%%K%%L%%V%%R%%G%%A%%P%%A%%H%%L%%K%%G%%F%%V%%L%%S%%L%%F%%L%%V%%P%%D%%L%%S%%I%%G%%D%%
1807% GCTTCTGCTCAATTAGATGAATTAAATTCACTGGGTTTAGTTGGATTCCGAGGTAACAAGGGCCAGGTGGCAGCATTGAATCGCCCGAGACAAGGTGATTCTAGTTATTATAATGGACAGCGTAGACAA%
422% %A%%S%%A%%Q%%L%%D%%E%%L%%N%%S%%L%%G%%L%%V%%G%%F%%R%%G%%N%%K%%G%%Q%%V%%A%%A%%L%%N%%R%%P%%R%%Q%%G%%D%%S%%S%%Y%%Y%%N%%G%%Q%%R%%R%%Q%%
1936% AAGAATGTTTATAATAACATACCCAGTAATGGTCAGCACAGGAGAGGTGAAATTTATAATGGCATGACTCGGTTGGACCTTTGGTACTGGCTAACCAATCATGGTGTTTCCAGGAATGAAATACATAGG%
465% %K%%N%%V%%Y%%N%%N%%I%%P%%S%%N%%G%%Q%%H%%R%%R%%G%%E%%I%%Y%%N%%G%%M%%T%%R%%L%%D%%L%%W%%Y%%W%%L%%T%%N%%H%%G%%V%%S%%R%%N%%E%%I%%H%%R%%
2065% AAGCCTACTGCATATTTGTTTGATCTGTATAAGCAGAAAAATTCTCAAACAAATGAAAGAAAGGCTACATTAGATCGTGGTAAACAGACAAATGAAAGAAAGGCTACATTAGATCGTGGTAAACAGCAA%
508% %K%%P%%T%%A%%Y%%L%%F%%D%%L%%Y%%K%%Q%%K%%N%%S%%Q%%T%%N%%E%%R%%K%%A%%T%%L%%D%%R%%G%%K%%Q%%T%%N%%E%%R%%K%%A%%T%%L%%D%%R%%G%%K%%Q%%Q%%
2194% TCTCGGCCAGTGAATCAATTTCCAGACTTGAGACAGTTTGCAGATCCAGAACCCCTTGAATGAAGGGGTGGCCAGGTTCCGCTGAGGAAGGATCTTGATAAGACACTCAAAGGTTTTGCTGTTACCCTT%
551% %S%%R%%P%%V%%N%%Q%%F%%P%%D%%L%%R%%Q%%F%%A%%D%%P%%E%%P%%L%%E%%*""R%%G%%G%%Q%%V%%P%%L%%R%%K%%D%%L%%D%%K%%T%%L%%K%%G%%F%%A%%V%%T%%L%%
2323% TCTCCAGTTCTTCCCCAGAGGGACCTACGGCCTTTTACAAGGGTAACTGTACACTGGGGAAAAGGAAATAATCAGACTTTTCGGGGTCTGCTGGATACTGGTTCTGAGTTGACACTGATCCCAGGGGAT%
594% %S%%P%%V%%L%%P%%Q%%R%%D%%L%%R%%P%%F%%T%%R%%V%%T%%V%%H%%W%%G%%K%%G%%N%%N%%Q%%T%%F%%R%%G%%L%%L%%D%%T%%G%%S%%E%%L%%T%%L%%I%%P%%G%%D%%
2452% CCCAAGAAACATTGTGGCCCTCCAGTTAAAGTAGGGGCTTATGGAGGGCAGGTGATTAATGGAGTTTTGACTGATGTCCGACTCACAGTAGGTCCAGTAGGTCCCCGGACACATCCTGTGGTGATTTCC%
637% %P%%K%%K%%H%%C%%G%%P%%P%%V%%K%%V%%G%%A%%Y%%G%%G%%Q%%V%%I%%N%%G%%V%%L%%T%%D%%V%%R%%L%%T%%V%%G%%P%%V%%G%%P%%R%%T%%H%%P%%V%%V%%I%%S%%
2581% CCAGTTCCAGAATGTATAATTGGGATAGATATACTCAGAAATTGGCAGAATTCTCATATTGGTTCCCTGAACTGTAGAGTGAGGGCTATTATGGTTGGAAAGGCCAAATGGAAGCCTTTAGAGTTGCCT%
680% %P%%V%%P%%E%%C%%I%%I%%G%%I%%D%%I%%L%%R%%N%%W%%Q%%N%%S%%H%%I%%G%%S%%L%%N%%C%%R%%V%%R%%A%%I%%M%%V%%G%%K%%A%%K%%W%%K%%P%%L%%E%%L%%P%%
2710% CTGCCAAAGAAAATAGTGAATCAAAAACAGTATCGTATTCCTGGAGGAATTGCAGAAATTACTGCCACTATCAAGGACTTGAAAGATGCAGGGGTGGTGGTTCCCACCACATCTCCGTTTAACTCTCCT%
723% %L%%P%%K%%K%%I%%V%%N%%Q%%K%%Q%%Y%%R%%I%%P%%G%%G%%I%%A%%E%%I%%T%%A%%T%%I%%K%%D%%L%%K%%D%%A%%G%%V%%V%%V%%P%%T%%T%%S%%P%%F%%N%%S%%P%%
2839% ATCTGGCCAGTGCAGAAAACAGATGGATCATGGAGAATGACAGTTGATTATCGAAAACTAAATCAGGTAGTAACTCCAATTGCAGCTGCTGTACCAGATGTAGTTTCGTTACTTGAGCAAATTAACACA%
766% %I%%W%%P%%V%%Q%%K%%T%%D%%G%%S%%W%%R%%M%%T%%V%%D%%Y%%R%%K%%L%%N%%Q%%V%%V%%T%%P%%I%%A%%A%%A%%V%%P%%D%%V%%V%%S%%L%%L%%E%%Q%%I%%N%%T%%
2968% TCTCCTGGCACCTGGTATGCGGCTATTGATCTGGCAAATGCCTTCTTCTCAGTACCTGTCCATAAGGACCACCAGAAGCAATTTGCTTTCAGTTGGCAAGGCCAACAGTATACCTTCACAGTTTTGCCT%
809% %S%%P%%G%%T%%W%%Y%%A%%A%%I%%D%%L%%A%%N%%A%%F%%F%%S%%V%%P%%V%%H%%K%%D%%H%%Q%%K%%Q%%F%%A%%F%%S%%W%%Q%%G%%Q%%Q%%Y%%T%%F%%T%%V%%L%%P%%
3097% CAAGGATATATTAACTCTCCTGCCCTGTGTCATAATTTAGTTAGAAGGGATCTTGATCGTTTGGATCTTCCACAAAATATCACATTGGTGCACTATATTGATGACATTATGCTGATTGGACCAAGTGAG%
852% %Q%%G%%Y%%I%%N%%S%%P%%A%%L%%C%%H%%N%%L%%V%%R%%R%%D%%L%%D%%R%%L%%D%%L%%P%%Q%%N%%I%%T%%L%%V%%H%%Y%%I%%D%%D%%I%%M%%L%%I%%G%%P%%S%%E%%
3226% CAGGAAGTAGCAACCACTTTGGACTCATTGGTAACACATATGCGTATCAGAGGATGGGAAATAAATCCAACCAAAATTCAAGGACCATCTACCTCAGTGAAATTCTTAGGAGTCCAGTGGTGTGGGGCA%
895% %Q%%E%%V%%A%%T%%T%%L%%D%%S%%L%%V%%T%%H%%M%%R%%I%%R%%G%%W%%E%%I%%N%%P%%T%%K%%I%%Q%%G%%P%%S%%T%%S%%V%%K%%F%%L%%G%%V%%Q%%W%%C%%G%%A%%
3355% TGCAGAGATATTCCTTCTAAGGTGAAAGATAAGTTATTGCACCTGGCCCCTCCTACAACCAAGAAAGAAGCACAACGTTTAGTGGGTCTATTTGGATTCTGGAGACAACACATCCCTCACTTGGGTGTG%
938% %C%%R%%D%%I%%P%%S%%K%%V%%K%%D%%K%%L%%L%%H%%L%%A%%P%%P%%T%%T%%K%%K%%E%%A%%Q%%R%%L%%V%%G%%L%%F%%G%%F%%W%%R%%Q%%H%%I%%P%%H%%L%%G%%V%%
3484% TTACTTAGGCCTATTTACCAAGTGACTCGGAAAGCTGCTAGCTTTGTGTGGGGCCTGGAACAGGAGAAGGCCCTTCAACAGGTCCAGGCTGCTGTGCAGGCTGCTCTACCACTTGGACCATATGACCCA%
981% %L%%L%%R%%P%%I%%Y%%Q%%V%%T%%R%%K%%A%%A%%S%%F%%V%%W%%G%%L%%E%%Q%%E%%K%%A%%L%%Q%%Q%%V%%Q%%A%%A%%V%%Q%%A%%A%%L%%P%%L%%G%%P%%Y%%D%%P%%
3613% GCAGACCCGATGGTACTTGAGGTGTCTGTGGCTGATAGAGATGCTGTTTGGAGCCTCTGGCAGGCCCCTGTAGGTGAATCACAGAAAAGACCTTTGGGATTTTGGAGCAAAGCTCTACCATCATCTGCA%
1024% %A%%D%%P%%M%%V%%L%%E%%V%%S%%V%%A%%D%%R%%D%%A%%V%%W%%S%%L%%W%%Q%%A%%P%%V%%G%%E%%S%%Q%%K%%R%%P%%L%%G%%F%%W%%S%%K%%A%%L%%P%%S%%S%%A%%
3742% GACAACTATTCTCCCTTTGAAAAACAGCTCTTGGCCTGCTATTGGGCCTTAGTGGAAACTGAACGTTTGACAATAGGACACCAAGTTACTATGCGACCTGAACTACCCATCATGAGCTGGGTACTATCA%
1067% %D%%N%%Y%%S%%P%%F%%E%%K%%Q%%L%%L%%A%%C%%Y%%W%%A%%L%%V%%E%%T%%E%%R%%L%%T%%I%%G%%H%%Q%%V%%T%%M%%R%%P%%E%%L%%P%%I%%M%%S%%W%%V%%L%%S%%
3871% GACCCTGCAAGTCATAAAGTGGGACGCGCACAGCAGCAGTCTATTATCAAATGGAAGTGGTATATACGTGATCGGGCCAGAGCAGGTCCTGAAGGCACAAGCAAGTTACATGAAGAAGTTGCTCAAATG%
1110% %D%%P%%A%%S%%H%%K%%V%%G%%R%%A%%Q%%Q%%Q%%S%%I%%I%%K%%W%%K%%W%%Y%%I%%R%%D%%R%%A%%R%%A%%G%%P%%E%%G%%T%%S%%K%%L%%H%%E%%E%%V%%A%%Q%%M%%
4000% CCTATGGTTTCTACTCCTGTTACAATGCCATCTGCTGCCAAGCATGCGCCTATAGCCTCATGGGGTGTTCCCTATGATCAACTGACCGAAGAGGAGAAGACTAGAGCCTGGTTTACTGATGGCTCTGCA%
1153% %P%%M%%V%%S%%T%%P%%V%%T%%M%%P%%S%%A%%A%%K%%H%%A%%P%%I%%A%%S%%W%%G%%V%%P%%Y%%D%%Q%%L%%T%%E%%E%%E%%K%%T%%R%%A%%W%%F%%T%%D%%G%%S%%A%%
4129% CGTTATGCAGGCACCACCCAGAAGTGGACAGCTGCAGCATTACAACCCCTTTCTGGGACAACCTTGAAAGACACAGGTGAAGGGAAATCTTCACAGTGGGCAGAACTTCGGGCAGTACACATGGTATTA%
1196% %R%%Y%%A%%G%%T%%T%%Q%%K%%W%%T%%A%%A%%A%%L%%Q%%P%%L%%S%%G%%T%%T%%L%%K%%D%%T%%G%%E%%G%%K%%S%%S%%Q%%W%%A%%E%%L%%R%%A%%V%%H%%M%%V%%L%%
4258% CAGTTTGTTTGCAAGAAGAAATGGCCAGATGTACGATTATTCACTGACTCATGGGCTGTAGCCAATGGATTGGCTGGATGGTCAGGGACTTGGAAAGATCACAATTGGAAAATTGGTGAGAAAGACATC%
1239% %Q%%F%%V%%C%%K%%K%%K%%W%%P%%D%%V%%R%%L%%F%%T%%D%%S%%W%%A%%V%%A%%N%%G%%L%%A%%G%%W%%S%%G%%T%%W%%K%%D%%H%%N%%W%%K%%I%%G%%E%%K%%D%%I%%
4387% TGGGGAAGAAGTATGTGGATAGATCTCTCCAAATGGGCAAAGGATGTGAAGATATTTGTGTCCCATGTAAATGCTCACCAAAAGGTGACTTCAGCCGAGGAGGAGTTCAATAATCAAGTGGATAAGATG%
1282% %W%%G%%R%%S%%M%%W%%I%%D%%L%%S%%K%%W%%A%%K%%D%%V%%K%%I%%F%%V%%S%%H%%V%%N%%A%%H%%Q%%K%%V%%T%%S%%A%%E%%E%%E%%F%%N%%N%%Q%%V%%D%%K%%M%%
4516% ACCCGTTCTGTGGACAGTCAGCCTCTCTCCCCAGCCATCCCTGTCATTGCTCAATGGGCACATGAACAAAGTGGCCATGGTGGTCGAGATGGAGGTTATGCTTGGGCTCAGCAACACGGGCTTCCACTC%
1325% %T%%R%%S%%V%%D%%S%%Q%%P%%L%%S%%P%%A%%I%%P%%V%%I%%A%%Q%%W%%A%%H%%E%%Q%%S%%G%%H%%G%%G%%R%%D%%G%%G%%Y%%A%%W%%A%%Q%%Q%%H%%G%%L%%P%%L%%
4645% ACCAAGGCTGACCTGGCTACAGCTGCTGCTGATTGCCAGATCTGCCAACAGCAGAAACCAACACTGAGCCCCAGATATGGCACCATTCCTCGAGGTGACCAGCCAGCAACCTGGTGGCAGGTTGACTAC%
1368% %T%%K%%A%%D%%L%%A%%T%%A%%A%%A%%D%%C%%Q%%I%%C%%Q%%Q%%Q%%K%%P%%T%%L%%S%%P%%R%%Y%%G%%T%%I%%P%%R%%G%%D%%Q%%P%%A%%T%%W%%W%%Q%%V%%D%%Y%%
4774% ATTGGACCACTTCCTTCGTGGAAAGGACAGCGTTTTGTTCTTACTGGAGTAGATACTTATTCTGGTTATGGATTTGCCTTTCCTGCACGTAATGCCTCTGCTAAAACCACCATTCACGGACTGACAGAA%
1411% %I%%G%%P%%L%%P%%S%%W%%K%%G%%Q%%R%%F%%V%%L%%T%%G%%V%%D%%T%%Y%%S%%G%%Y%%G%%F%%A%%F%%P%%A%%R%%N%%A%%S%%A%%K%%T%%T%%I%%H%%G%%L%%T%%E%%
4903% TGCCTTATCTATCGTCATGGTATTCCACACAGTATTGCTTCTGACCAAGGAACTCATTTCACAGCCAGAGAAGTACGACAGTGGGCCCACGATCATGGAATTCACTGGTCTTACCACATTCCCCATCAT%
1454% %C%%L%%I%%Y%%R%%H%%G%%I%%P%%H%%S%%I%%A%%S%%D%%Q%%G%%T%%H%%F%%T%%A%%R%%E%%V%%R%%Q%%W%%A%%H%%D%%H%%G%%I%%H%%W%%S%%Y%%H%%I%%P%%H%%H%%
5032% CCTGAAGCAGCTGGTCTGATAGAAAGATGGAATGGCCTTTTGAAGACGCAGTTACAGCGCCAATTAGGTGGTAACAGCTTGGAAGGCTGGGGCAGAGTTCTTCAGAAGGCAGTATATGCTTTGAATCAG%
1497% %P%%E%%A%%A%%G%%L%%I%%E%%R%%W%%N%%G%%L%%L%%K%%T%%Q%%L%%Q%%R%%Q%%L%%G%%G%%N%%S%%L%%E%%G%%W%%G%%R%%V%%L%%Q%%K%%A%%V%%Y%%A%%L%%N%%Q%%
5161% CGCTCGATATATGGTACAGTTTCACCCATAGCCAGGATTCATGGGTCCAGGAATCAAGGGGTGGAAAACGGAATAGTTCCACTTACTATCACTCCTAGTGACCCTCTAGGAAAATTTTTGCTTCCTGTC%
1540% %R%%S%%I%%Y%%G%%T%%V%%S%%P%%I%%A%%R%%I%%H%%G%%S%%R%%N%%Q%%G%%V%%E%%N%%G%%I%%V%%P%%L%%T%%I%%T%%P%%S%%D%%P%%L%%G%%K%%F%%L%%L%%P%%V%%
5290% CCCATAACTCTAGGTTCTGCTGGCCTAGAAGTTTTGGCTCCAGAGAGGGGAGTGCTCCTACCAGGAGCTACAACAAACATTCCATTGAACTGGAAGCTCAGACTTCCCCCTGGTCATTTTGGGCTTCTA%
1583% %P%%I%%T%%L%%G%%S%%A%%G%%L%%E%%V%%L%%A%%P%%E%%R%%G%%V%%L%%L%%P%%G%%A%%T%%T%%N%%I%%P%%L%%N%%W%%K%%L%%R%%L%%P%%P%%G%%H%%F%%G%%L%%L%%
5419% ATGCCCTTAAACCAACAGGCTAAAAAAGGAATAACAGTGTTAGGAGGGGTGATAGATCCAGATTACCATGGGGAAATTGGATTACCTCTTCACAATGGTGGTAAGCAAGATTATGTCTGGAGTGTAGGA%
1626% %M%%P%%L%%N%%Q%%Q%%A%%K%%K%%G%%I%%T%%V%%L%%G%%G%%V%%I%%D%%P%%D%%Y%%H%%G%%E%%I%%G%%L%%P%%L%%H%%N%%G%%G%%K%%Q%%D%%Y%%V%%W%%S%%V%%G%%
5548% GATCCCTTAGGGCGTCTCTTAGTACTACCATGTCCTGTGATTAAAGTCAATGGGAAACTACAACAGCCTAATCCAAGCAGGATGACAAAGGACGCAGACCCATCAGGAATGAAGGTATGGGTCAATCCT%
1669% %D%%P%%L%%G%%R%%L%%L%%V%%L%%P%%C%%P%%V%%I%%K%%V%%N%%G%%K%%L%%Q%%Q%%P%%N%%P%%S%%R%%M%%T%%K%%D%%A%%D%%P%%S%%G%%M%%K%%V%%W%%V%%N%%P%%
5677% CCAGGAAAAGAGCCAAGACCTGCTGAGGTGCTGGCTGAAGGTGAAGGAAATACAGAATGGGTAGTAGAGGAAGGTAGTTATAAATACCAATTAAGGCCACGTAACCAGTTGCAGAAACGAGGATTATAA%
1712% %P%%G%%K%%E%%P%%R%%P%%A%%E%%V%%L%%A%%E%%G%%E%%G%%N%%T%%E%%W%%V%%V%%E%%E%%G%%S%%Y%%K%%Y%%Q%%L%%R%%P%%R%%N%%Q%%L%%Q%%K%%R%%G%%L%%*%%
5806" AGTAATATGAATGCCCCATTGTAAATTTACAAATGCGTTTGCGATTGTACGAGGGATAGTTATATCATGTTAGGCGTATTTACAACCTTGTTATTGTTTCATGTGAACATGAGATATTATTTGTGTCAA"
5935" GTTGACAAGGGGTGGATTGTAGTGGCTATTCCTGGTTGTCAACTTGACAATATTTGGAATGAACTACAATCCGGAATTGGAAGGCTCACCAGTGACCCTTATCTGGAGGCTTGGAGATCCTTATCTGGA%
6064% TCTTGGTATGGAGATCTTGAGCCATAGTGGCTATGGATTCCAGAAGATTGAATCTCCGAGTTTAAGGAACACACCTTTAATCTGGGCTACGCCTTTCATCTGGGATTAAAGGTGTGGTGGAACACACCT%
6193% TTAATCTGGGCTACACCTTCTGCTGGAGACAATATAAGGACATTGGAAGAAGGGAGTCTAGCTCTAGCTCTTGCTCTTGCTCCTTCGCCTGCTTGCTGCGTGAGACTGAGTAACTGCTAGATCCTTGGA%
6322% CTTCCATTCACAGCTGCGACTGAACAATTGTTGGGAATTGGGCTGCCGACTGTAAGTCATCAATAAATTCCTTTACTATCTAGAGACTATCCATAAGTTCTGTGACTCTAGAGAACCCTGACTAATACA% %
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ancML is infectious and its activity is dependent on a functional reverse 
transcriptase. 
In order to assess the infectiousness of the reconstructed ancestral sequence, 
we cloned the full-length ancML sequence into an expression vector by replacing 
the U3 region of the 5’ UTR by a CMV promoter. A G418 resistant (neo) gene 
controlled by a separate SV40 promoter and interrupted by an intron was further 
inserted at the end of pol and before the 3’ LTR promoter (Figure 4.1D). The 
splice donor and acceptor sites of the intron are in the same orientation as the 
ancML transcription, in a way that only if ancML undergoes reverse transcription 
and integrates in the host cell genome, the intron is removed and a functional 
G418 resistance protein is expressed (Moran et al., 1996).  
We then determined if such a plasmid could produce G418 resistant colonies in 
cell lines. For this purpose we tested a set of 16 cell lines: 8 from primates, 6 
from rodents, 1 from a carnivore and 1 from an avian species (Table 4.1).  
Despite efficient transfection in the majority of the cells tested, the ancML 
expression plasmid was able to derive G418 resistant colonies only in Chinese 
hamster ovary K1 (CHO) cells and the related pgsA cells, and to a much lower 
extent in Vero cells (Figure 4.3A and Table 4.1). Surprisingly a control plasmid 
expressing a LINE1 element under the same replication dependent neo gene 
(L1.3 plasmid) (Moran et al., 1999) failed to produce G418 resistant colonies in 7 
of the cells tested, including Vero (Table 4.1).  
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To further investigate the nature of these G418 resistant colonies, we mutated 
the ancML RT active site from YIDD to AIAA (Figure 4.2). This RT mutation 
completely abolished the production of G148 resistant colonies in CHO cells 
(Figure 4.3B). Additionally we observed that the ancML and L1.3 constructs are 
slightly sensitive to the presence of azidothymidine (AZT), a retroviral RT inhibitor 
(Figure 4.3B), indicated by the reduction of G418 resistant colonies. However, 
increasing concentrations of AZT also show a modest toxicity in CHO cells 
transfected with a control plasmid expressing the neo gene, particularly at a 
concentration of 500uM (Figure 4.3B). This observation may obscure the real 
effect of this inhibitor on ancML and L1.3 replication.   
As we mentioned previously, the fate of the intron that interrupts the neo gene is 
in direct correlation with the appearance of G418 resistance colonies. We 
isolated genomic DNA (gDNA) from CHO cells transfected with the ancML 
plasmid or an empty vector and determined the fate of the intron by PCR (Figure 
4.3D). In CHO cells transfected with the ancML plasmid the vast majority of the 
amplified sequences correspond to the proper processing of the intron 
interrupting the neo gene. We also observed the presence of molecules (in low 
abundance) whose size corresponds to the retention of the intron, possibly 
accounting for traces of the transfected plasmid (Figure 4.3D). It is important to 
notice that the primer-binding site (PBS) is separated from the 5’ LTR U5 region 
by a five-nucleotide linker sequence (Figure 4.2 and Figure 4.4B). This 
separation is uncommon between exogenous retroviruses and in fact is only 
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observed in one other ERV, HERV-E (Repaske et al., 1985). Elimination of this 
five nucleotides in the ancML sequence resulted in a ~4 fold reduction in the 
number of G418 resistant colonies and the incorrect processing of the intron 
interrupting the neo reporter gene (Figure 4.3C), suggesting a role in MuERV-L 
replication. Overall, these results indicate that the reconstructed ancestral 
MuERV-L sequence is infectious and is able to undergo reverse transcription and 
integration upon transfection into CHO cells. 
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Table 4.1: Cell lines tested for replication of ancML. 
Cell Line Organism  Order GFP# NEO L1.3 ancML 
DF-1 Gallus gallus Galliforme *** +++ ++ - 
CRFK Felis catus Carnivora ** +++ + - 
CV-1 Cercopithecus aethiops Primate * ++ + - 
Vero Cercopithecus aethiops Primate *** +++ - + 
HT1080 Homo sapiens Primate ** ++ + - 
HOS Homo sapiens Primate * ++ - - 
Huh7.5 Homo sapiens Primate * ++ - - 
TE671 Homo sapiens Primate - - - - 
MRC-5 Homo sapiens Primate - - - - 
HeLa Homo sapiens Primate *** +++ ++ - 
pgsA745 Cricetulus griseus Rodent ** ++ + ++ 
CHO-K1 Cricetulus griseus Rodent ** ++ + ++ 
MusDunni Mus dunni Rodent *** +++ + - 
SC-1 Mus musculus Rodent ** ++ - - 
NIH3T3 Mus musculus Rodent ** ++ ++ - 
Rat2 Rattus norvegicus Rodent - - - - 
All cell lines were transfected using lipofectamine 2000. 
#A plasmid expressing GFP was utilized as a transfection control.  
Percentage of GFP positive cells: (-) 0%, (*) < 10%, (**) 10-50%, (***) > 50%. 
Number of G418 resistant colonies: (-) None, (+) ≤ 10, (++) > 10, (+++) > 50. 
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Figure 4.3: Infectivity of ancML is dependent on reverse transcription.  
(A) G418 resistant colonies on 15 cm cell culture plates derived from CHO cells 
transfected with plasmids expressing ancML, L1.3 or an empty vector. (B-C) 
G418 resistant colonies of CHO cells cultured with increasing amounts of AZT. 
CHO cells were transfected with plasmids expressing a neo gene (NEO), L1.3, 
ancML, (B) an ancML construct with inactivating mutations in the RT active site 
(ancML-RTmut), or (C) an ancML construct with the 5nt linker sequence deleted 
(ancML ΔGAAGT). AZT treatment in (B) lasted for 2 days before G418 selection. 
Data from 3 independent experiments. (D) PCR amplification of the neo gene in 
genomic DNA (gDNA) of CHO cells transfected with a plasmid expressing 
ancML, ancML ΔGAAGT or an empty vector. A scheme of the PCR amplification 
strategy is shown on top. The usage of DNA from plasmid or from CHO gDNA as 
well as a water control is indicated. L: molecular weight ladder. In all experiments 
CHO cells were transfected with 1µg of plasmid DNA and placed on G418 
selection 3 dpt. Cells were cultured under selection for an additional 10 days 
before treatment with paraformaldehyde (PFA) and crystal violet staining (A, B 
and C), or gDNA extraction (D). 
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Figure 4.3: Infectivity of ancML is dependent on successful reverse 
transcription. 
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Analysis of ancML integration sites in CHO cells. 
We next aimed to determine the pattern of integration of ancML when transfected 
into CHO cells. For this purpose we utilized a genome walker technique 
(Clontech) to PCR amplify integration sites using primers specific to the flanking 
LTRs and an adaptor sequence (Figure 4.4A). We extracted gDNA from G418 
resistant single cell clones of CHO cells transfected with ancML. The gDNA was 
further digested with EcoRV (absent from ancML) and ligated to adaptors. 
Nested PCR reactions on gDNA from these cells showed bands of different sizes 
and intensities consistent with multiple integration sites per cell (Figure 4.4B). We 
selected the most intense bands and cloned them into a TOPO vector (Life 
technologies) for sequencing. All of the sequences amplified from the 5’ flanking 
side corresponded to neo-intron ancML sequences from priming on the 
homologous U3 sequence on the 3’ LTR (Figure 4.4A). Similarly, the majority of 
the sequences amplified from the 3’ flanking side corresponded to plasmid DNA 
and leader-gag ancML sequences from priming on the homologous R sequence 
on the 5’ LTR (Figure 4.4A).  Although there is no EcoRV site in the ancML 
sequence, possible shearing of gDNA during processing of the samples might 
have resulted in the amplification of sequences derived from the opposite LTR 
(Figure 4.4A). Despite this fact, we were able to PCR amplify, clone and 
sequence 26 bona-fide 3’ flanking integration sites (Figure 4.4C and Table 4.2).  
Initial inspection revealed that 10 of the 26 integration sites included a portion of 
the leader sequence containing different lengths of the PBS and the five-
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nucleotide linker sequence (Figure 4.4C). During reverse transcription and after 
the synthesis of the plus-strand strong-stop DNA (+sssDNA), RNase H removes 
the primer tRNA, thereby exposing sequences on the +sssDNA that are 
complementary to the PBS which will guide the second strand transfer 
(Champoux and Schultz, 2009; Coffin et al., 1997) (Figure 1.5). Inefficient 
removal of the tRNA primer might result in the synthesis of additional PBS 
sequences after the 3’ LTR on plus strand viral DNA, which might explain the 
integration pattern we observe for ancML.  
The CHO genome (CriGri_1.0) is currently assembled to the scaffold level and 
has been annotated by distinct de novo, expression-based and homology gene 
prediction systems (Xu et al., 2011). In order to determine if ancML integration 
events had a preference for particular regions in the genome we mapped the 
gDNA of the 26 integration sites in the Chinese hamster genome using the UCSC 
genome browser (Figure 4.4D and Table 4.2) (Kent et al., 2002; Xu et al., 2011). 
Similarly to the MuERV-L loci present in the mouse genome, the majority of the 
ancML integration sites (19 sites) corresponded to intergenic regions, 5 sites 
corresponded to introns and one to an exon (exon 3 of znf462) (Table 4.2). The 
remaining site could not be classified as intergenic or in genes because it 
mapped to multiple scaffolds. Regarding repetitive sequences of the 26 
integration sites 10 integrated in elements corresponding to SINE (4), LINE (4) 
and ERV-L (2) elements (Table 4.2). In order to account for biases due to 
location and density of EcoRV restriction sites, we compared the distribution of 
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the 26 ancML integration sites to matched random controls. Each integration site 
was matched to three random genomic locations that were at the same distance 
to an EcoRV site as the one showed in the flanking CHO DNA sequence 
(Marshall et al., 2007). We observed that the distribution of the integration sites 
within genes or in intergenic regions, as well as for the integration in/outside 
repetitive sequences, did not differ significantly to randomized controls (p-value = 
0.97 and 0.56 respectively) (Figure 4.4D). Although the distribution of the 
sequenced ancML integration sites and the distribution of MuERV-L elements in 
the mouse genome are different (Figures 3.5 and 4.4D), statistical significance 
could not be established due to the reduced sample size. These results suggest 
that the proportions of ancML integration sites we observed for different genomic 
regions correspond closely to what we would expect if the integration events 
would occur by chance, arguing against a particular preference for ancML 
integration. 
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Figure 4.4: Integration site analysis of ancML in CHO cells.  
(A) Schematic representation of the genome walker strategy used to sequence 
ancML integration sites. Forward and reverse primers (green and red triangles) 
were designed to anneal to the R and U3 region of the LTRs, respectively. 
Additional primers (white triangles) were designed to anneal to an adaptor 
sequence (white box). True EcoRV restriction sites are depicted by an orange 
thunder. An accidental break in the middle of the provirus is depicted by a purple 
thunder. Additional adaptors might be ligated to accidental breaks and primer 
anneal might result in the amplification of internal parts of the provirus (dotted 
lines). CHO gDNA is represented by a grey line. Red and green lines indicate 5’ 
and 3’ integration sites, respectively. (B) Example of a genome walker 
experiment to determine the 3’ flanking sequence of ancML integration events on 
15 single cell clones resistant to G418. Nested PCRs were performed on gDNA 
of single cell clones of CHO cells transfected with a plasmid expressing ancML 
and previously digested with EcoRV and ligated to adaptors. Forward primers 
were designed to anneal to the R region of the 3’LTR and the reverse primers to 
an adaptor sequence. L: molecular weight ladder. (C) Sequences of 26 ancML 
integration sites in the CHO genome. Sequences of the Chinese hamster Leucine 
(TAA) tRNA as well as the ancML U5-PBS region are included in the first and 
second rows, respectively. Sequence from the U5 region of the ancML LTR is 
indicated in bright blue. The 5nt linker sequence is indicated in black. The PBS 
sequence is indicated in violet. CHO genomic sequence is indicated in bold. 
Residues highlighted in green indicate conservation in 30% of all sequences. (D) 
Distribution of ancML integration sites in genic, intergenic, or repeat regions 
relative to matched random controls. The measured value indicates the 
percentage of ancML integration sites in each population divided by that of the 
matched random controls (each integration site was matched to three random 
genomic sequences equidistant to the EcoRV site where the adaptor was 
ligated). The horizontal black line indicates no difference between the ratio of 
ancML integration sites in each population and that of the matched controls. 
	   120 
 
 
 
 
Figure 4.4: Integration site analysis of ancML in CHO cells. 
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Table 4.2: ancML integration sites on the CHO genome. 
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ancML is sensitive to host innate antiviral defenses 
We then determined the potential for ancML to be inhibited by the mouse innate 
immune defenses. In order to address if ancML replication is affected by the 
interferon response, we transfected CHO cells with plasmids expressing ancML, 
L1.3 or a neo gene and cultured them with media containing increasing amounts 
of mouse IFN-α for two days before G418 selection (Figure 4.5A). We noticed a 
reduction in G418 resistant colonies in CHO cells expressing ancML or L1.3, but 
not a control neo gene. While the replication of L1.3 is reduced up to ~4 fold upon 
IFN-α treatment, there was a dose dependent effect on ancML reaching a ~20 
fold reduction of G418 resistant colonies with 50u/ml of mouse INF-α (Figure 
4.5A). 
We also tested if specific innate immune effectors can have an effect on ancML 
replication. For this purpose we constructed CHO cells stably expressing mouse 
orthologs of known restriction factors apobec3, mov10 and samhd1 (isoform 2), 
that have been previously implicated in the control of endogenous and 
exogenous retroviruses and retro-elements (reviewed in (Rehwinkel, 2014)) 
(Figure 4.5B). Strikingly only mouse APOBEC3 (mA3) was able to restrict ancML 
showing a ~30 fold reduction in G418 resistant colonies compared to control 
CHO cells (Figure 4.5B). There was no effect of mouse MOV10 and SAMHD1 on 
ancML replication or of any of the restriction factors tested in L1.3 replication 
(Figure 4.5B). Surprisingly mouse MOV10 was not able to restrict the replication 
of L1.3, contrary to what has previously been observed for human MOV10 (Arjan-
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Odedra et al., 2012). To further investigate the effect that mA3 might have on 
MuERV-L replication we determined the mutational profile of the 230 gag-pol 
containing MuERV-L elements that were used to derive ancML gag (Figure 4.1C) 
by using Hypermut 2.0 (Rose and Korber, 2000) (Figures 6C, 6D and 6E). For 
each MuERV-L element we calculated the ratio of G to A transitions in mA3-
preferred motifs (5’ G(A|G)(A|G|T) 3’) and control sites (5’ G(C|T)N 3’ or 5’ 
G(A|G)C 3’) compared to a consensus sequence. Only three MuERV-L elements 
showed significant (p-value < 0.05) evidence of mA3 dependent hypermutation 
when no 5’ context was enforced (Figure 4.5C). Because spontaneous 
deamination of methylated CpG dinucleotides can also produce G to A 
transitions, we excluded sites containing a C 5’ to the mutated G. When these 
sites were excluded 10 MuERV-L elements showed a significant (p-value < 0.05) 
evidence for mA3 dependent hypermutation (Figure 4.5D). Only two MuERV-L 
elements were significant for mA3 dependent hypermutation in both analyses (p-
value < 0.01) (Figure 4.5E). These results suggest that although ancML 
replication is strongly impaired by mA3 there is no sufficient evidence to conclude 
that mA3 dependent hypermutation had an inhibitory effect on MuERV-L during 
its evolution. 
	    
	   124 
 
 
Figure 4.5: ancML is sensitive to mouse innate immune effectors.  
(A) G418 resistant colonies of CHO cells cultured with increasing amounts of 
mouse IFN-α. CHO cells were transfected with plasmids expressing a neo gene 
(NEO), L1.3, or ancML and cultured with increasing amounts of mouse IFN-α for 
2 days before G418 selection. Data from 3 independent experiments. (B) G418 
resistant colonies of single cell clone CHO cells expressing mouse APOBEC3, 
MOV10 and SAMHD1 (isoform 2) genes. Single cell clone CHO cells were 
transfected with plasmids expressing a neo gene (NEO), L1.3, or ancML. Data 
from 3 independent single cell clone populations. (C and D) Mutational analysis 
of MuERV-L elements using Hypermut 2.0 (Rose and Korber, 2000). Ratio of G 
to A mutations from possible mA3 mutation sites (RD 3’ to a G) versus control 
(YN|RC 3’ to a G) with: (C) no 5’ context or (D) excluding sites with a 5’ C next to 
a G. 230 gag-pol containing MuERV-L elements in the mouse genome were 
compared to a consensus sequence. Data points in red and purple indicate 
MuERV-L sequences statistically significant hypermutated (p-value < 0.05). Data 
points in purple are statistically significant MuERV-L sequences shared between 
(C) and (D) (P-value < 0.01). (E) Profile of G to A transitions of two MuERV-L 
hypermutated proviral sequences compared to a consensus sequence. The 
profile of the reference MuERV-L sequence is shown for comparison (MLref, non 
significantly hypermutated). Lines in red and cyan represent mA3-derived G to A 
transitions (GG to AG and GA to AA respectively), whereas lines in green and 
magenta represent non mA3-derived G to A transitions (GC to AC and GT to AT 
respectively). Lines in yellow indicate gaps compared to the consensus 
sequence. 
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Figure 4.5: ancML is sensitive to mouse innate immune effectors. 
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Summary 
In this chapter, we described the analysis and reconstruction of an infectious 
ancestral MuERV-L (ancML) sequence through paleovirological analyses of 
MuERV-L elements in the mouse genome. The resulting ancML sequence was 
infectious in CHO cells and its replication was dependent on efficient reverse 
transcription. We found that IFN-α could reduce ancML replication by ~20 fold. 
Additionally, we found that the expression of mouse APOBEC3 was able to 
restrict the replication of ancML. However, inspection of endogenous MuERV-L 
sequences suggested that the impact of APOBEC3-mediated hypermutation on 
MuERV-L evolution was limited. The development of a ~2 MYA ancestral 
MuERV-L sequence highlights the impact that retroviral elements have had in 
animal evolution, and the potential for the retroviral “fossil record” to uncover new 
biological processes. 
	    
	   127 
Chapter V. Paleovirology of a human ERV 
As mentioned in chapter III, HERV-T is a human ERV that is closely related to 
extant gammaretroviruses. The low copy numbers and the integrity of its env 
gene suggest for an expansion through reinfection mechanisms (Belshaw et al., 
2005). These observations make HERV-T a suitable candidate to further 
investigate its evolution and to reconstruct a possible infectious ancestral 
sequence. 
 
Ancestral reconstruction of HERV-T. 
As described previously (chapter III), there are three classes of HERV-T 
sequences (Figure 3.1). Because most likely the HERV-T2 class originated from 
a subset of inactivated and hypermutated sequences that expanded through 
retrotransposon-like mechanisms (Figures 3.2 and 3.3), we discarded this class 
and center our analysis on the other two classes, HERV-T1 and the older HERV-
T3. We downloaded proviral elements from these two classes that contained 
coding sequences flanked by two paired LTRs (LTR-gag-pol-env-LTR) in 
catarrhine primates. There were only 5 such elements belonging to the HERV-T1 
class in the genomes of human and chimpanzee, whereas there were 27 HERV-
T3 elements present in all catarrhine genomes analyzed.  The proviral 
sequences were aligned to a consensus HERV-T reference sequence and were 
used to guide the construction of a ML phylogenetic tree (Figure 5.1). Analysis of 
the 5’ and 3’ flanking sequences revealed that there were only two and fourteen 
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unique HERV-T1 and HERV-T3 integration events (orthologous groups), 
respectively. The integration dates of these elements, approximated by the 
divergence of their paired LTRs, corroborated previous estimates for the 
expansion of HERV-T1 and HERV-T3 elements (Figures 3.2 and 5.1). Due to the 
paucity of HERV-T1 sequences we decided to use the proviral elements 
belonging to the HERV-T3 class to guide a ML ancestral reconstruction of its root 
node (Figure 5.1). The resulting ~32 MY old ancestral sequence was corrected 
for possible mutations derived from deamination of methylated CpG dinucleotides 
(see chapter II). The final ancestral sequence showed complete ORFs for all 
three genes (gag, pol and env), an unusually long leader sequence and an 
identical pair of LTRs.  
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Figure 5.1: Phylogenetic tree of HERV-T1 and HERV-T3 proviral sequences 
in catarrhine primates. 
LTR-gag-pol-env-LTR containing proviruses were aligned to a consensus HERV-
T sequence and used to guide a ML phylogenetic tree. Black brackets represent 
orthologous groups. Dates of integration based on the divergence of their paired 
LTRs. Bootstrap support for internal nodes are indicated by numbers (10,000 
bootstrap replicates). Red circle denotes the HERV-T3 ancestral node 
reconstructed by baseml.   
HERV-T1!
HERV-T3!
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The long leader sequence of HERV-T encodes a predicted transmembrane 
protein. 
A closer look into the HERV-T ancestral and consensus sequence revealed a 
remarkably long leader sequence (1795nt), uncommon among 
gammaretroviruses and closely related ERVs (Figure 5.2). The retroviral un-
translated leader sequence usually contains the PBS, regulatory RNA structures 
such as signals for packaging (Ψ), splicing, genome dimerization, and in some 
retroviruses an internal ribosome entry site (IRES) (Corbin and Darlix, 1996; 
Ohlmann et al., 2000). Additionally, an unconventional CUG codon present in the 
leader sequence of an exogenous gammaretrovirus, MLV, results in the 
production of an 88 amino acid extension of the canonical Gag protein, its 
translocation to the ER and its expression at the cell surface as a glycosylated 
transmembrane protein (MLV glycoGag) (Berlioz and Darlix, 1995; Pillemer et al., 
1986; Prats et al., 1989). Moreover, the 815-nucleotide HERV-H leader sequence 
also encodes for an additional ORF upstream of gag with unknown function (Jern 
et al., 2005). In order to address if the unusually long HERV-T3 leader sequence 
could potentially encode for an additional ORF, we translated the ancestral 
leader sequence in all three frames and found one clear 726nt ORF 165nt 
upstream of the gag start codon. The preliminary translation of the “pre-gag” ORF 
resulted in a 242 amino acid protein with no sequence homology (nucleotide or 
protein) to any sequence present in public databases (Figure 5.3A). An ancestral 
sequence representing the HERV-T1 root node in Figure 5.1 also showed the 
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present of the pre-gag ORF but with a 132-nucleotide extension that encoded for 
a predicted tramsmembrane domain (Figure 5.3A). This extension was the result 
of a seven-nucleotide frameshift deletion in HERV-T1 proviruses compared to 
HERV-T3 (Figure 5.3A), which eliminated the stop codon. We then decided to 
revisit the HERV-T3 ancestral sequence to include those 43 codons that 
contained a transmembrane domain, and reassessed the state of particularly 
polymorphic sites, taking into account the variation present in HERV-T1 
sequences (Figure 5.3A). The resulting 285-amino acid long pre-Gag protein 
(HTpG) was codon optimized for humans, synthesized and cloned into an 
expression vector that incorporated a HA-tag in its N-terminus (Figure 5.3A). 
Immunofluorescence assays of HA-tagged HTpG transfected into 293T cells 
shows a primarily intracellular and perinuclear localization in discrete structures 
most likely representing the ER and the membranous system (Figure 5.3B). 
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Figure 5.2: The leader sequence of the ancestral HERV-T3 genome 
contains a pre-gag gene. 
(A) Length of the sequence between the end of the 5’ LTR and the beginning of 
gag in nucleotides (nt), for selected endogenous and exogenous 
gammaretroviruses and closlely related ERVs. Phylogenetic relations are based 
on a distance (neighbor-joining) tree constructed from an alignment of consensus 
RT sequences. Gammaretroviruses have branches colored in blue. HERV-T 
branch is indicated in red. (B) Ancestral HERV-T3 genome. Coding sequences in 
different frames are indicated. Leader sequence is denoted in grey. 
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Figure 5.3: Sequence, expression and localization of the HERV-T pre-Gag 
protein. 
(A) Logo plot of the translated pre-gag sequence in HERV-T3 proviruses. The 
total column height represents the sequence conservation on that site (in bits). 
The height of each residue represents its frequency at that particular site. The 
frameshift indel with respect to HERV-T1 proviruses is indicated by a red triangle. 
A red bracket indicates positions predicted to form a transmembrane domain. 
The HTpG final sequence is showed on top of the logo plots. (B) Subcellular 
localization of HTpG in 293T cells. Immunofluorescence of 293T cells transfected 
with and empty vector (Empty) or plasmids expressing GFP or an N-terminal HA-
tagged HTpG protein. Fixed 293T cells were incubated with anti-HA antibodies. 
Nuclear DNA was labeled with DAPI. 
  
Figure 5.3 Sequence, expression and localization of the HERV-T pre-
Gag protein. (A) Logo plot of the translated pre-gag sequence in HERV-
T3 proviruses. The total column height represent the sequence 
conservation on that site (in bits). The height of each residue represent its 
frequency at that particular site. The frameshift indel with respect to 
HERV-T1 proviruses is indicated by a red triangle. Positions predicted to 
form a transmembrane domain are indicated by a red bracket. The HTpG 
final sequence is showed on top of the logo plots. (B) Subcellular 
localization of HTpG in 293T cells. Immunofluorescence of 293T cells 
transfected wi h and empty vector (Empty) or plasmids expr ssing GFP 
or an N-terminal HA-tagged HTpG protein. Fixed 293T cells were 
incubated with anti-HA antibodies. Nuclear DNA was labeled with DAPI.!
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The MLV glycoGag, mentioned before has been implicated to help viral infection 
and disease progression in vivo by a wide range of functions. MLV glycoGag 
enhances viral budding by redirecting virion assembly into lipid rafts (Low et al., 
2007; Nitta et al., 2010) and inhibits the action of mouse APOBEC3 (Stavrou et 
al., 2013). More recently, its cytoplasmic tail has proven responsible for the 
rescue in infectivity of incoming Nef deficient HIV-1 particles (Pizzato, 2010; 
Usami et al., 2014) by inhibiting the action of the antiviral protein SERINC5 (Rosa 
et al., 2015; Usami et al., 2015). The action of SERINC5 and SERINC3 seems to 
be dependent on the envelope used (Pizzato, 2010; Rosa et al., 2015; Usami et 
al., 2015). In order to address if HTpG might replicate some of the functions 
associated with glycoGag we produced MLV particles pseudotyped with 
ecotropic or amphotopic MLV envelopes in 293T cells co-transfected with 
increasing amounts of a plasmid expressing HA-tagged HTpG or an empty vector 
(Figure 5.4). We were able to show a slight increase in infectivity of MLV particles 
pseudotyped with the amphotropic envelope (MLV-A), but not with the ecotropic 
envelope (MLV-E) (Figure 5.4A), in accordance with previous publications for 
MLV glycoGag (Pizzato, 2010).  Although the effect of HTpG is small, the 
increase in infectivity of MLV-A pseudotyped particles is dependent on the 
amount of plasmid expressing HTpG (~2 fold increase in infectivity with the 
highest concentration of HTpG expressing plasmid) (Figure 5.4A). It is worth 
mentioning that there is a faint signal, about the size of the HA-tagged HTpG, in 
virion lysates produced from cells transfected with higher concentrations of the 
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plasmid expressing HA-tagged HTpG, perhaps suggesting minor incorporation of 
HTpG molecules into viral particles (Figure 5.4B).  
 
Reconstruction of a functional ancestral HERV-T3 envelope. 
As described in chapter III, HERV-T proviruses seem to have preserved the 
integrity of their env genes (Belshaw et al., 2005), which might be exploited in 
order to reconstruct a functional envelope. In order to approximate this possibly 
infectious env sequence, we refined the previously ~32 MY old predicted 
ancestral HERV-T3 env sequence by reassessing the state of particularly 
polymorphic sites taking into account the variation present in HERV-T1 
sequences, in a way similar to the procedure used to reconstruct the HTpG 
protein (see also chapter II). The resulting 631-amino acid long gamma type-C 
refined ancestral envelope protein (ancHTenv) was codon optimized for humans, 
synthesized and cloned into an expression vector (Figure 5.5).  
To determine if the reconstructed ancHTenv was infectious we produced MLV 
particles pseudotyped with this construct and tested its ability to infect a variety of 
animal cells (Figure 5.6A). Strikingly, ancHTenv was able to infect all primate, 
rodent and carnivore cell lines tested, with the exception of mouse NIH3T3, rat 
Rat2 and chicken DF-1 cells. The infectivity of the ancHTenv pseudoyped MLV 
particles was similar, or even better in some cell lines, than the infectivity of MLV 
particles pseudotyped with MLV-A (Figure 5.6A). 
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Figure 5.4: Effect of HTpG in MLV infectivity. 
(A) Infectivity of MLV particles pseudotyped with ecotropic (MLV-E) or 
amphotropic (MLV-A) envelopes. Viruses expressing a GFP reporter protein 
were produced from 293T cells co-transfected with increasing amounts of a 
plasmid expressing HA-tagged HTpG or an empty vector. Viral titers were 
measured on NIH3T3 cells. (B) Western blot analyses of cell lysates and virions 
produced in (A). The cell lysates and virions were probed with anti-CA and anti-
HA antibodies. L: molecular ladder. Ø: no envelope. 
  
Figure 5.4 Effect of HTpG in MLV infectivity. (A) Infectivity of MLV 
particles pseudotyped with ecotropic (MLV-E) or amphotropic (MLV-A) 
envelopes. Viruses expressing a GFP reporter protein were produced 
from 293T cells co-transfected with increasing amounts of a plasmid 
expressing HA-tagged HTpG or an empty vector. Viral titers were 
measured on NIH3T3 cells. (B) Western blot analyses of cell lysates and 
virions produced in (A). The cell lysates and virions were probed with 
anti-CA and anti-HA antibodies. L: molecular ladder. Ø: no envelope.!
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We then tested if the HTpG might have a positive effect on MLV particles 
pseudotyped with its own envelope (ancHTenv). For this purpose, and in order to 
directly test the activity of human SERINC5 on the ancestral envelope, we 
produced MLV particles pseudotyped with ancHTenv or the VSV glycoprotein 
(VSV-g), using 293T cells co-transfected with a plasmid expressing human 
SERINC5 and increasing amounts of the plasmid expressing HA-tagged HTpG, 
MLV glycoGag, SIV and HIV Nef or an empty vector. The produced viruses were 
then used to infect naïve 293T cells (Figure 5.6B). As expected human SERINC5 
was not able to restrict MLV particles pseudotyped with VSV-g. However, MLV 
particles pseudotyped with ancHTenv were sensitive to human SERINC5 
showing a reduced infectivity of almost 10 fold (Figure 5.6B). In agreement with 
previous reports the activity of human SERINC5 was blocked by the expression 
of SIV or HIV Nef and MLV glycoGag (Rosa et al., 2015; Usami et al., 2015) in a 
dose dependent manner (Figure 5.6B). Nevertheless, the expression of HTpG 
was not able to alleviate the inhibitory effect of human SERINC5 on ancHTenv 
pseudotyped MLV particles (Figure 5.6B), arguing against the functionality of 
HTpG as an analogous protein to MLV glycoGag. 
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Figure 5.5: Refined ancestral HERV-T envelope sequence. 
Logo plot of the translated env sequence in HERV-T3 proviruses. The total 
column height represents the sequence conservation on that site (in bits). The 
height of each residue represents its frequency at that particular site. The 
ancHTenv final sequence is showed on top of the logo plots. Signal peptide and 
propeptide furin cleavage sites are indicated by purple and red triangles, 
respectively. Sequence of the fusion peptide and transmembrane domain are 
indicted in cyan and orange boxes, respectively. Cleavage sites were predicted 
using ProP 1.0 (Duckert et. al. 2004). 
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Figure 5.6: Infectivity of ancHTenv pseudotyped MLV particles and their 
inhibition by human SERINC5. 
(A) Infectivity of MLV particles pseudotyped by ancHTenv or MLV-A in a variety 
of cell lines. Viruses expressing a GFP reporter protein were produced from 293T 
cells. (*): Not tested. (B) Effect of human SERINC5 on MLV particles 
pseudotyped by ancHTenv or VSV-g. Virus expressing a GFP reporter protein 
were produced from 293T cells co-transfected with 15ng of a plasmid expressing 
human SERINC5 and increasing amounts of plasmids expressing HTpG, MLV 
glycoGag, SIV and HIV Nef or an empty vector. Viral titers were measured on 
naïve 293T cells.  
Figure 5.6 Infectivity of ancHTenv pseudotyped MLV particles and 
their inhibition by human SERINC5. (A) Infectivity of MLV particles 
pseudotyped by ancHTenv or MLV-A in a variety of cell lines. Viruses 
expressing a GFP reporter protein were produced from 293T cells. (*): 
Not tested. (B) Effect of human SERINC5 on MLV particles pseudotyped 
by ancHTenv or VSV-g. Virus expressing a GFP reporter protein were 
produced from 293T cells co-transfected with 15ng of a plasmid 
expressing human SERINC5 and increasing amounts of plasmids 
expressing HTpG, MLV glycoGag, SIV and HIV Nef or an empty vector. 
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Existence of a ~17 MY old HERV-T3 env ORF in the human genome 
As described in chapter I, although the vast majority of ERV sequences in animal 
genomes are highly mutated and inactivated, there are some examples of 
preserved (complete or partial) genes and structures that have been co-opted by 
the host as part of their genetic repertoire. A previous analysis for potentially 
complete ERV genes in the human genome revealed 16 protein coding env 
genes including one for HERV-T in chromosome 19 (de Parseval et al., 2003). 
This HERV-T envelope protein was mostly expressed in thyroid tissue with minor 
expression in prostate, kidney and other healthy tissues (de Parseval et al., 
2003). Further studies by the same group showed that this envelope has lost its 
fusogenic property (Blaise et al., 2003).  A closer look into this element in the 
human genome showed that this env gene was flanked by two HERV-T3 paired 
LTRs with inactivated gag and pol remains. A cDNA sequence is publicly 
available in GenBank (ID: AB266802) and indicates that the env mRNA is not 
generated from its 5’ LTR, but from a HERV-L-like soloLTR (LTR66) located 
3.5Kb upstream of HERV-T provirus.  A search for orthologous loci to this 
particular provirus found its conservation in the genomes of gorillas and 
orangutans, but not in gibbons (Figure 5.7A), suggesting an integration date of 
~13 to 20 MYA (Perelman et al., 2011). Whereas the human and orangutan 
sequences showed an env with full coding potential, the gorilla ORF is truncated 
due to a single nucleotide insertion at codon 234. This locus is also absent in 
chimpanzees due to a ~196Kb segmental deletion. The human HERV-T 
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envelope protein shares 85% identity (91% similarity) to the ancHTenv and its 
most obvious difference is the lack of the last five amino acids present at the C-
terminus of ancHTenv. We cloned this human HERV-T3 env sequence 
(HsaHTenv) in an expression vector and tested its ability to pseudotype MLV 
particles. We also generated HA-tagged versions of ancHTenv, HsaHTenv and a 
codon-optimized version of HsaHTenv for expression in human cells (Figure 
5.7B). MLV particles pseudotyped with ancHTenv were infectious, in accordance 
with previous experiments, with a slight reduction in infectivity for particles 
pseudotyped with a HA-tagged version of this envelope. On the contrary none of 
the constructs expressing HsaHTenv were able to pseudotype MLV particles and 
produce infection (Figure 5.7B). Western blot analyses of producer cells and 
virus lysates clearly showed a defect in the processing of HsaHTenv, compared 
to the ancHTenv, that prevents incorporation of a ~25kDa protein fragment into 
virions (Figure 5.7C), most likely corresponding to the TM protein domain 
predicted to weight 23.92kDa (Figures 5.5) (see chapter II). As expected the 
codon-optimized version of HsaHTenv is expressed at higher levels than the 
sequence cloned form human gDNA (Figure 5.7C). For this reason all the 
experiments referring to HsaHTenv from this point forward will be performed 
using the codon-optimized version of this envelope.  
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Figure 5.7: Conservation of a human HERV-T3 env gene with coding 
potential and its infectivity.  
(A) Graphical representation of a glocal sequence alignment of a human HERV-T 
env and its orthologs in gorillas and orangutans generated using mVISTA (Frazer 
et al., 2004). Each graph shows the percentage of conservation between the 
DNA sequences of that organism with the corresponding human sequence at any 
given coordinate. Sequences that show more than 90% similarity with the human 
sequence are indicated in color. Non-coding regions are indicated in pink. Coding 
env sequences are indicated in purple, HERV-T3 proviral sequence is indicated 
in light blue. The location of the LTR66 promoter is also indicated. (B) Infectivity 
of MLV particles pseudotyped with HA tagged and untagged MLV-A, ancHTenv 
or the human HERV-T envelope (HsaHTenv). (opti-) indicates a codon optimized 
version for expression in human cells. Viruses expressing a GFP reporter protein 
were produced from 293T cells. Viral titers were measured on 293T and HT1080 
cells. Data from 3 independent experiments. (C) Western blot analyses of cell 
lysates and virions produced in (B). The cell lysates and virions were probed with 
anti-CA and anti-HA antibodies. L: molecular ladder. Ø: no envelope. 
  
	   143 
 
 
 
 
Figure 5.7: Conservation of a human HERV-T3 env gene with coding 
potential and its infectivity. 
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The failure of HsaHTenv to produce infectious particles despite its coding 
potential, made us speculate that perhaps an ancestral sequence for this 
particular locus would revert the inactivating mutations and produce infectious 
particles. The reduced set of sequences (only three sequences from human, 
gorilla and orangutan) prevents us from using previously described ML 
methodologies. Instead, we produced an ancestral sequence for this locus by 
selecting residues based on the phylogenetic relationships of the three 
sequences. Particularly polymorphic sites were resolved by comparison to the 
ancHTenv sequence. The resulting ancestral sequence for this particular locus 
(ancHsaHTenv) was codon-optimized, synthesized and cloned into an 
expression vector to test its infectivity. Similarly to HsaHTenv, MLV pseudotyped 
particles with ancHsaHTenv were non-infectious and showed similar defects in 
processing and virion incorporation compared to ancHTenv (Figures 5.8B and C). 
Comparisons of the envelope protein sequences revealed the presence of a 
mutated and non-functional furin cleavage site in HsaHTenv and their 
orthologous sequences in gorilla and orangutan (Figures 5.5 and 5.8A), possibly 
explaining the defects in processing and incorporation into virions.  In order to 
construct a furin site mutant ancHTenv and an HsaHTenv and ancHsaHTenv 
with the furin site repaired, we switched the furin cleave motifs between 
ancHTenv and both HsaHTenv and ancHsaHTenv. These constructs were used 
to pseudotype MLV particles and test their processing and infectivity. The furin 
site mutation introduced in ancHTenv was sufficient to impair the production of 
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infectious particles, the correct processing of the envelope protein and the 
incorporation of the TM domain into virions (Figures 5.8B and C). Strikingly, 
neither HsaHTenv nor ancHsaHTenv with the furin sites repaired were able to 
produce infectious particles (Figure 5.8B). The repair of the furin cleavage site of 
HsaHTenv also failed to produce the correct signal corresponding to the TM 
domain and instead resulted in the emergence of higher molecular weight 
fragments (Figure 5.8C). However, the same modification in ancHsaHTenv was 
able to produce a similar processing pattern as the functional ancHTenv and the 
presence of a fragment corresponding to the molecular weight of the TM domain 
(Figure 5.8C). This fragment was also incorporated into viral particles, although 
to a lesser extent than the one produced by ancHTenv (Figure 5.8C). 
Additionally, only the expression of ancHTenv, but no other HERV-T envelopes, 
results in the production of syncytia in 293T cells (Figure 5.9), supporting the 
fusogenic potential of this ancestral envelope and confirming its absence in the 
rest of the HERV-T envelopes tested. These results indicate that the complete 
protein-coding HERV-T env present in the human genome is not able to serve as 
a functional envelope protein and an alternative function should be further 
assessed.  
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Figure 5.8: Infectivity and processing of HERV-T envelopes. 
(A) Multiple sequence alignment of ancHTenv and HERV-T envelopes in primate 
genomes. The propeptide furin cleavage site is indicated by a red box and 
triangle. Numbers above the alignment indicate amino acid positions. (B) 
Infectivity of MLV particles pseudotyped with HA tagged ancHTenv, HsaHTenv, 
and a recent ancestral sequence of the human protein-coding env loci 
(ancHsaHTenv) with or without a predicted functional furin site (FurinFix, 
FurinMut).  Viruses expressing a GFP reporter protein were produced from 293T 
cells. Viral titers were also measured on 293T cells. Data from 3 independent 
experiments. (C) Western blot analyses of cell lysates and virions produced in 
(B). The cell lysates and virions were probed with anti-CA and anti-HA 
antibodies. L: molecular ladder.   
Figure 5.8 Infectivity and processing of HERV-T envelopes. (A) 
Multiple sequence alignment of ancHTenv and HERV-T envelopes in 
primate genomes. The propeptide furin cleavage site is indicated by a red 
box and triangle. Numbers above the alignment indicate amino acid 
positions. (B) Infectivity of MLV particles pseudotyped with HA tagged 
ancHTenv, HsaHTenv, a recent ances ral sequence of the human protein-
coding env loci (ancHsaHTenv) with or without a predicted functional furin 
site (FurinFix, FurinMut).  Viruses expressing a GFP reporter protein 
were produced from 293T cells. Viral titers were also measured on 293T 
cells. Data from 3 independent experiments. (C) Western blot analyses of 
cell lysates and virions produced in (B). The cell lysates and virions were 
probed with anti-CA and anti-HA antibodies. L: molecular ladder.!
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Figure 5.9: Fusogenic properties of different HERV-T envelopes. 
(A) Ratio of cells with more than 5 nuclei over the total number of cells 
expressing the different HERV-T envelopes. Data calculated from 30 frames of 
293T cell lines stably expressing different HERV-T envelopes. Envelope 
expression correlates with the expression of a GFP reporter gene included in the 
lentiviral vector used to produce the stable cell lines. (B) Example of 
multinucleated cells quantified in (A). Fixed 293T cells were incubated with anti-
HA antibodies. Nuclear DNA was labeled with DAPI. Images were amplified and 
centered on features of interest. 
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Selective pressures have conserved the coding potential of HsaHTenv. 
The inability of HsaHTenv to produce infectious particles despite coding potential, 
made us re-evaluate the significance of finding such a complete env gene in the 
human genome. We first aimed to address how likely is to find a complete env 
ORF assuming there are no selective pressures to conserve any function (i.e. 
Neutral evolution). For this purpose we performed Monte-Carlo simulations of in 
silico neutral evolution on the ancHsaHTenv sequence for 13.45 and 19.68 MY 
(the minimum and maximum estimates of the origin of hominids (Perelman et al., 
2011)). On average, only 5% of all simulated sequences (2–8% of 10,000 
iterations) retain coding potential showing no truncation of its ORF and a 5’ 
methionine codon (Figure 5.10A). The majority of the sequences (83.3–85.5%) 
retained the 5’ methionine but they were truncated by the presence of at least 1 
stop codon (Figure 5.10A). The distribution of stop codons among the simulated 
sequences had a median of 2–3 with 70–86% of the sequences showing at least 
2 stop codons. The results of these simulations are probably an underestimate 
because we are not taking in to account the additional inactivating mutations 
derived from insertion/deletion processes introduced by genetic drift. Therefore it 
is unlikely that the preserved env ORF present in the human genome is the result 
of ~17 MY of evolution under no selective pressures.  
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Figure 5.10: Analysis of protein-coding HERV-T env sequences under 
neutral evolution.  
(A) Results of the Monte-Carlo simulations of in silico neutral evolution. The 
ancHsaHTenv nucleotide sequence was evolved for 13.45 (minimum estimate) 
and 19.68 (maximum estimate) MY under a human neutral substitution rate of 
2.2x10-9 substitutions per site per year (Lander et al., 2001). 10,000 simulated 
sequences were generated using seq-gen (Rambaut and Grassly, 1997). 
Sequences were classified as: Complete: showing 5’ Methionine and no stop 
codons. No start: absence of 5’ Methionine. Truncated: presence of 1 or more 
stop codons. Destroyed: absence of 5’ Methionine and presence of 1 or more 
stop codons. The average values are plotted with maximum and minimum 
estimates indicated by error bars. (B) Distribution of stop codons along the 
coding-sequence of HERV-T proviruses present in human, gorilla and orangutan. 
Stop codons present in the forward 1st, 2nd and 3rd frames are indicated by red, 
blue and black circles, respectively. The location of the env coding sequence is 
colored in gray. (C) Estimation of speciation dates was performed separately for 
gag-pol and env sequences by adjusting the divergence of any given sequence 
to each other under a human neutral substitution rate. (*) As comparison, 
maximum and minimum estimations of the speciation dates were obtained from 
Perelman et al., 2011. A cladogram with the phylogenetic relations between the 
species is shown on the left. The numbers in the cladogram indicate internal 
nodes corresponding to speciation events.  
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Figure 5.10: Analysis of protein-coding HERV-T env sequences under 
neutral evolution. 
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While the env gene has remained complete in humans and orangutans, the gag 
and pol genes show inactivating mutations suggestive of neutral evolution. In 
fact, by mapping the existence of stop codons along the entire proviral coding 
sequence, it is strikingly obvious that the region where env is present has been 
refractory to non-sense mutations, compared with the gag-pol region, in all three 
species (Figure 5.10B). It is worth noting that despite the truncation of the gorilla 
env ORF, the remaining env sequence is preserved in a different frame (frames 2 
and 3 of the gorilla sequence) (Figure 5.10B). We decided to exploit this 
discrepancy and approximate the speciation dates of hominids utilizing both 
types of sequences separately. The estimated speciation dates were calculated 
by adjusting the divergence of any given sequence to each other under a human 
neutral substitution rate of 2.2 x 10-9 substitutions per site per year (Lander et al., 
2001) (Figure 5.10C). Whereas the putative speciation dates obtained from gag-
pol sequences were almost equal to the minimum previous estimates (5.30 and 
13.55 MYA for human-gorilla and orangutan speciation events, respectively) 
(Perelman et al., 2011) (Figure 5.10C), the approximated dates obtained using 
the env sequences were smaller (4.95 and 9.93 MYA human-gorilla and 
orangutan speciation events, respectively) (Figure 5.10C). Although the 
discrepancy between the dates obtained using distinct sequences of the same 
locus is small, this difference suggests that the env sequence is evolving slower 
than the rest of the provirus. This observation, together with the results of the 
simulation and the resistance to non-sense mutations, point out for the existence 
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of selective pressures that have acted on this locus to preserve its coding 
capacity. The completeness of the env ORF perhaps reflects its co-option by an 
ancestral hominid to perform an unknown, but critical function and therefore was 
fixed in the ancestral population ~17 MYA.  
 
The HsaHTenv is a potent inhibitor of particles pseudotyped with ancHTenv. 
One intriguing possibility is that the protein-coding env copy was co-opted to 
block infection by HERV-T or related incoming viruses. In order to test this 
hypothesis we transduced 293T cells with lentiviral vectors containing the 
different HERV-T envelope constructs together with a GFP reporter gene to 
monitor their expression. These cells were then challenged with MLV particles 
pseudotyped with ancHTenv that express a RFP reporter gene upon infection. 
The resulting fluorescent cell populations were quantified by fluorescence-
activated cell sorting (FACS). As expected, ancHTenv expression is able to 
potently block infection of MLV particles pseudotyped with the same envelope 
(ancHTenv) showing a ~300 fold reduction in infectivity compared to cells 
transduced with non-relevant proteins (HIV-1 Nef and GFP) (Figure 5.11). The 
effect on infectivity is slightly reduced upon mutation of the Env furin cleavage 
site, showing that the efficient processing of the env polyprotein is not necessary 
for its inhibitory effect (Figure 5.11). In accordance with this finding the non-
functional complete envelope present in humans and its most recent ancestor 
(HsaHTenv and ancHsaHTenv) showed a 13 and 35 fold inhibition of MLV 
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particles pseudotyped with the functional ancHTenv, respectively, when 
compared to non-relevant proteins (Figure 5.11). These results argue for a 
possible antiviral function of the human complete env gene (HsaHTenv) that was 
preserved for ~17 MY. 
To further corroborate these findings, we produced single cell clones of 293T 
cells stably expressing distinct HERV-T envelopes and characterized their ability 
to be infected by MLV particles pseudotyped with ancHTenv. Although single cell 
clones were selected using an antibiotic resistant marker, there were 
subpopulations of cells showing distinct sensitivity to ancHTenv virus (Figure 
5.12). In order to correctly address the expression of the different HERV-T 
envelopes, we produced single cell clones stably expressing HA-tagged versions 
of the HERV-T envelopes and quantified their expression by 
immunofluorescence  (Figure 5.12D). After classifying each single cell clone into 
four discrete categories depending on the expression of its correspondent 
envelope (Figure 5.12D), we challenged them with MLV particles pseudotyped 
with ancHTenv (Figure 5.12A, B and C). This classification resulted in a 
homogeneous sensitivity to ancHTenv viruses, that is inversely correlated with 
the percentage of cells expressing the HERV-T envelopes, showing on average a 
~10 fold reduction in infectivity by the highest expressing cells.  Remarkably, the 
antiviral effect of the HERV-T envelopes is specific to viruses pseudotyped with 
ancHTenv having no effect on viruses pseudotyped with a different envelope 
(MLV-A). In summary the previous experiments indicate that despite their failure 
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as functional envelopes, HsaHTenv and ancHsaHTenv show a specific inhibitory 
activity against viruses pseudotyped with ancHTenv, suggesting that this antiviral 
function might have been exploited by an ancestral hominid leading to the fixation 
of the proviral locus and the preservation of the coding capacity of the env gene.  
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Figure 5.11: Antiviral capacity of different HERV-T envelopes. 
(A) FACS plots showing the inhibitory effect of HERV-T envelopes. 293T cells 
were transduced with lentiviral vectors expressing ancHTenv, HsaHTenv, 
ancHsaHTenv, ancHTenv-FurinMut, HIV-1 Nef and GFP together with a GFP 
reporter gene. Cells were challenged with concentrated MLV particles 
pseudotyped with ancHTenv that express RFP upon infection. Plots describe the 
percentage of RFP positive cells gated on the GFP positive cell population. Ø: no 
virus. (B) Percentage of RFP and GFP positive cells over total GFP positive 
population. Data of 3 individual experiments performed as in (A). 
Figure 5.11 Antiviral capacity of different HERV-T envelopes. (A) 
FACS plots showing the inhibitory effect of HERV-T envelo . 293T cells 
were transduced with lentiviral vectors expressing ancHTenv, HsaHTenv, 
ancHsaHTenv, ancHTenv-FurinMut, HIV-1 Nef and GFP together with a 
GFP reporter gene. Cells were challenged with concentrated MLV 
particles pseudotyped with ancHTenv that express RFP upon infection. 
Plots describ  the percentage of RFP positive cells gated on the GFP 
positive cell population. Ø: no virus. (B) Percentage of RFP and GFP 
positive cells over total GFP positive population. Data of 3 individual 
xperiments performed s in (A).!
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Figure 5.12: The antiviral effect of different HERV-T envelopes is specific to 
particles pseudotyped with ancHTenv and is dependent on their 
expression.  
293T single cell clones stably expressing HA-tagged or un-tagged versions of (A) 
ancHTenv, (B) HsaHTenv or (C) ancHsaHTenv were infected with concentrated 
MLV particles pseudotyped with ancHTenv or MLV-A and expressing a GFP 
reporter protein. Single cell clones expressing HA-tagged versions of the HERV-
T envelope proteins were classified depending on the percentage of cells 
expressing the different envelopes. (D) Criteria for classification of HA-tagged 
proteins in (A, B and C). Single cell clones stably expressing the different HERV-
T envelopes were fixed and incubated with anti-HA antibodies. Nuclear DNA was 
labeled with DAPI.  
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Figure 5.12: The antiviral effect of different HERV-T envelopes is specific to 
particles pseudotyped with ancHTenv and is dependent on their 
expression.  
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Identification of the receptor used by ancHTenv 
A probable mechanism by which HsaHTenv and ancHsaHTenv restrict infection 
by ancHTenv viruses could be by blocking and sequestering the available 
receptor molecules used by ancHTenv to infect cells. In order to test this 
hypothesis we first needed to determine the identity of this receptor. For this 
purpose we created a lentiviral library expressing mRNAs cloned from cDNA 
molecules from a permissible cell line (293T), together with an antibiotic 
resistance selection marker (blasticidin). The resulting library contained a 
complexity of 3.5 x 106 colony forming units (cfu), suggesting a good 
representation of the different cDNA molecules. We first tested the infectivity of 
our cDNA library in cells that were not sensitive to ancHTenv pseudotyped 
particles (Figure 5.6A). Viruses containing the cDNA library were 10 fold more 
infectious in DF-1 cells than NIH3T3 (3.7 x 105 cfu/ml and 3 x 106 cfu/ml, 
respectively), therefore we chose to perform the screening for the ancHTenv 
receptor in DF-1 cells.  
Preliminary infections of DF-1 cells with MLV particles pseudotyped with 
ancHTenv containing a neo resistant gene revealed a minor, but reproducible, 
infection in this cells with titers of ~4 x 102 G418-resistant colonies/ml. Intrigued 
by this finding we also infect NIH3T3 cells with the same virus pseudotyped with 
ancHTenv and found that these cells were also sensitive to ancHTenv viruses 
with titers of ~1 x 103 G418-resistant colonies/ml. It is possible that the level of 
infection showed on these cells were below the detection power of previous 
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experiments using GFP as a reporter gene, such that the few infected cells 
needed to expand in order to acquire the significant levels required for detection, 
levels that were achieved by 10 days in antibiotic selection.  
This “background” infection in DF-1 cells complicated our efforts to perform the 
receptor screening. To overcome this difficulty we decided to challenge and 
select DF-1 cells expressing the cDNA library with ancHTenv pseudotyped MLV 
particles expressing different fluorescence and antibiotic resistant genes 
iteratively. The rationale was that every time we challenge cDNA expressing DF-
1 cells and select infected cells for another challenge, we would be sequentially 
increasing the population of “true receptor” expressing DF-1 cells over the 
population of “irrelevant cDNA” expressing cells (selected at random due to 
background infection (Figure 5.13A)). Following this strategy we infected DF-1 
cells with cDNA library containing lentiviruses at an MOI of 8, to increase the 
chance that cells will express the “true receptor” regardless of its representation 
in the library. Two days after the initial infection, cDNA expressing DF-1 cells 
were challenged with MLV particles pseudotyped with ancHTenv containing a 
neo resistant gene. Cells were placed in G418 selection two days post infection 
(dpi) and resistant colonies were collected after 10 days. G418 resistant DF-1 
cells were then challenged with ancHTenv pseudotyped MLV particles containing 
a hygromycin resistant gene. Cells were placed in hygromycin selection two dpi 
and resistant colonies were collected after 10 days (Figure 5.12A). At this point, 
although the number of hygromycin resistant colonies was low, they were 
	   160 
sufficiently higher than background infection observed for naïve DF-1 control 
cells, using the same virus. Finally, hygromycin resistant DF-1 cells were infected 
with ancHTenv pseudotyped MLV particles expressing RFP upon infection 
(Figure 5.13A). Almost 18% of the hygromycin resistant DF-1 cells were also 
RFP positive, compared to less than 1% for the naïve DF-1 control cells. Next, 
we extracted gDNA from three RFP positive cell populations and amplified 
possible receptor candidates by PCR (with primers designed to anneal to the 
lentiviral vector) (Figure 5.13B). Surprisingly only two products were amplified 
from gDNA, the strongest band corresponded to a non-coding RNA (ncRNA) 
derived from the human autophagy related 12 (atg12) gene (Figure 5.13B). This 
strong signal might be due to an overrepresentation of this ncRNA in the cDNA 
library reflecting their endogenous levels in 293T cells. Alternatively its size and 
composition might have out-competed other PCR substrates present. The 
second, and much weaker ~1.8Kb band corresponded to the human 
monocarboxylate transporter 1 (MOT1, also known as SLC16A1) a multi-
transmembrane protein that mediates the transport of monocarboxylates such as 
lactate and pyruvate across the plasma membrane (Halestrap and Wilson, 2012) 
(Figure 5.13B). Given the propensity for gammaretroviruses to utilize multi-
transmembrane solute transporters as their receptors (Tailor et al., 2003) (Figure 
1.4A), MOT1 was a strong candidate to be the receptor used by ancHTenv. 
To validate the function of MOT1 as the receptor once used by HERV-T, we 
cloned the amplified MOT1 sequence (Figure 5.13B) back into a lentiviral vector 
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to make DF-1 cells stably expressing human MOT1. MLV particles pseudotyped 
with ancHTenv, expressing GFP or RFP upon infection, are able to infect 
exclusively DF-1 cells that stably express human MOT1 but not naïve DF-1 cells 
or those stably expressing GFP (Figure 5.14). These results confirm that MOT1 
is indeed the receptor used by ancHTenv and probably used initially by HERV-T 
~34 MYA.  
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Figure 5.13: ancHTenv receptor screening using a cDNA library derived 
from 293T mRNA.  
(A) Scheme of the receptor screening strategy. DF-1 cells were infected with the 
cDNA lentiviral library. Two dpi cells were challenge with an ancHTenv 
pseudotyped MLV particles containing a neo gene. Two dpi cells were placed in 
G418 selection for 10 days. G418 resistant cells were challenged with ancHTenv 
pseudotyped MLV particles containing a hygromycin resistance gene. Two dpi 
cells were placed in hygromycin selection for 10 days. Hygromycin resistant cells 
were challenged with an ancHTenv pseudotyped MLV particles expressing RFP 
upon infection. Two dpi cells were analyzed for the expression of RFP. gDNA 
was extracted from RFP positive cells and receptor candidates were amplified by 
PCR using primers that annealed to the lentiviral vector. Virus and cells 
expressing the cDNA of the ancHTenv receptor or other cDNA are colored in 
cyan and red, respectively. The contour of the cell colonies represents the 
expression of a particular reporter gene. Cell plates on the right represent the 
control DF-1 cells that were not infected with the lentiviral library. (B) Principal 
products of the PCR amplification in the last step of (A). The bands 
corresponding to the atg12 non-coding RNA and MOT1 are indicated. Image 
from gDNA PCR from 3 RFP positive DF-1 cell populations. 
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Figure 5.13: ancHTenv receptor screening using a cDNA library derived 
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Figure 5.14: Validation of MOT1 as the ancHTenv receptor. 
(A-B) Fluorescent microscopy of 293T, naïve DF-1 or DF-1 cells stably 
expressing GFP or MOT1 infected with MLV particles pseudotyped with 
ancHTenv and expressing (A) RFP or (B) GFP upon infection. (C) Viral titers of 
the infections in (A-B). Data from 2 independent cell populations. (*): Not tested. 
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Summary  
In this chapter we reconstructed the ancestral genomic sequence of HERV-T, a 
low copy number primate ERV that is closely related to gammaretroviruses. By 
analyzing the unusually long ancestral HERV-T3 leader sequence we were able 
to find an 855nt ORF separated from gag by 36nt. This pre-gag ORF of unknown 
function putatively codes for a protein that includes a transmembrane domain. 
Additional analysis of the HERV-T3 ancestral sequence allowed us to estimate 
the corresponding ancestral envelope protein sequence (ancHTenv). We found 
that a modern gammaretrovirus (MLV) could be pseudotyped with ancHTenv 
enabling it to infect a wide variety of primate cell lines with titers that are similar to 
MLV particles carrying the amphotropic MLV envelope. A single HERV-T proviral 
insertion in the genome of all great apes contains an env gene with full coding 
potential. Proteins encoded by the extant human HERV-T env gene (HsaHTenv) 
and one estimated to be encoded by the hominid ancestor were not able to 
generate infectious MLV pseudotyped particles, probably because HsaHTenv is 
not correctly processed into its mature, functional form. Statistical and 
phylogenetic analyses indicate that the env gene in this locus is evolving slower 
than the rest of the proviral sequences, and its coding capacity cannot be 
explained by genetic drift, suggesting that selective pressures have acted on this 
locus to conserve its envelope sequence. Remarkably, we found that expression 
of the extant HsaHTenv was able to block infection by MLV particles 
pseudotyped with the ancHTenv, but not particles pseudotyped with the 
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amphotropic MLV envelope. These results suggest a potential role of HsaHTenv 
as a restriction factor. Additionally, we identified MOT1 as the receptor used by 
ancHTenv. However, further experiments are needed in order to test the 
hypothesis that HsaHTenv served as a restriction factor through the interference 
with the receptor once used by HERV-T.   
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Chapter VI. Origin and evolution of an orphan antiviral gene 
The other side of paleovirology is the study of the host antiviral defenses and the 
effects that ancient viruses have had on them. As described in chapter I, the 
tetherin gene encodes an antiviral protein with no known homologs that traps a 
broad spectrum of enveloped viruses at infected cell surfaces. Its highly unusual 
architecture (TM-CC-GPI, chapter I), rather than primary sequence, is critical for 
Tetherin function (Perez-Caballero et al., 2009). The uniqueness of this antiviral 
mechanism, along with the absence of any known homolog gene or analogous 
process in the normal functioning of cells prompted us to ask the question of how 
this gene and antiviral mechanism arose. The body of work presented in this 
chapter was produced in collaboration with Dr. Siddarth Venkatesh. 
 
Candidate ancestors of tetherin. 
Every sequenced genome harbors a significant fraction of "orphan" genes whose 
origins are obscure due to the absence of homologs (Khalturin et al., 2009; 
Palmieri et al., 2014; Tautz and Domazet-Loso, 2011). Unlike other antiviral 
restriction factors, tetherin is an orphan gene in eutherian mammals whose 
origins are unknown. Moreover, tetherin is a non-essential gene in mice 
(Liberatore and Bieniasz, 2011) and is only expressed in response to interferon 
in most cells. Thus, it is difficult to envisage a scenario wherein tetherin arose 
from a gene of similar, necessary function. Homology searches for possible 
ancestors of tetherin have been unsuccessful. However, orphan genes that are 
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unusually divergent might preserve structural but not sequence similarity with 
their parents (Domazet-Loso and Tautz, 2003). Therefore, we searched for 
candidate sister genes that encode proteins of similar predicted architecture, 
irrespective of its sequence. We initially focused on the human and mouse 
genomes because they are well annotated and regularly updated. We searched 
for annotated genes whose products are predicted to have the following features: 
(i) a single TM domain, (ii) a CC domain C-terminal to the TM domain, and, (iii) a 
GPI modified C-terminus (see chapter II). Among the 22,691 and 22,709 
annotated human and mouse protein coding genes (Ensembl Release 71) (Flicek 
et al., 2013), Tetherin was the only protein that is predicted to have a TM-CC-GPI 
architecture.  
We reasoned that the genesis of tetherin might have involved the acquisition of a 
third domain by gene products encoding 2 out of the 3 contiguous Tetherin 
features, i.e. proteins with either TM-CC or CC-GPI domains. A search of the 
Ensembl database found 66 to 211 human and 47 to 175 mouse TM-CC 
proteins, depending on the length requirement imposed to form a bona fide coiled 
coil (Table 6.1). Analysis of a previously predicted set of GPI-modified human 
proteins revealed that Tetherin and 12 other proteins had a CC-GPI configuration 
(Pierleoni et al., 2008) (Table 6.2). Overall, ~1% of all annotated human or 
mouse genes encode proteins that have TM-CC or CC-GPI architectures from 
which Tetherin could plausibly have arisen through acquisition of its third defining 
feature.  
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Table 6.1: Identification of genes in the human and mouse genomes that 
encode TM-CC proteins 
Species 
Minimum 
Length 
of 
Coiled-
coil 
domain 
TM-CC 
proteins 
Homologous 
adjacent 
gene pairs 
(same 
orientation) 
Non-
homologous 
adjacent 
gene pairs  
(same 
orientation) 
Non-
homologous 
adjacent 
gene pairs  
(reverse 
orientation) 
Human 
21 211 
7: AREG and 
AREGB, 
PCDHA4 and 
PCDHA5, 
PCDHA8 and 
PCDHA9, 
PCDHA9 and 
PCDHA10, 
PCDHA11 
and 
PCDHA12, 
NDUFA13 
and YJEFN3, 
FCER2 and 
CLEC4G 
3: BCAP29 
and 
SLC26A4, 
CLEC4M and 
EVI5L, PV1 
and Tetherin 
1: EVC and 
EVC2 
28 107 1: FCER2 and CLEC4G 
1: PV1 and 
Tetherin 
1: EVC and 
EVC2 
35 78 1: FCER2 and CLEC4G 
1: PV1 and 
Tetherin 
1: EVC and 
EVC2 
42 66 0 1: PV1 and Tetherin 
1: EVC and 
EVC2 
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Continuation of Table 6.1  
Species 
Minimum 
Length 
of 
Coiled-
coil 
domain 
TM-CC 
proteins 
Homologous 
adjacent 
gene pairs 
(same 
orientation) 
Non-
homologous 
adjacent 
gene pairs  
(same 
orientation) 
Non-
homologous 
adjacent 
gene pairs  
(reverse 
orientation) 
Mouse 
21 175 
5: CLEC4F 
and CD207, 
CYP2B9 and 
CYP2B13, 
BC096441 
and 
TNFSF12, 
MGL2 and 
CLEC10A, 
FCER2 and  
1: PV1 and 
Tetherin 
3: BC035947 
and 
MOGAT1, 
EVC and 
EVC2, 
CYP4B1 and 
EFCAB14 
  CLEC4G   
28 81 
3: CLEC4F 
and CD207, 
MGL2 and 
CLEC10A, 
FCER2 and 
CLEC4G 
1: PV1 and 
Tetherin 
1: EVC and 
EVC2 
35 57 
3: CLEC4F 
and CD207, 
MGL2 and 
CLEC10A, 
FCER2 and  
1: PV1 and 
Tetherin 
1: EVC and 
EVC2 
  CLEC4G   
42 47 1: CLEC4F and CD207 0 
1: EVC and 
EVC2 
*Number of homologous and non-homologous gene pairs depending on the 
threshold set for the length of the coiled-coil domain. 
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Table 6.2: Identification of genes in the human genomes that encode CC-
GPI proteins 
Om
eg
a 
si
te
5  
41
9 
64
6 
29
6 
49
1 
22
2 
40
3 
11
09
 
28
4 
79
0 
15
7 
79
7 
52
9 
1  O
rie
nt
at
ion
 o
f t
he
 g
en
e.
 2  
Nu
m
be
r o
f T
M
 d
om
ain
s p
re
dic
te
d 
by
 T
M
HM
M
. 3
 N
um
be
r o
f C
C 
blo
ck
s p
re
dic
te
d 
by
 C
OI
LS
. 4
 N
um
be
r o
f a
m
ino
 a
cid
s i
n 
th
e 
co
ile
d-
co
il d
om
ain
s. 
5  O
m
eg
a 
sit
e 
pr
ed
ict
ed
 u
sin
g 
Pr
ed
-G
PI
. 
Le
ng
th
 
of
 th
e 
CC
 
do
m
ai
n 
(a
a)
4  
21
 
35
 
24
 
21
 
21
 
25
3 
22
 
21
 
21
 
49
 
21
 
28
 
CC
 
bl
oc
ks
3  
1 1 1 1 1 5 1 1 1 1 1 1 
TM
 
nu
m
be
r2  
0 0 7 0 0 0 0 8 0 1 3 0 
Le
ng
th
 
(a
a)
 
45
1 
67
2 
32
5 
52
1 
24
5 
43
5 
11
38
 
31
0 
81
6 
18
1 
82
6 
55
5 
St
ra
nd
1  
1 1 1 -1
 
-1
 1 -1
 1 1 -1
 
-1
 1 
Ge
ne
 E
nd
 
(b
p)
 
67
22
68
90
 
15
48
95
93
9 
55
98
70
95
 
13
31
26
29
1 
15
04
31
92
4 
12
82
49
41
9 
18
98
13
1 
20
53
98
70
 
21
67
95
51
 
17
37
74
01
 
52
66
69
34
 
13
56
16
14
 
Ge
ne
 
St
ar
t (
bp
) 
67
15
32
27
 
15
48
78
35
7 
55
95
68
77
 
13
31
06
70
3 
15
04
25
97
9 
12
82
18
78
4 
17
71
38
4 
20
53
72
59
 
21
59
73
36
 
17
37
47
50
 
52
62
37
35
 
13
49
76
45
 
Ch
ro
m
os
om
e 
1 1 4 6 6 7 12
 
14
 
16
 
19
 
19
 
X 
As
so
ci
at
ed
 
Ge
ne
 N
am
e 
M
IE
R1
 
BC
AN
 
TM
EM
16
5 
VN
N2
 
UL
BP
3 
CC
DC
13
6 
CA
CN
A2
D4
 
SL
C3
9A
2 
OT
OA
 
Te
th
er
in
 
SL
C8
A2
 
EG
FL
6 
  
	   172 
One likely mechanism by which tetherin arose is the duplication and 
neofunctionalization of another gene (Ohno, 1970). Because duplicated genes 
are often positioned adjacent to each other in genomes (Pan and Zhang, 2008), 
we inspected the organization of genes proximal to tetherin in human and mouse 
genomes. Strikingly, two genes whose protein product had a TM-CC 
configuration were found to be positioned proximal to tetherin in human and 
mouse genomes (Figure 6.1A). One such gene is pv1 that encodes an essential 
component of the stomatal diaphragms of caveolae and the diaphragms of 
fenestrae and transendothelial channels (Stan et al., 1999b; Stan et al., 2012). 
Another TM-CC gene, that we have designated TM-CC, adjacent to tetherin, tm-
cc(at), is of unknown function and is located between pv1 and tetherin (Figure 
6.1A). tm-cc(at) was not identified in our initial searches of mouse and human 
genomes because it is not annotated in the Ensembl database and is the 
translated product of a Gnomon-predicted transcript (GenBank: 
XM_011242347.1) whose existence in mammals is supported only by a single 
cDNA  sequence (GenBank: AK141396.1, RIKEN C430049E01) from an early 
mouse embryo. Thus, it was initially uncertain whether tm-cc(at) is a bona fide 
gene. However, PCR analysis of day 7 mouse embryo mRNA confirmed that a 
transcript encoding tm-cc(at) was present therein, and spliced at the predicted 
intron-exon junctions (Figure 6.2A). Additionally, tm-cc(at) exons appear to be 
better conserved compared to flanking genome sequence across mammals 
(Figure 6.2B), again supporting its existence as a bona fide gene. Moreover, a 
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cDNA encoding a homologous protein has been found in the chicken 
transcriptome (GenBank: BU332041.1, cDNA clone ChEST413k13). Even 
though there is no mRNA evidence for tm-cc(at) expression in humans, a 
homologous sequence is present in the syntenic genomic location of humans 
(GenBank:  XM_011528476.1) and RNA-seq data suggest that it is expressed at 
low abundance and is spliced in a similar way to mouse TM-CC(aT), but includes 
a fifth exon (Figure 6.2C). Thus, this sequence appears to be (or has been) a 
gene that is poorly annotated because it is rarely expressed.  
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Figure 6.1: Location and architecture of TM-CC gene products proximal to 
tetherin in human and mouse genomes. 
(A) Diagram of genes surrounding tetherin in the human and mouse genomes, 
generated using NCBI and UCSC Genome Browsers. (B) Organization of TM-CC 
genes and their protein products for human Tetherin (GenBank: NP_004326.1), 
mouse TM-CC(aT) (GenBank: XP_003945491.1), and human PV1 (GenBank: 
NP_112600.1) proteins. Glycosylation and cysteine residues are indicated as 
brown Y symbols and stars respectively. Numbers indicate amino acid positions. 
Structural features of TM-CC(aT) and PV1 are based on predictions using 
TMHMM (Krogh et al., 2001), COILS (Lupas et al., 1991), and Pred-GPI 
(Pierleoni et al., 2008). Tetherin features are based on structural and functional 
data. 
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Figure 6.2: Validation of tm-cc(at) as a bona-fide gene.  
(A) PCR amplification of tm-cc(at) from mouse total RNA using (i) a forward 
primer specific to the first exon and a reverse primer specific to the third exon, 
and (ii) a forward primer specific to the third exon and a reverse primer specific to 
the 3’UTR. L: DNA ladder. Lanes (i) and (ii). PCR amplicons from cDNA derived 
from 7-day mouse embryo RNA. The transcript structure of mouse tm-cc(at) and 
the expected 280 bp and 867 bp amplicons are indicated. (B) Evolution of tm-
cc(at). Graphical representation of a glocal sequence alignment of human tm-
cc(at) with its orthologs in the indicated animal species generated using mVISTA 
(Frazer et al., 2004). Each graph shows the percentage of conservation between 
the DNA sequence of that organism with the corresponding human sequence at 
any given coordinate. Introns that cross the 50% sequence similarity threshold 
are indicated as pink regions, whereas coding exons are indicated as purple 
regions and untranslated regions are indicated as light blue regions. (C) 
Alignment of human (adapted from GenBank: XP_011526778.1), mouse 
(GenBank: XP_003945491.1) and chicken (adapted from GenBank: 
XP_015155597.1) TM-CC(aT) protein sequences. Sequences spanning the 
cytoplasmic tail (CT), transmembrane domain (TM) and extracellular coiled-coil 
domain (CC) are indicated. Residues that comprise the proline-rich domain are 
indicated in red. 
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Figure 6.2: Validation of tm-cc(at) as a bona-fide gene. 
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Tetherin, PV1 and TM-CC(aT) proteins have a short N-terminal CT, a single TM 
domain, and a predominantly CC extracellular domain with multiple cysteine 
residues that, in the case of Tetherin and PV1, are known to stabilize parallel 
homodimer formation via the formation of disulfide bonds (Andrew et al., 2009; 
Perez-Caballero et al., 2009; Stan et al., 1999a) (Figure 6.1B). Analysis of intron-
exon architecture reveals that tetherin has 4 exons, pv1 has 5-7 exons 
(depending on the species) and cDNA sequences indicate that tm-cc(at) has 4 
(mouse) or 5 (chicken) exons. The organization of exons and protein coding 
domains in tetherin, pv1 and tm-cc(at) is similar, particularly when tetherin and 
tm-cc(at) are compared, with the first exon of all three genes encoding the CT, 
TM and the N-terminal portion of their CC domains. Notably, human and mouse 
pv1 and tm-cc(at) both encode proline-rich sequences at their C-termini, rather 
than the GPI anchor encoded by Tetherin (Figure 6.1B). The unusual structural 
similarity of these genes and proteins, along with their adjacent genomic location, 
suggests that pv1, tm-cc(at) and tetherin might share a common ancestor, 
despite the absence of sequence similarity. 
To determine how unexpected this apparent clustering of TM-CC encoding genes 
should be, we looked at the annotated human and mouse genes for adjacently 
positioned pairs that encode TM-CC proteins. Among the 211 and 175 TM-CC-
encoding genes in the human and mouse genomes respectively, 10 (human) and 
6 (mouse) gene pairs were found adjacent to each other and are in the same 
orientation (Table 6.1). Seven of 10 TM-CC gene pairs in humans, and 5 of 6 
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pairs in mice, share clear sequence similarity usually belonging to obvious gene 
families (e.g. CLEG and CTEG proteins) and therefore very likely arose via gene 
duplication (Table 6.1), in accordance to the fact that most adjacent duplicated 
genes (72-94%) occur in the same orientation (Pan and Zhang, 2008). Overall, 
TM-CC genes account for ~1% of all annotated genes, and most of the few 
adjacent TM-CC gene pairs obviously arose via duplication of the neighboring 
gene. Thus, the probability that tetherin originated de novo in a distal 
chromosomal location, and was then inserted adjacent to two genes that encode 
proteins of similar TM-CC architecture appears to be low (< ~211 TM-CC 
encoding genes / 22,691 genes in the human genome, or < 0.01). 
 
TM-CC(aT) and PV1 can be endowed with antiviral activity by the addition of a 
GPI anchor. 
Both the TM and GPI anchor domains present in Tetherin are essential for virion 
entrapment at the cell surface (Perez-Caballero et al., 2009). A clear difference in 
the overall architectures of human and mouse PV1, TM-CC(aT) and Tetherin is 
the presence of the GPI anchor in Tetherin. If the three proteins indeed share a 
common ancestor, then a model for the genesis of Tetherin would include 
acquisition of a GPI anchor by an ancestral duplicated gene. Indeed, given the 
apparent plasticity of Tetherin protein sequences, this simple modification might 
be sufficient to endow PV1 and/or TM-CC(aT) with antiviral activity.  
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We measured the yield of HIV-1 particles from transfected 293T cells expressing 
unmodified PV1 and TM-CC(aT) proteins, or derivatives of PV-1 and TM-CC(aT) 
proteins that were appended with a GPI modification signal from human Tetherin. 
This analysis revealed that the engineered human and mouse TM-CC(aT) 
proteins with GPI modified C-termini inhibited HIV-1 particle release nearly as 
potently as human Tetherin (Figures 6.3A and B). Interestingly, the unmodified 
TM-CC(aT) proteins also had some propensity to trap virions, while the 
unmodified PV1 protein had little if any antiviral activity (Figures 6.3A and B). The 
addition of a GPI anchor provided PV1 with virion entrapment activity that was 
less potent than that exhibited by the GPI-modified TM-CC(aT) proteins (Figures 
6.3A and B). Western blot analysis of N-terminally tagged derivatives of these 
proteins confirmed that active and inactive proteins were approximately 
equivalently expressed (Figure 6.3C).  
We assessed the antiviral activity of two unrelated TM-CC proteins, CD72 and 
CLEC1A, which have been demonstrated to form dimers and to reside at the cell 
surface (Sattler et al., 2012; Von Hoegen et al., 1990). The unmodified CD72 
protein had a minor propensity to inhibit HIV-1 virion release (Figure 6.4). 
However, unlike PV1 or TMCC(aT), the addition of a GPI anchor did not confer 
either protein with the ability to trap virions (Figure 6.4), suggesting that the ability 
to inhibit virion release upon acquisition of a C-terminal GPI anchor is not 
generalizable to all TM-CC proteins. 
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Figure 6.3: Antiviral activity of GPI-modified TM-CC(aT) and PV1 proteins. 
(A) Infectious virion yield measured using HeLa TZM-bl indicator cells following 
transfection with a Vpu-deficient HIV-1 proviral plasmid along with increasing 
amounts of the indicated unmodified or GPI-modified Tetherin, TM-CC(aT) or 
PV1 proteins. RLU: relative light units. Data from 3 independent experiments. (B) 
Western blot analyses (anti-CA) of cell lysates and virions corresponding to (A). 
Numbers at the bottom represent virion CA protein levels relative to those 
obtained in the absence of an inhibitor. (C) Western blot analyses following 
transfection of plasmids expressing HA-tagged Tetherin or GPI-modified TM-
CC(aT) and PV1 proteins. The cell lysates were probed with anti-HA antibodies.  
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Figure 6.4: Antiviral activity of unrelated TM-CC proteins. 
(A) Infectious virion yield measured using HeLa TZM-bl indicator cells following 
transfection with Vpu-deficient proviral plasmid along with plasmids expressing 
the modified CD72 and CLEC1A proteins. RLU: relative light units. Data from 3 
independent experiments. (B) Western blot analyses of transfected 293T cell 
lysates and virions corresponding to (A), except that varying amounts of the 
indicated plasmids were used. The cell lysates were probed with anti-CA and 
anti-HA antibodies. Virions were probed with anti-CA antibody.   
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Sequence and structural homologs of Tetherin in diverse vertebrates. 
Typically, sister genes exhibit sequence similarity, but homology was not evident 
in human or mouse PV1, Tetherin and TM-CC(aT) proteins or genes. Therefore, 
we next sought to delineate the evolutionary history of tetherin by identifying 
homologs in diverse species. BLAST searches revealed that homologs of human 
Tetherin are present in therian mammals (marsupials and eutherian mammals) 
(Figure 6.5) suggesting an origin predating the emergence of mammals. Tetherin 
sequence homologs could not be found in any other vertebrate species by 
BLAST. However, the marginal sequence similarity among some mammalian 
Tetherin proteins suggested that sequence divergence over >150 million years 
may have eroded sequence similarity to a point that orthologs might not be 
detected in more diverse species, using only their sequences. 
Therefore, we next collected all annotated and predicted transcript sequences 
(Gnomon (Souvorov et al., 2010)) from representative diverse species of 
monotremes (platypus), birds (chicken, saker falcon, turkey), reptiles (Chinese 
alligator and painted turtle), amphibians (frog), lobe-finned fish (coelacanth), ray-
finned fish (medaka and zebrafish) and cartilaginous fish (elephant shark). We 
also obtained transcriptomic data for a jawless vertebrate, the sea lamprey 
(Smith et al., 2013). We searched these actual and putative transcripts for 
sequences that were predicted to encode TM-CC-GPI proteins. By this approach 
we were able to identify putative Tetherin-like proteins (i.e. proteins exhibiting a 
TM-CC-GPI architecture, but lacking sequence homology to Tetherin) in most of 
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the aforementioned species (Figure 6.5) except platypus, chicken, turkey and 
frog. There was no statistically significant sequence similarity between these TM-
CC-GPI proteins and known or putative Tetherin proteins from mammals. Thus, if 
the genes encoding these proteins share a common ancestor with Tetherin, they 
diverged from all previously analyzed eutherian mammal proteins ~150 to 500 
MYA (Inoue et al., 2010; Janvier, 2006; Venkatesh et al., 2014).  
Although an inspection of other bird genomes did not yield any Tetherin 
homologs, we found homologs of the saker falcon TM-CC-GPI protein in eagles 
(Canadian eagle and the bald eagle), ibises (crested ibis), penguins (emperor 
penguin), hummingbirds (Anna’s hummingbird), cuckoos (common cuckoo) and 
other falcons (peregrine falcon); some of these are supported by transcriptomic 
evidence (Canadian eagle, bald eagle, emperor penguin and saker falcon). 
BLAST searches also revealed sequences in the turkey genome that were similar 
to the falcon TM-CC-GPI protein in the predicted terminal four exons of a 
proximal gene (cilp2) (Figure 6.5). However, the inclusion of these four exons in 
turkey cilp2 is unsupported by RNA-seq data and likely represents an annotation 
error. We also found sequences adjacent to the chicken tm-cc(at) gene that are 
predicted to encode a TM-CC-GPI protein. These observations suggest that the 
genomes of both Neoaves (i. e. falcons, eagles, ibises, etc.) and Galloanseres 
(i.e. chicken and turkey) have the potential to code for Tetherin/TM-CC-GPI 
proteins. 
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Figure 6.5: Alignment of Tetherin/TM-CC-GPI protein sequences. 
Human (GenBank: NP_004326.1), mouse (GenBank: NP_932763.1), opossum 
(GenBank: XP_007489270.1 and XP_007489271.1), Tasmanian devil (GenBank: 
XP_012399618.1), turtle (GenBank: XP_008169758.1, XP_005279001.1 and 
XP_005279003.1), turkey (inferred from GenBank: XP_010723307.1), falcon 
(inferred from GenBank: XP_005444407.1 and Gnomon prediction: 
2189215010.p), alligator (GenBank: XP_006017475.1 and XP_006017476.1), 
coelacanth (Gnomon prediction: 16424589.p), elephant shark (GenBank: 
XP_007897024.1). Sequences spanning the TM, CC domains and GPI anchor 
are indicated. Conserved residues are highlighted and predicted omega (GPI 
modification) sites are indicated in grey.  
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Antiviral activity of divergent Tetherin and TM-CC-GPI proteins. 
Previously, only Tetherin proteins encoded by eutherian mammals and by one 
reptile have been identified and demonstrated to exhibit strong antiviral activity 
(Arnaud et al., 2010; Heusinger et al., 2015; Takeda et al., 2012). We next 
determined whether widely divergent Tetherin homologs encoded by marsupials 
(opossum and Tasmanian devil), as well as the TM-CC-GPI proteins encoded by 
a bird (saker falcon), a reptile (Chinese alligator) a lobe-finned fish (coelacanth), 
a cartilaginous fish (elephant shark), and a jawless fish (lamprey), possessed 
antiviral activity.  
We transfected 293T cells with a panel of plasmids encoding Tetherin/TM-CC-
GPI proteins, along with a Vpu-deficient HIV-1 (ΔVpu) proviral plasmid. Because 
antibodies to these proteins were not available, we tested authentic untagged 
proteins as well as derivatives encoding HA-epitope tags at their amino termini in 
most cases (Figure 6.6). The putative Tetherin/TM-CC-GPI proteins encoded by 
opossum, Tasmanian devil, alligator, falcon, coelacanth and elephant shark, all 
inhibited HIV-1 virion release, in most cases with an apparent potency that was 
similar to human Tetherin (Figure 6.6). The addition of a N-terminal HA tag 
verified expression (Figure 6.6C), but affected potency in some cases (not 
shown). In contrast, the TM-CC-GPI protein encoded in the lamprey genome was 
poorly expressed and inactive (Figures 6.6A, B and C). Two divergent Tetherin 
proteins (Tasmanian devil and Chinese alligator) were tested for susceptibility to 
antagonism by HIV-1 Vpu and, predictably, were found to be resistant (Figure 
	   186 
6.6D and E). These findings suggest that virion entrapment is a nearly universal 
feature of TM-CC-GPI proteins that have arisen in jawed vertebrates within the 
past ~450 million years. 
 
Genomic loci harboring tetherin/TM-CC-GPI genes. 
In eutherian mammals, tetherin and its neighboring genes form a syntenic block: 
gtpbp3–pv1–tm-cc(at)–tetherin–mvb12–[2Mb]–cilp2) (Figure 6.1A). While most 
mammals possess a single tetherin gene, recent duplications have led to the 
presence of multiple homologous tetherin genes in some species, such as cows, 
sheep, and bats (Arnaud et al., 2010; Takeda et al., 2012). Inspection of this 
genomic locus in diverse species revealed that in the opossum and the wallaby, 
tetherin has been recently duplicated, tm-cc(at) is absent, and pv1 is separated 
from the two tetherin genes by ~31 mega bases (MB). Moreover, the tetherin 
genes are adjacent to a gene, cilp2 that is located ~2 MB distal to tetherin in 
eutherian mammals (Figure 6.1A and 6.7A). We could not reconstruct an 
analogous locus in a monotreme (platypus) because its genome is incompletely 
assembled.  
Remarkably, we found that all of the aforementioned TM-CC-GPI encoding genes 
in avians, reptiles, coelacanth, medaka and shark species were present in nearly 
the same location in their respective genomes, i.e. between pv1 and cilp2 (Figure 
6.7A). By manual curation of genomic sequence in this interval in some species, 
including searches of translated genomic sequences, and inspection of RNAseq 
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data, we also found that there likely have been several duplication and deletion 
events involving tm-cc(at) and/or tm-cc-gpi genes in the gtpbp3–pv1–cilp2 
interval during the course of vertebrate evolution (Figure 6.7). For example, 
single tm-cc-gpi and tm-cc(at) genes are present in most eutherian mammals 
and avian species, but in reptiles, there is a single tm-cc(at) gene and multiple 
tm-cc-gpi genes including some that appear to generate different TM-CC-GPI 
protein isoforms via alternative splicing of duplicated exons (Figure 6.7B). In an 
amphibian (frog) the locus lacks a tetherin homolog or a putative tetherin gene. In 
the coelacanth, a single tm-cc-gpi and three tm-cc(at) genes are present. In a 
ray-finned fish (medaka), a tm-cc-gpi gene is linked to this locus, but positioned 
outside the gtpbp3–cilp2 interval and the genes are arranged in a manner 
consistent with the possibility that a segmental inversion has occurred. In the 
elephant shark genome, tm-cc(at) is absent and a tm-cc-gpi gene is present in 
this interval proximal to cilp2 (separated from it by an intron-less gene) and 
separated from pv1 by ~223 KB (Figure 6.7A). It was not possible to reconstruct 
the configuration of this locus in the lamprey due to the fragmented nature of the 
genome sequence. Nevertheless, these findings suggest that one or more tm-
cc(at) and/or tm-cc-gpi genes, including tetherin, appeared in vertebrates in at 
the genomic locus containing gtpbp3–pv1–cilp2 (Figure 6.7).  
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Figure 6.6: Antiviral activity of divergent Tetherin/TM-CC-GPI proteins.  
(A) Infectious virion yield measured using HeLa TZM-bl indicator cells following 
transfection of Vpu-deficient HIV-1 proviral plasmids along with plasmids 
expressing Tetherin/TM-CC-GPI proteins. RLU: relative light units. Data from 3 
independent experiments. (B) Western blot analyses (anti-CA) of cell lysates and 
virions corresponding to (A). Numbers at the bottom represent virion CA protein 
levels relative to those obtained in the absence of an inhibitor. (C) Western blot 
analyses following transfection of Vpu-deficient HIV-1 proviral plasmids along 
with plasmids expressing HA-tagged Tetherin/TM-CC-GPI proteins. The cell 
lysates were probed with anti-HA antibodies. (D) Infectious virion yield measured 
using HeLa TZM-bl indicator cells and given in relative light units (RLU) following 
transfection of wild type (WT) HIV-1 proviral plasmids along with plasmids 
expressing Tetherin proteins in a eutherian mammal (human), a marsupial 
(Tasmanian devil) and a reptile (Chinese alligator). (E) Western blot analyses 
(anti-CA) of cell lysates and virions corresponding to (D). Numbers at the bottom 
represent virion CA protein levels relative to those obtained in the absence of an 
inhibitor. 
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Figure 6.6: Antiviral activity of divergent Tetherin/TM-CC-GPI proteins. 
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Figure 6.7: Organization of genes in the tetherin locus.  
(A) Diagrams were generated using NCBI, UCSC, Ensembl Genome Browsers 
and sequence similarity approaches. Branches in gray indicate incomplete 
genome assemblies. Proteins with TM-CC and TM-CC-GPI structures were 
identified in annotated, predicted proteins or RNA-seq data using TMHMM 
(Krogh et al., 2001), COILS (Lupas et al., 1991), and Pred-GPI (Pierleoni et al., 
2008). Inclined figures indicate genes in incompletely assembled scaffolds. White 
and black stars indicate genes that were active or not active respectively in virion 
release-inhibition assays. Potential alternatively spliced versions of alligator and 
turtle tetherin are indicated by dotted lines. Phylogeny and speciation dates were 
based on (Inoue et al., 2010; Janvier, 2006; Venkatesh et al., 2014). (B) 
Genomic loci and spliced isoforms of human, alligator and turtle tetherin/tm-cc-
gpi. CT, TM, CC and GPI anchor are indicated in color. GenBank accession 
numbers are indicated in brackets. Gray shaded forms indicate the relationship 
between a specific genomic position and the transcript variant it encodes.  
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Figure 6.7: Organization of genes in the tetherin locus. 
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Apparent differences in selective pressures acting on pv1, tm-cc(at) and tetherin 
pv1, tm-cc(at) and tetherin do not exhibit sequence similarity to each other in 
mammals. If the hypothesis that they indeed share a common ancestor is 
correct, then a key question is whether they should be expected to share 
sequence similarity, given the time at which they diverged, and the types of 
selection pressure that have acted on them. 
We first determined the types of selection pressures to which pv1, tm-cc(at) and 
tetherin have been subjected, using codon-based tests in CODEML (Yang, 1997) 
and nested pairs of models (M0 and M3, M1a and M2a, M7 and M8) (Table 6.3). 
Because sequence divergence in other animal species confounded the reliable 
assignment of homologous sites in Tetherin, (Figure 6.5) we restricted our 
analyses to therian mammals, which have diverged over the past ~150 million 
years, Positive selection appears to have influenced tetherin evolution in most 
therian mammals (M1a vs. M2a: p-value < 0.002; M7 vs. M8: p-value < 0.001) 
(Table 6.3). In contrast, pv1 and tm-cc(at) have evolved under purifying selection 
in therian mammals (dN/dS < 1). Although there was evidence for variable 
selective pressures among pv1 and tm-cc(at) sites (M0 vs M3: p-value < 0.001) 
(Table 6.3), this variation does not appear to be explained by positive selection 
(M1a vs. M2a: p-value > 0.99; M7 vs. M8: p-value > 0.01; no positively selected 
sites with a PP > 0.95) (Table 6.3). Overall, these results are consistent with the 
notion that pv1, and perhaps tm-cc(at), have conserved cellular functions in 
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therian mammals, while varying pressures in different mammalian species have 
selected for changes in tetherin sequences.  
Notably, introns share little sequence similarity across pv1 in divergent amniotes, 
indicating that neutral evolution over ~300 MY is sufficient to diminish sequence 
similarity to nearly undetectable levels at presumed neutrally evolving sites 
(Figure 6.8). Thus, genetic drift followed by the very different selection pressures 
imposed on pv1, tm-cc(at) and tetherin, can explain the paucity of sequence 
similarity among modern tm-cc genes that putatively originated from a single 
common ancestor early in vertebrate evolution. 
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Table 6.3: Likelihood ratio test on nested models of variable ω ratios 
among sites and Naive Empirical Bayes (NEB) probabilities per site for TM-
CC(aT), PV1 and Tetherin coding sequences. 
Gene Data Set -2 ln(λ) df P-value PSS 
Tetherin 
M0 vs. M3 152.675032 4 P < 0.001 4 
M1 vs. M2 13.171016 2 0.0014 3 
M7 vs. M8 19.830186 2 P < 0.001 4 
PV1 
M0 vs. M3 852.432408 4 P < 0.001 0 
M1 vs. M2 0.000366 2 0.9998 (NS) 0 
M7 vs. M8 8.029462 2 0.0180 (NS) 0 
TM-CC(aT) 
M0 vs. M3 198.13646 4 P < 0.001 0 
M1 vs. M2 -2E-06 2 NA (NS) 0 
M7 vs. M8 1.160924 2 0.5596 (NS) 0 
Neutral	  models	  of	  selection	  (M0,	  M1,	  M7)	  were	  compared	  to	  models	  that	  allow	  
variation	  in	  dN/dS	  among	  sites	  (M3)	  or	  selection	  models	  (M2,	  M8).	  p-­‐values	  were	  
calculated	  using	  a	  chi	  square	  distribution.	  df:	  degrees	  of	  freedom.	  PSS:	  number	  of	  
positive	  selection	  sites	  (Naïve	  Empirical	  Bayes)	  with	  posterior	  probabilities	  >	  0.95.	  
NS:	  Non-­‐significant.	  NA:	  p-­‐value	  ~	  1.	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Figure 6.8: Sequence conservation of the pv1 gene. 
Graphical representation of a glocal sequence alignment of human pv1 with its 
orthologs in the indicated animal species generated using mVISTA (Frazer et al., 
2004). Each graph shows the percentage of conservation between the DNA 
sequence of that organism with the corresponding human sequence at any given 
coordinate. Introns that cross the 50% sequence similarity threshold are indicated 
as pink regions, whereas coding exons are indicated as purple regions and 
untranslated regions are indicated as light blue regions.  
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Relationship between PV1, TM-CC(aT) and tetherin/TM-CC-GPI proteins and 
genes. 
Although these findings suggest that tetherin arose from duplication of pv1 or tm-
cc(at), the gold standard used to demonstrate that two genes share a common 
ancestor is to detect sequence similarity between them. To potentially facilitate 
the detection of homology between distantly related sequences, we used ML 
methods to reconstruct ancestral amniote PV1 and TM-CC(aT) protein 
sequences. It was not feasible to reconstruct reliable ancestral Tetherin 
sequences due to the large divergence. Thus, we searched for sequence 
similarity among extant and ancient PV1, TM-CC(aT) and Tetherin/TM-CC-GPI 
protein sequences using local alignment tools (BLAST).  
While PV1 sequences were clearly homologous across all jawed vertebrates, 
TM-CC(aT) and Tetherin were more variable. In the case of Tetherin/TM-CC-GPI 
sequences, only the common protein architecture and position in genomes 
suggested that the proteins from mammals, birds, reptiles, fish and shark might 
share a common origin (Figures 6.7A and 6.9A). Conversely, TM-CC(aT) 
proteins from mammals, reptiles, avian, and coelacanth exhibited sequence 
similarity to each other, indicating an unambiguous common origin for vertebrate 
tm-cc(at) genes (Figure 6.9A). Attempts to detect homology between PV1 and 
TM-CC(aT) or Tetherin were statistically inconclusive, even when amniote 
ancestral sequences were used. Nevertheless, probabilistic models to detect 
distant homologs (HMMER3 (Finn et al., 2011)) found a significant hit (e-value = 
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2E-5) between coelacanth PV1 and a HMM profile of TM-CC(aT) proteins 
(Figures 6.9C and 6.10). 
As noted above, the coelacanth has three tm-cc(at) genes and one tetherin/tm-
cc-gpi gene in the pv1–cilp2 interval (Figure 6.7A). Strikingly, the coelacanth 
Tetherin/TM-CC-GPI protein exhibited clear sequence similarity to the TM-
CC(aT) proteins, particularly the TM-CC(aT)B protein encoded by the neighboring 
gene, unambiguously indicating a common ancestor (Figures 6.9B and C). 
Because coelacanth Tetherin/TM-CC-GPI is clearly a functional antiviral protein 
(Figures 6.6A and B) sequence similarity reveals that coelacanth tetherin/tm-cc-
gpi shares a common ancestor with tm-cc(at) genes in diverse vertebrates. 
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Figure 6.9: Sequence similarity between PV1, TM-CC(aT) and Tetherin/TM-
CC-GPI proteins.  
(A) A heat map showing e-values of all combinations of reciprocal BLASTp 
analyses using the PV1, TM-CC(aT) and Tetherin/TM-CC-GPI proteins in this 
study. NS: non significant (B) Phylogenetic tree of divergent TM-CC(aT) protein 
sequences. ML tree was constructed using RAxML with 1000 bootstrap 
replicates and the alignment in (C). Numbers indicate bootstrap values. (C) 
Alignment of divergent TM-CC(aT) and Tetherin/TM-CC-GPI protein sequences 
from human (adapted from GenBank: XP_011526778.1), mouse (GenBank: 
XP_003945491.1), turkey (GenBank: XP_010723297.1), alligator (GenBank: 
KQL90195.1), turtle (adapted from GenBank: XP_008169839.1) and coelacanth 
(GenBank: XP_006001674.1 and XP_014347293.1, Gnomon prediction: 
16424589.p and TM-CC(aT)A adapted from RNAseq reads on 
NW_005819727.1). Sequences spanning the TM, CC domains and GPI anchor 
are indicated. Residues that comprise the proline-rich domain in human and 
mouse TM-CC(aT) proteins are indicated in red. 
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Figure 6.9: Sequence similarity between PV1, TM-CC(aT) and Tetherin/TM-
CC-GPI proteins. 
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Figure 6.10: Sequence similarity between TM-CC(aT) and Coelacanth PV1 
proteins. 
Sequence alignment between coelacanth PV1 and a model inferred from a 
multiple sequence alignment (MSA) of TM-CC(aT) proteins (Figure 6.9C). 
Alignment built using HMMER3. Sequences spanning the transmembrane 
domain (TM) and coiled-coil domain (CC) are indicated. Conserved residues in 
the TM-CC(aT) MSA are shown in uppercase. A Dot (.) indicates the introduction 
of a gap in the model TM-CC(aT). Plus (+) signs indicate similar residues 
between the sequences. PP represents the posterior probability of each aligned 
residue (4 = 35-45%, 5 = 45-55%, … 9 = 85-95%, (*) = 95-100%). 
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Potential for tm-cc(at) to encode a GPI anchor in some species. 
Although tm-cc(at) and tetherin/tm-cc-gpi genes share no sequence similarity in 
most vertebrates, and appear to have been placed under different types of 
selection in mammals, the finding that tm-cc(at) and tetherin/tm-cc-gpi (and 
possibly pv1 (Figure 6.10)) are clear homologs in the coelacanth prompted us to 
ask how one might have arisen from the other. Because a key difference 
between these two proteins in mammals is the presence of a proline rich C-
terminus in TM-CC(aT) versus a C-terminal GPI anchor in Tetherin, we inspected 
the annotated 3’ exons of tm-cc(at) in non-mammalian species to determine how 
the GPI modification might has arisen. Notably, bona fide, near full length tm-
cc(at) cDNA sequences from mouse and chicken differ in the number of exons, 
that contribute to sequence encoding the tm-cc(at) C-terminus. Specifically, 
mouse tm-cc(at) has four exons, with the fourth exon encoding a proline-rich C-
terminal sequence (Figure 6.11A). Conversely the chicken tm-cc(at) fourth exon 
is truncated by splicing to a fifth exon encoding only two C-terminal amino acids 
(Figure 6.11A). Human tm-cc(at) is predicted to include a fifth exon that appends 
seven C-terminal amino acids that are absent in mouse tm-cc(at). RNAseq data 
indicates that coelacanth tm-cc(at)A and tm-cc(at)B includes a fifth exon that 
encodes only two or one amino acid respectively, while the 3’ end of the fourth 
exon in tm-cc(at)B encodes C-terminal sequences that have a high probability for 
a GPI modification, followed by a stop codon (Figure 6.11A). Thus, unlike 
	   202 
mammalian and avian TM-CC(aT) proteins, it is highly likely that coelacanth TM-
CC(aT)B is GPI modified at its C-terminus, whether or not the fifth exon is used. 
The tm-cc(at) gene in two reptile species (painted turtle and Chinese alligator) 
has sequences that potentially encode a hydrophobic amino acid-rich sequence 
immediately 3’ to the fourth exon, while a potential fifth exon codes for 3-7 amino 
acids and a termination codon. We reasoned that, similar to the coelacanth 
variant, the hydrophobic amino acid-rich sequence in reptilian TM-CC(aT) 
proteins might confer GPI modification (Figure 6.11A). Due to a paucity of 
RNAseq data, it is unknown whether modern reptile tm-cc(at) genes encode four- 
or five-exon proteins or if they are GPI-modified at their C-termini. However, 
unlike their mammalian counterparts, reptile TM-CC(aT) genes have the potential 
to encode C-terminally GPI-modified proteins. 
We constructed cDNAs expressing the coelacanth TM-CC(aT)B protein and the 
potential alternatively spliced versions of the alligator and turtle TM-CC(aT) 
proteins. The coelacanth TM-CC(aT)B proteins were not glycosylated and were 
poorly active, despite abundant expression (Figures 6.11B, C and D). However, 
the inclusion of the hydrophobic amino acid-rich sequence (i.e. GPI-modified) in 
the alligator and turtle TM-CC(aT) proteins conferred antiviral activity that was 
enhanced by the presence of the fifth exon (Figures 6.11B and C). Strikingly, 
both the four and five-exon versions of the turtle TM-CC(aT) proteins that 
contained the hydrophobic sequence potently inhibited the release of infectious 
HIV-1 particles by ~100-fold at the highest dose tested (Figures 6.11B and C). 
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These data suggest that tm-cc(at) genes in reptiles have the potential to encode 
GPI-modified proteins, with some isoforms exhibiting potent antiviral activity. 
 
Summary 
Tetherin encodes an antiviral protein with no known homologs. In this chapter, 
we describe scenarios by which this orphan gene may have arisen and evolved 
that exemplify how protein modularity, evolvability and robustness can create 
new functions and preserve them, despite sequence divergence due to genetic 
conflict. We find that Tetherin function is encoded by genes that exhibit no 
sequence similarity and share only a common architecture and location in 
modern genomes. Moreover, tetherin is part of a cluster of three potential sister 
genes that encode proteins of similar architecture, some variants of which exhibit 
antiviral activity while others can be endowed with antiviral activity following a 
simple modification. Only in a slowly evolving species (e.g. coelacanths) tetherin 
exhibits sequence similarity to one potential sister gene. We suggest that 
neofunctionalization, drift and positive selection lead to an intense sequence 
diversification among modern tetherin genes, and between tetherin and its sister 
genes, which obscured the ability to detect their homology. 
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Figure 6.11: Antiviral activity of non-mammalian TM-CC(aT) variants.  
(A) Transcript structure and C-terminal protein sequences of potential 
alternatively spliced isoforms of tm-cc(at) in non-mammalian species. The TM, 
CC, proline-rich domains and hydrophobic patch are indicated in color. The 
omega site (underlined in blue) and specificity (1 – false positive rate) were 
predicted using PredGPI (Pierleoni et al., 2008). The number of RNAseq reads 
supporting the occurrence or absence of splicing events is indicated between 
exons. (B) Infectious virion yield measured using HeLa TZM-bl indicator cells 
following transfection of Vpu-deficient HIV-1 proviral plasmids along with 
plasmids expressing alternatively spliced isoforms of TM-CC(aT) proteins. RLU: 
relative light units. Data from 3 independent experiments. (C) Western blot 
analyses (anti-CA) of cell lysates and virions corresponding to (B). Numbers at 
the bottom represent virion CA protein levels relative to those obtained in the 
absence of an inhibitor. (D) Western blot analyses following transfection of Vpu-
deficient HIV-1 proviral plasmids along with plasmids expressing HA-tagged four- 
or five-exon versions of TM-CC(aT) proteins. The cell lysates were probed with 
anti-HA antibodies.  
  
	   205 
 
Figure 6.11: Antiviral activity of non-mammalian TM-CC(aT) variants. 
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Chapter VII. Discussion 
In the preceding chapters we performed a comprehensive paleovrological study 
of selected ERV lineages and host defense mechanisms. We first developed a 
framework (DIGS) to heuristically explore the genomic landscape of ERVs 
through BLAST-based screens used in combination with strategically chosen 
reference datasets. We used DIGS to expand a previously produced 
phylogenetic screen based on RT in order to guide the recovery of proviral loci 
and the inference of ancestral genome sequences. This analysis showed the 
capability of DIGS to identify complex proviral structures despite the numerous 
mutational processes by which these sequences have evolved and revealed that 
most ERV lineages analyzed have a significant amount of mosaic species, which 
might represent true recombination events. 
Although with no identifiable env gene, its high copy numbers in the mouse 
genome, its recent expansion and the opportunity to uncover a potential role in 
mouse development made MuERV-L an interesting candidate for ancestral 
reconstruction. We presented the successful resurrection of a ~2 MY old 
infectious ancestral MuERV-L sequence (ancML) by analysis of the “fossilized” 
MuERV-L elements in the mouse genome. These elements account for a 
particularly reduced set of all the integration events that occurred since its origin. 
Despite the probable random integration pattern of ancML (Figure 4.4D), the 
analysis of fixed MuERV-L elements showed that there is a significant selective 
pressure to eliminate integrations in genic regions and this pressure seems to 
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have being stronger for older elements (Figure 3.5). ERV-L elements differ from 
other highly abundant env-defective ERVs in that the env gene is completely 
absent and it is yet not clear if the env gene was lost in the founder element or if 
this ERV never had an env gene. Whichever the case, the bulk of the replication 
of these elements must have been entirely intracellular through retrotransposon-
like mechanisms (Magiorkinis et al., 2012).  
According to previous studies (Costas, 2003), and corroborated by ours, MuERV-
L originated ~10 MYA after the Rattus-Mus split and underwent a very prolific 
expansion ~2 MYA in modern mouse species. In fact almost 65% of soloLTRs 
and MuERV-L proviruses identified in this study have an integration date below 3 
MY. It is possible to speculate that the co-option of the MuERV-L LTR as a 
promoter for the genes involved in the zygotic genome activation might have also 
occurred ~2 MYA. Therefore, the sudden change in the transcriptional profile at 
an early developmental stage of the mouse embryo resulted in the highly 
productive expansion. Additionally, it is also possible that the embryonic 
environment could contribute to MuERV-L expression and replication, perhaps 
explaining the reduced set of cell lines in which ancML could replicate. Recent 
studies have shown that some ERV sequences have a fundamental role on 
mammalian development (Lavialle et al., 2013; Lu et al., 2014; Macfarlan et al., 
2012; Wang et al., 2014). However, it yet remains to be determined if the 
presence of MuERV-L transcripts, proteins and virus-like particles at the two-cell 
stage play a role in early mouse development, or if this expression is merely a 
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byproduct of the LTR co-option. The generation of ancML certainly represents a 
unique opportunity to resolve this question and potentially uncover a new role for 
ERVs in mammalian development. 
Currently there is no evidence that the ongoing expression of MuERV-L elements 
at the two-cell stage of the mouse embryo results in successful re-integration 
(Guallar et al., 2012). Consequently, either inactive MuERV-L elements recently 
lost the ability to be complemented in-trans, or an additional mechanism has 
recently evolved that inhibits re-integration of active MuERV-L elements. We 
observed that mouse IFN-α is able to inhibit ancML replication and therefore 
mount a successful antiviral response (Figure 4.5A). Expression analyses of the 
IFN-α receptor (IFN-α/β receptor composed of two subunits IFNAR1 and 
IFNAR2) during mouse development showed that ifnar2 is poorly expressed at 
the two-cell stage whereas ifnar1 (the other subunit) belongs to the top 30% most 
expressed genes at that developmental stage (Xie et al., 2010). It has previously 
been shown that IFNAR1 can mount a type I IFN signaling response in the 
absence of IFNAR2 (de Weerd et al., 2013). Therefore, it is possible that type I 
IFN responses might inhibit MuERV-L replication at the two-cell stage of the 
mouse embryo and have kept MuERV-L copy numbers under control. 
We also observed that mouse APOBEC3, but not mouse MOV10 or SAMHD1, 
potently inhibits ancML replication (Figure 4.5B). However, mutational profiles of 
MuERV-L elements in the mouse genome failed to identify sufficient evidence for 
mA3-dependent hypermutation as a mechanism for inactivation (Figures 4.5C, D 
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and E), suggesting that the effects of hypermutation have not being critical for 
MuERV-L replication during its evolution. The expression profile of the mA3 
during mouse development showed transcription at the two-cell stage of the 
mouse embryo with a ~3 fold increase at the four-cell stage becoming one of the 
top 30% most expressed genes at that developmental stage (Xie et al., 2010). 
The epigenetic silencing of MuERV-L after the two-cell stage makes improbable 
that the abundance of mA3 at the four-cell stage has had any effect on MuERV-L 
replication. Nevertheless, the presence of mA3 at the two-cell stage indicates 
that it is at least possible for mA3 to have acted on replicating MuERV-L 
elements through deaminase-independent mechanisms (MacMillan et al., 2013). 
Although there is no definitive answer as to what mechanism was responsible for 
the halt of MuERV-L replication, our results suggest that mA3, as well as a 
subset of IFN-stimulated genes, might have acted upon replicating MuERV-L 
elements and contributed to its extinction. 
Despite its low copy number, another interesting candidate for ancestral 
reconstruction was HERV-T, due to the relative conservation of its env gene, the 
intriguing long leader sequence and the fact that no extant human 
gammaretrovirus is known. Analysis of HERV-T sequences in catarrhine primate 
genomes revealed that there are three classes of HERV-T elements, which 
possibly derived from independent infection and integration events, distinct 
expansion periods, or a mixture of both. Establishing with absolute certainty 
which of these scenarios was responsible for the existence of a particular class is 
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impossible. However, at least for HERV-T2 elements we hypothesize that they 
might have shared an early evolutionary history with HERV-T1, indicated by their 
clustering into a well supported monophyletic clade (Figure 3.1), as well as by 
their initial expansion times ~32 MYA (Figure 3.2). At some point along the way a 
subset of HERV-T2 elements were subjected to APOBEC3-mediated 
hypermutation, and subsequently expanded in apes, most likely through 
retrotransposon-like mechanisms. The oldest class, HERV-T3, originated 
previous to the old world monkey – ape split (~43 MY) and might have derived 
from HERV-T-like elements present in new world monkeys. These HERV-T-like 
elements share sequence similarity with the HERV-T3 coding sequence but not 
to the LTRs. 
HERV-T elements show a striking long leader sequence that is unusual for 
gammaretroviruses and exogenous retroviruses in general. In fact the length of 
the HERV-T leader sequence is only exceeded by HERV-W with a leader 
sequence of 1937 nucleotides (Jurka et al., 2005). Although rare, several 
endogenous and exogenous retroviruses show an additional ORF in their leader 
sequence, such as the fish epsilonretrovirus WDSV (Holzschu et al., 1995) and 
HERV-H (Jern et al., 2005). Phylogenetic and statistical analyses of HERV-T3 
and HERV-T1 ancestral sequences revealed an ORF previous to gag and 
spanning almost half of the leader sequence. The translated product of this pre-
gag ORF encodes a putative transmembrane domain that shows no sequence 
similarity to any protein in public databases. Expression of a reconstructed 
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ancestral pre-Gag protein (HTpG) in virus producer cells shows a minor pro-viral 
effect specific to the MLV amphotropic envelope but not to the ecotropic. 
Attempts to determine if HTpG is a functional analogous of the gammaretroviral 
glycoGag have been futile. Although we cannot discard the possibility that the 
reconstructed sequence do not represent the real functional ancestor, the 
function of this ORF is yet unknown. 
We additionally reconstructed a ~32 MY old infectious ancestral HERV-T3 
envelope (ancHTenv) that is able to pseudotype MLV particles and infect a 
variety of primate, rodent and carnivore cell lines. This ancestral envelope 
pushes back the boundaries of time for paleovirological studies, representing the 
oldest retroviral protein “resurrected” so far. The ancHTenv sequence shows a 
predicted functional propeptide furin cleavage site, a signal peptide, a 
transmembrane domain and a fusion peptide. Its fusogenic ability was further 
corroborated by the ability to form syncytia in 293T cells. This reconstruction was 
certainly facilitated by the relative conservation of the env sequences of HERV-T 
elements, which suggest that this ERV expanded to moderate copy numbers by 
reinfection of germ line cells using a functional envelope. By expressing a 293T-
derived cDNA library in a non-susceptible cell line (chicken DF-1 cells) we were 
able to identify MOT1 as the receptor used by ancHTenv. This receptor has 12 
transmembrane domains and facilitates solute (monocabroxylates) transport 
across the plasma membrane, similarly to other gammaretroviruses receptors 
(Figure 1.4A). This observation highlights the close phylogenetic relation between 
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HERV-T and gammaretroviruses, and supports the possibility of HERV-T being 
itself an extinct human gammaretrovirus.  
MOT1 is part of the solute carrier 16 (SLC16) family of proteins that contains 14 
members, four of which (MOT1-MOT4) have been identified as true 
monocarboxylate transporters (Halestrap and Wilson, 2012). MOT1 is widely 
expressed in human tissues, including thyroid, ovary and testes (Consortium et 
al., 2014), and its sequence is highly conserved among animal species, which 
might explain the broad tissue and species tropism observed for ancHTenv.  
Moreover, there are a couple of residues in the extracellular loops of MOT1 that 
are conserved between species whose cells were permissible to infection of 
ancHTenv containing particles (primates, Chinese hamster and dog) but not 
among species whose cells were non-permissible (mouse, rat and chicken) 
(Figures 5.6A and 7.1). These residues might be responsible for the reduced 
ability of ancHTenv pseudotyped particles to infect DF-1, NIH3T3 and possibly 
Rat2 cells. Further experiments are needed to corroborate the ancHTenv–MOT1 
interaction and to address its possible determinants.   
	    
	   213 
 
 
 
 
 
Figure 7.1: Sequence of the extracellular domains of MOT1 in species 
tested for susceptibility to infection by ancHTenv. 
Multiple sequence alignment for the extracellular domains of MOT1 in selected 
species. Residues in black are conserved by at least 30% of the sequences. 
Residues colored in red are those ones that differ exclusively in mouse, rat and 
chicken and might confer resistance to ancHTenv. The number of the 
extracellular loops is indicated on top. Dots in the alignment represent continuity 
of the MOT1 sequence. N and C termini are indicated in italics. AGM: African 
Green Monkey. Ch. Hamster: Chinese hamster. 
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Remarkably, we identified a HERV-T proviral locus with a complete protein-
coding env gene in the human genome (HsaHTenv), which is unable to 
pseudotype MLV particles, but shows a potent and specific inhibitory effect 
against the functional ancestral HERV-T envelope (ancHTenv). Although it is 
documented that HsaHTenv is well expressed in healthy thyroid tissue (but also 
expressed in others (de Parseval et al., 2003)), we were unable to amplify it by 
RT-PCR from cancerous cells lines of thyroid origin. The thyroid gland is a 
complex tissue composed of mainly two types of cells, follicular epithelial cells 
and parafollicular cells, surrounded by highly vascular connective tissue (Fawcett 
and Jensh, 1997). Therefore, the expression of HsaHTenv might be specific to 
one healthy type of cell and could have been misrepresented in the cancerous 
cell lines tested. One mode of action by which this antiviral env gene might act is 
by receptor interference, where the product of this gene (HsaHTenv) could 
interact with the receptor used by ancHTenv (MOT1), thereby preventing its 
interaction with the functional ancestral envelope and the subsequent infection 
(Figure 7.2).  During its transport to the plasma membrane, MOT1 could be 
sequestered into internal vesicles by interacting with HsaHTenv, reducing its 
surface expression and inhibiting infection by ancHTenv pseudotype particles 
(Figure 7.2B). Alternatively HsaHTenv might be expressed on the cell surface 
and interact with MOT1, resulting in the blockage of available receptors and the 
inhibition of ancHTenv infection (Figure 7.2C). It is unlikely that HsaHTenv (or 
some portion) has to be secreted in order to interact with MOT1, due to the 
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presence of a transmembrane domain and the lack of a functional furin cleavage 
site.  
Infection by ancHTenv pseudotyped MLV particles is almost 3 fold lower in cells 
expressing the most recent ancestor of HsaHTenv (ancHsaHTenv) compared to 
the human copy. Suggesting, that the inhibitory function of this env gene was 
evolved shortly after its integration in the ancestral hominid genome ~13-19 
MYA. This env ORF is complete in humans and orangutans but an extra cytidine 
in a 7-citidine low complexity region in the gorilla ortholog results in a premature 
termination. However, the otherwise complete env sequence continues 
undisrupted in a different reading frame (Figure 5.10B). It is possible that this 
frameshift insertion occurred recently and the remains of the ORF have not had 
time to diverge. Alternatively, the genomic sequence of the gorilla might not be 
completely accurate at this low complexity region and a complete env ORF is still 
present in gorillas. Analysis of all hominid env sequences shows that they are 
evolving slower than the rest of the provirus and they have been remarkably 
refractory to non-sense mutations, in contrast to their cognate gag-pol 
sequences. Although, in silico evolution simulations showed a small but 
significant amount of sequences retaining coding potential (2-8% of simulated 
sequences), these results are not taking into account the further inactivating 
mutations derived from insertion/deletion events fixed by genetic drift. With all of 
these observations taken into consideration it is unlikely that this env gene has 
retained its coding potential in the absence of any selective pressures (neutral 
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evolution). Indicating its probable co-option as a hominid restriction factor for 
HERV-T and/or related viruses.  
Examples of ERV env genes mediating receptor interference have been 
documented in chickens (Robinson et al., 1981), sheep (Spencer et al., 2003), 
mice (Gardner et al., 1991; Odaka et al., 1980; Wu et al., 2005) and cats (Ito et 
al., 2013). Therefore, it seems that this strategy represents an efficient way to 
inhibit viral infections to an extend that it has been recurrently adapted at different 
times by different hosts to deal with viral infections. Further experiments are 
needed to address if this is the mode of action of HsaHTenv, which would 
represent the first documented case for a human restriction factor to be derived 
from an ERV env gene. 
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Figure 7.2: Model for the possible antiviral effect of HsaHTenv through 
receptor interference in humans. 
(A) ancHTenv  uses MOT1 as a receptor to mediate viral entry. (B) MOT1 could 
be sequestered into internal vesicles by interaction with the product of the 
protein-coding env gene in the human genome (HsaHTenv), thereby preventing 
its surface expression and inhibiting infection by ancHTenv pseudotype particles. 
(C) Alternatively HsaHTenv might be expressed in the cell surface and interact 
with MOT1, resulting in the blockage of available receptors and inhibiting 
infection by ancHTenv pseudotype particles. Afterwards MOT1 could be 
internalized in to intracellular vesicles and target for degradation.  
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Based on the integration dates estimated for HERV-T3 soloLTRs (Figure 3.2), we 
infer that the end of the major expansion period for this HERV-T class (10-15 
MYA) overlaps with the estimated dates for the acquisition of the antiviral env 
copy (13-19 MYA). These dates also coincide with the estimated ones based on 
paired LTR comparisons (Figure 5.1), except for a pair of 8 MY old proviruses 
specific to macaques, which do not encode for this antiviral env gene. This 
circumstantial, but suggestive observation, argues in favor for the co-option of the 
protein-coding env gene to protect against HERV-T3 infection, resulting in the 
halt of its expansion and perhaps even its extinction. Under this hypothesis it 
would be unclear how HERV-T1 viruses escaped the action of this env gene and 
continued to expand in hominids (estimated by the dates of its soloLTRs) (Figure 
3.2). However, env containing HERV-T1 loci have dates that would also overlap 
with the acquisition of the antiviral env copy (Figure 5.1). Thus, it might still be 
possible that the few remaining HERV-T1 elements continued expanding through 
mechanisms independent of infection. As seductive as this hypothesis might 
sound the idea is just merely speculative.  
As paleovirology also studies the evolution of the host defense mechanisms that 
have been shaped by past retroviral infections, we investigated the origins and 
evolution of Tetherin, an orphan antiviral protein with no known homologs. The 
lack of sequence similarity to other proteins and the inaccuracies of the assembly 
and annotation of some vertebrate genomes complicated this endeavor. 
Nevertheless, our findings strongly suggest that the genesis of tetherin occurred 
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by duplication and neofunctionalization of an ancestor of a neighboring gene 
encoding a TM-CC protein (pv1 and/or tm-cc(at)). This conclusion is based on 
the findings that: (i) genes encoding TM-CC proteins constitute ~1% of all genes 
and most of those that are arranged contiguously obviously share a common 
ancestor; (ii) pv1, tm-cc(at) and tetherin/tm-cc-gpi are proximal in many modern 
species and share a similar exon-intron structure; (iii) PV1 and especially TM-
CC(aT) are able to trap virions following a simple manipulation that could have 
plausibly been acquired to enable GPI modification; (iv) in the coelacanth, TM-
CC(aT) and Tetherin/TM-CC-GPI are obvious homologs; and (v) some modern 
tm-cc(at) genes have the potential to encode GPI modified proteins and exhibit 
antiviral activity. 
It is clear that the detection of distant homologs is still a challenge for current 
sequence similarity methods. Nevertheless, probabilistic models to detect distant 
homologs (HMMER3 (Finn et al., 2011)) found a significant hit (e-value = 2E-5) 
between coelacanth PV1 and a HMM profile of TM-CC(aT) proteins (Figures 
6.9C and 6.10). This finding, coupled with our observation that the coelacanth 
Tetherin/TM-CC-GPI protein shares significant sequence similarity with the TM-
CC(aT)B protein, might reflect the slow neutral substitution rate in the coelacanth 
(Amemiya et al., 2013). However, we were unable to detect sequence similarity 
between Tetherin, or TM-CC(aT), and PV1 in another apparently slowly evolving 
species such as turtle (Shaffer et al., 2013), although there are residual levels of 
similarity between turtle Tetherin and TM-CC(aT) (Figure 6.9A).  
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Presumably, following acquisition of sequences specifying a GPI anchor, nascent 
Tetherin/TM-CC-GPI sequences were optimized in various species through 
positive selection pressures imposed by past viruses in order to enhance its 
potency and/or to avoid viral antagonists. Therefore, while it is intuitive to expect 
sequence similarity between proteins that have a common ancestor, our findings 
reveal that the lack of sequence similarity between tetherin genes in most 
species should be expected since initial genetic drift and subsequent positive 
selection for some fraction of ~450 MYA, appeared to have erased sequence 
similarity within its orthologs in other species to nearly the same degree as its 
sister genes, ultimately resulting in extreme diversity of Tetherin/TM-CC-GPI 
proteins and its previous classification as an orphan gene in modern vertebrates. 
In the absence of sequence similarity, the occurrence of TM-CC-GPI protein-
encoding genes in syntenic vertebrate genomic positions neighboring other TM-
CC protein-encoding genes is the strongest single piece of evidence that modern 
tetherin/tm-cc-gpi genes share a common ancestor. The conservation and 
essential function of pv1 strongly suggests that it was present in the vertebrate 
ancestor, with one or two duplications of it giving rise to tm-cc(at) and/or 
tetherin/tm-cc-gpi in the various vertebrate lineages. The strong antiviral effect of 
some GPI-modified TM-CC(aT) proteins, the homology between coelacanth TM-
CC(aT)B and functional Tetherin/TM-CC-GPI proteins, and the shared gene 
structure suggest that most modern Tetherin proteins arose from TM-CC(aT)-like 
proteins. One possible model for the genesis of tetherin/tm-cc-gpi genes is that 
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pv1 duplicated first into pv1–tm-cc(at). Subsequent tm-cc(at) duplication yielded 
pv1–tm-cc(at)–tetherin/tm-cc-gpi resulting in a single common tetherin/tm-cc-gpi 
ancestor that was derived from tm-cc(at) prior to the division of sharks from other 
jawed vertebrate lineages (Figure 7.3A). In this model, gene loss and 
rearrangement events in sharks, ray-finned fish and amphibians would give the 
modern genome configurations, with sequence homology between tetherin/tm-
cc-gpi and the ancestral tm-cc(at) detected only in the coelacanth lineage. Our 
finding that all vertebrate Tetherin/TM-CC-GPI proteins tested exhibit potent 
antiviral activity fits in this model and suggest that tetherin/tm-cc-gpi 
neofunctionalization occurred early during vertebrate evolution, prior to the 
division of sharks from other vertebrate lineages.  
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Figure 7.3: Possible evolutionary scenarios for the emergence of 
tetherin/tm-cc-gpi genes in the pv1–cilp2 locus. 
(A) tetherin/tm-cc-gpi originated once, prior to the division of sharks from other 
jawed vertebrate lineages via sequential duplications of pv1 and tm-cc(at). (B) 
tetherin/tm-cc-gpi originated independently in multiple vertebrate lineages via 
duplications of pv1 and tm-cc(at). This figure was kindly provided by Dr. Paul D. 
Bieniasz. 
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Figure 7.3. Possible evolutionary scenarios for the emergence of 
tetherin/tm-cc-gpi genes in the pv1–cilp2 locus. (A) tetherin/tm-cc-gpi 
originated once, prior to the division of sharks from other jawed 
vertebrate lineages via sequential duplications of pv1 and tm-cc(at). (B) 
tetherin/tm-cc-gpi originated independently in multiple vertebrate lineages 
via duplications of pv1 and tm-cc(at). This figure was kindly provided by 
D . Paul D Bieniasz.!
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However, it is not necessarily the case that a single ancestral tetherin/tm-cc-gpi 
gene arose in vertebrates on one occasion and gave rise to all modern 
Tetherin/TM-CC-GPI proteins. Another possible model would be one where pv1 
duplicated into pv1–tm-cc(at) in the sarcopterygiian ancestor (lobe-finned fish 
and terrestrial vertebrates), after the separation of sharks and ray-finned fish. 
Thereafter, an independent pv1 duplication in sharks, and separate tm-cc(at) 
duplication events in coelacanths and various amniote lineages yielded 
tetherin/tm-cc-gpi genes in their modern configurations (Figure 7.3B). In this 
model, it is implausible that tm-cc-gpi genes could have arisen on multiple 
occasions in nearly the same genomic location, unless they are indeed 
duplications of proximal TM-CC genes (pv1 or tm-cc(at)).  
While PV1 is essential for mouse viability, and its function in the generation of 
diaphragms in caveolae, fenestrae and transendothelial channels has been 
elucidated (Stan et al., 2012), the function of TM-CC(aT) proteins is unknown. 
RNA-Seq data suggests that it is poorly or rarely expressed in humans, however 
we were able to detect a spliced mRNA species in 7-day old mouse embryos. 
The apparent absence of tm-cc(at) in opossums, as well as in fish and shark 
lineages suggests that it does not play an essential role in the life of cells. 
Notably, some versions of tm-cc(at), like pv1, encode a proline rich-C terminus, 
others are predicted to encode a GPI anchor, and still others have no defining C-
terminal feature. It is then plausible that tm-cc(at) has different functions in 
different species. It is also possible that tm-cc(at) was, or might still be a 
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functional tetherin in some species, particularly since some reptile tm-cc(at) 
genes have the potential to encode a protein with potent antiviral activity. Our 
results suggest a key role for the loss or acquisition of splicing signals in the 
genesis of Tetherin proteins encoding the critical C-terminal GPI anchor. 
To our knowledge, the pv1–tm-cc(at)–tetherin cluster is the only known gene 
triplet whose members share structural, but not sequence similarity with their 
sister genes, and have unrelated functions. However, Tetherin is unusual in that 
its biological function can be attributed largely to its unique TM-CC-GPI dual-
anchored topology, rather than to its specific amino acid sequence. Therefore, 
the modular structure and rather simple function of Tetherin appears to have 
resulted in an unusual combination of extreme robustness and evolvability that 
first led to its genesis from a protein of unrelated function, and then enabled it to 
adapt to evade viral antagonists while maintaining antiviral activity. These 
findings highlight the key role of genomic duplication as a raw material for genetic 
innovation. Moreover, predicted structure comparisons, synteny and functional 
analyses might serve as valuable approaches for revealing the evolutionary 
history of other orphan genes. 
In the present work we have identified the ERV diversity in primate and murine 
genomes, reconstruct ancestral infectious retroviruses and characterized how 
past viral infections have driven the evolution of host antiviral proteins. Overall, 
this study highlights the stunning potential of the retroviral “fossil record” to 
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uncover new biological processes and how the combination of in silico and in 
vitro analyses can answer profound evolutionary questions. 
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